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Stroke due to intracerebral haemorrhage (ICH) is the most devastating and least treatable 
type of stroke, where onset is sudden, often leaving the individual and family ill-prepared to 
deal with the long-term consequences. Associations between cognitive impairment and 
ischaemic stroke have been well described in the literature however fewer data are available 
for ICH and cognitive impairment. Although some studies have investigated the prevalence 
and risk factors of cognitive decline before and after ICH, very little is known about the 
influence of cognitive decline on functional outcome after ICH. Furthermore, there have been 
no qualitative studies designed specifically to examine the experiences of people living with 
cognitive impairment after intracerebral haemorrhage. 
 
Aims 
To explore the outcomes and experiences of people living with cognitive impairment and 
intracerebral haemorrhage:  
 (a) To study the prevalence of pre-existing dementia and cognitive impairment in patients 
with ICH, and to quantify their incidence at specific time points thereafter,  
(b) To investigate the demographic, clinical, radiographic and functional outcomes associated 
with the occurrence of cognitive impairment following an ICH, and  
(c) Evaluate the experience of life after ICH with cognitive impairment.   
 
Methods 
(a) A retrospective analysis of all patients diagnosed with ICH in one region of Scotland 
between June 2010 and May 2013, who had available CT data from the time of the index ICH 
(n=404), was conducted. Data were taken from the Lothian Audit of the Treatment of 
Cerebral Haemorrhage, including people aged ≥ 16 years at the time of diagnosis. Data on 
demographics, medical history, and medication was drawn on. In addition to determining the 
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prevalence and risk factors of pre-existing cognitive decline, survival analysis was used to 
determine cumulative rates of patients remaining free of cognitive decline up to 5 years after 
their ICH (LATCH COG).    
(b) A prospective observational cohort sub-study (LINCHPIN COG) of adults with ICH (n=45) 
was conducted using a detailed assessment of cognition and functional outcomes at 6 and 
12-24 months after ICH. Pre-existing cognitive decline was measured using the IQCODE 
informant questionnaire, whilst also collecting basic demographic data, data on vascular risk 
factors, stroke severity, level of dependency, and neuroimaging features on computed 
tomography and magnetic resonance imaging. The primary outcome was new-onset 
cognitive impairment (defined as MoCA score <26) at 6 months, when functional outcomes 
(depression, fatigue, health-related quality of life) were also measured.  
(c) In an embedded qualitative study, six ICH survivors and four family members participated 
in semi-structured interviews and gave details about their experiences of life after ICH. The 
data collected was analysed using a thematic analysis approach. 
 
Results 
(a) Using data from LATCH COG, I found that roughly 1 in 4 (23%) patients had cognitive 
decline prior to their ICH. Forty-one patients (10%) had cognitive impairment with no 
dementia. Fifty-two patients met the criteria for pre-existing dementia (13%).  
In univariate analysis of LATCH COG, CT neuroimaging markers of cerebral amyloid 
angiopathy and small vessel disease were associated with pre-existing cognitive decline. In 
logistic regression analysis, patients who had a lobar ICH were twice as likely to exhibit pre-
existing cognitive decline and 3 times more likely to exhibit pre-existing dementia than those 
who had a non-lobar ICH. Patients with central (deep) atrophy were over 4 times more likely 
to exhibit cognitive decline and 8 times more likely to exhibit dementia before their stroke 
than those without. In line with this, severity of white matter changes was associated with 
pre-existing cognitive decline, suggesting a neurodegenerative process. Increasing age and 
larger haemorrhage volume were also associated with an increased likelihood of patients 
having cognitive decline prior to their stroke. 
iii 
 
During the first 5 years of follow-up of LATCH COG, of the 168 patients who survived longer 
than 30-days after their ICH, 47 patients developed new-onset cognitive decline (cognitive 
impairment and dementia). Cumulative survival rates for patients remaining free of cognitive 
decline were 82% in the first year and 65% at 5 years.  
In univariate analysis of LATCH COG, presence of posterior white matter lucencies was 
associated with new-onset dementia, indicating an association with markers of small vessel 
disease. In Cox regression analysis, patients who had a lobar ICH were twice as likely to 
exhibit new-onset cognitive decline than those who had a non-lobar ICH.  In those who 
survived past 30 days, the incidence of new-onset cognitive decline was 37% in patients with 
lobar ICH and 20% in patients with non-lobar ICH.  
(b) Cognitive impairment is frequent after ICH with 43% of participants from LINCHPIN COG 
scoring <26 on the MOCA at 6 months. 
In univariate analysis of LINCHPIN COG, new-onset cognitive impairment at 6 months was 
associated with pre-ICH history of hypertension. I could not detect statistically significant 
associations between new-onset cognitive impairment and functional outcomes at 6 months. 
The small sample size may have been a significant contributory factor, making it difficult to 
identify any statistically significant differences between those with and without cognitive 
impairment 
(c) Thematic analysis of the qualitative interviews identified four overarching themes relating 
to how survivor’s and their family members experienced life after stroke: ‘the effects of 
stroke on sense of self and identity’, ‘adaptions and adjustment’, ‘uncertainty’, and ‘impact 
on family members’. These findings were interpreted in relation to theories of biographical 
disruption and suggest the necessity for individualised assessment of needs and the planning 
of services to best assist stroke survivors in coming to terms with their illness and its long-
term consequences.  
 
Conclusion 
Pre-existing cognitive decline affects more than one-fifth of patients with ICH. For survivors 
of ICH without pre-existing cognitive decline, over two-fifths develop new-onset cognitive 
impairment by 6 months after ICH. Neuroimaging markers of cerebral amyloid angiopathy 
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and small vessel disease were associated with pre-existing and new-onset cognitive decline. 
New-onset cognitive impairment at 6 months was associated with pre-ICH history of 
hypertension. This implies an important role of vascular processes on the pathophysiology of 
post-ICH cognitive decline. The qualitative accounts in this study indicate the devastating 
effect that a stroke due to haemorrhage can have on the lives of survivors and their families, 
with participants often indicating that they could no longer be the person that they were 
before the stroke. These data may help inform patients, their family and caregivers about the 


















Lay Summary  
Imagine waking up one day and not being able to find the words to talk to your family or 
friends? For many, this is the reality of life after stroke. Each year, around 150,000 people in 
the UK have a stroke, which is roughly one stroke every five minutes.   
A stroke is a brain attack. It happens when the blood supply to part of the brain is cut off, 
killing brain cells. There are two main types of stroke: ischaemic and haemorrhagic. Ischaemic 
stroke occurs when a clot is formed and blocks off blood supply to part of the brain. Stroke 
due to bleeding in the brain, also known as a haemorrhage, is the most devastating and least 
treatable form of stroke. Within one month of the haemorrhage over 40% of patients will 
have died. More than half of the people who survive a brain haemorrhage are left dependent 
on family members or carers as a result of the long-term consequences.  
One such consequence might be problems with thinking, known as cognitive impairment. 
Cognitive impairment is an umbrella term for a range of symptoms, including memory loss, 
problems with thinking, and difficulties in speaking, understanding, reading and writing. 
Cognitive impairment can make simple tasks, such as making a cup of tea, very difficult and 
may worsen over time, leading to a diagnosis of dementia. Stroke and cognitive impairment 
are closely related. However, most research in this area has focussed on patients who had 
an ischaemic stroke. 
This is where my PhD comes in. Survivors of stroke due to haemorrhage were given the 
opportunity to take part in a detailed assessment of their cognition at 6 and 12-24 months 
after their stroke. In addition to simply looking at the number of stroke survivors with 
cognitive impairment, participants were also offered the chance to have an MRI scan of their 
brain so that I could look for potential risk factors, for example the location of the bleed and 
how that affects cognitive impairment.  
I found that around 1 in 4 (23%) patients had cognitive impairment before their stroke, and 
over two fifths (43%) developed new cognitive impairments 6 months after their stroke.  
In this study, cognitive impairment seemed to be a consequence of small vessel disease, 
which is caused by the narrowing of small blood vessels deep inside the brain. I also found 
that cognitive impairment was strongly linked to having a history of high blood pressure. 
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Although my findings would support the reduction of cognitive impairment using blood 
pressure lowering tablets, at the moment, relatively little is known about the link between 
high blood pressure, its treatment and cognition impairment.  
However, this is not the full story. We know very little about what having a cognitive 
impairment means to stroke survivors. As such, I decided to carry out interviews with a small 
group of participants to find out whether the cognitive impairments were interfering with 
their daily lives. What I found was that, despite many of the participants having other issues, 
such as problems with mobility or mood, it was often the cognitive impairment that was the 
biggest thing to happen to them.   
No matter whether the participant wanted to be able to say their wife and children’s names, 
learn the skills needed to drive their car, read to their grandchildren or return to paid 
employment, it took hard work, determination and a really good support network. However, 
not everyone had this. Although rehabilitation services in the community were available for 
most, it simply wasn’t enough. Many of the stroke survivors felt abandoned after they left 
hospital and missed out on services that could have supported them to achieve their best 
possible, individual, quality of life. Patients need to feel empowered through tailored support 
and improved rehabilitation. Getting these basic things right could transform the lives of 
many people and their families. 
This is why research like this is so important. By gaining a more comprehensive picture of the 
stroke experience through the use of both questionnaires and interviews, I am hopeful that 
we can use this information to improve services so that we can help more people get back to 
doing the things they love after stroke.
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This thesis aims to explore the outcomes and experiences of people living with cognitive 
impairment and intracerebral haemorrhage. In the first chapter, the reader is provided with 
the relevant background information and is introduced to the wider context of intracerebral 
haemorrhage, definitions for mild cognitive impairment, dementia and vascular cognitive 
impairment, and the differences between quality of life and health-related quality of life. The 
subsequent two chapters provide in-depth literature reviews specifically looking at (1) 
intracerebral haemorrhage and cognitive decline and (2) the influence of cognitive 
impairment on health-related quality of life after stroke. Chapter 4 presents an overview of 
the thesis design, providing the reader with an orientation to the research studies linked to 
this thesis, the overall research design and ethical considerations. Subsequently, the thesis is 
divided into methodology and result chapters, each containing study-specific sections based 
upon the three research objectives. Chapter 11 presents a summary of the principal findings, 
drawing them together with an overall conclusion, followed by clinical implications, 













1. Background: definitions and concepts  
This chapter outlines the relevant background to this thesis. It begins by setting out the 
current context of intracerebral haemorrhage including its incidence, risk factors, diagnosis 
and management. The differences between dementia, mild cognitive impairment and 
vascular cognitive impairment are then laid out and criteria for diagnosis provided. This 
chapter then ends with a brief review of the literature on definitions for quality of life and 
health-related quality of life.  
 
 Stroke and intracerebral haemorrhage  
 Stroke 
Stroke represents a major cause of death globally and is the leading cause of long-lasting 
severe disability (Warlow et al, 2003; Jackman, Cumming and Miller 2016). The World Health 
Organization (WHO) definition of stroke is:  
“rapidly developing clinical signs of focal (or global) disturbance of cerebral 
function, with symptoms lasting 24 hours or longer or leading to death, with 
no apparent cause other than of vascular origin” (Hatano 1976 p. 541).  
The two main categories of stroke are ischaemic and haemorrhagic. 
 
 Intracerebral haemorrhage 
Spontaneous non-traumatic intracerebral haemorrhage (ICH) accounts for around 9-27% of 
all strokes (Feigin et al, 2009). It results from the rupture of blood vessels directly into the 
brain parenchyma, in the absence of trauma or surgery, primarily by leakages from small 
intracerebral arteries. The remainder of strokes are ischaemic in nature and are produced by 
the occlusion of a cerebral artery.  ICH should be distinguished from other types of 
intracranial haemorrhage including subarachnoid haemorrhage (SAH), pure intraventricular 
haemorrhage, subdural haemorrhage and extradural haemorrhage, although an ICH may 
extend into one or more of these compartments (see Figure 1; Al-Shahi Salman, Labovitz and 
Stapf 2009).  The relevance of this distinction is that the risk factors, causes and management 
options for each differ (Al-Shahi Salman, Labovitz and Stapf 2009).   
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Figure 1: Schematic diagram of the brain showing types of intracranial haemorrhage  
(reproduced from Al-Shahi Salman, Labovitz, and Stapf 2009) 
 
 
 Lobar vs non-lobar haemorrhage 
ICH is typically subdivided by location as being either ‘lobar’ or ‘non-lobar’, the latter of which 
is often referred to as deep (see Figure 1). While ICH located deep in the brain is a result of 
the rupture of small arterioles most commonly in the basal ganglia or thalamus, lobar ICH 
results from the rupture of small and medium-sized perforating arteries in the cortex 
(cerebrum) and subcortical white matter (Qureshi, Mendelow and Hanley 2009; Xiong et al, 
2016). It is useful to discriminate between lobar and non-lobar ICH in this way because the 
associated causes, risk factors and likelihood of recurrence differ by location (Bailey et al, 
2001; Woo et al, 2002; Samarasekera et al, 2015).    
Given the distribution of vessels affected, lobar ICH in the elderly is commonly attributed to 
the vessel fragility and rupture caused by cerebral amyloid angiopathy (CAA) and non-lobar 
ICH is usually attributed to hypertension-related arteriolosclerosis (although unlike CAA, this 
can cause ICH anywhere in the brain) (Woo et al, 2002; Smith and Eichler 2006; Viswanathan 
and Greenberg 2011; Charidimou, Gang and Werring 2012). However, since any single ICH is 




 Incidence and prognosis of ICH 
Stroke due to spontaneous ICH annually affects around 3.4 million adults worldwide and has 
a higher risk of morbidity and mortality than ischaemic strokes and subarachnoid 
haemorrhages (Feigin et al, 2015). The age-specific incidence of ICH is stable or decreasing, 
most likely due to better treatment of hypertension, which is the major modifiable risk factor. 
However, almost two-thirds of adults with ICH are aged 75 years or older, therefore incidence 
is likely to become more prevalent in our aging population (Lovelock, Molyneux and Rothwell 
2007). 
The recurrence rate for strokes in survivors of primary ICH is 4.3% per year (Bailey et al, 2001). 
From a systematic review of long-term prognosis after ICH, two studies found that the risk of 
recurrent ICH was higher in patients who had a lobar ICH (10%) when compared with a 
concurrent group of patients with non-lobar ICH (2%) (Poon, Fonville and Al-Shahi Salman 
2014). Rational steps to prevent recurrence include blood pressure reduction and cessation 
of smoking and alcohol use (Chapman et al, 2004; Broderick et al, 2007).  
Two of the greatest challenges for nursing patients with ICH are that 30-day case fatality is 
over 40% and over half the survivors are left dependent on family members or carers, with 
considerable economic consequences (Dennis 2003; Russell et al, 2006; van Asch et al, 2010). 
Despite advances in the treatment of cerebral infarction, there are no effective acute or 
specific treatments for ICH. Better prevention of ICH (first-ever and recurrent) is likely to be 
a more promising strategy to decrease its burden.  
 
 Risk factors and causes 
The major risk factors for ICH are increasing age, male sex, hypertension, smoking, diet, high 
waist-to-hip ratio and high alcohol intake (Ariensen et al, 2003; Pantoni 2010). Many of these 
precipitating risk factors are likely to lead to vascular changes, such as small vessel disease, 
which may in turn cause ICH. Small vessel diseases are a group of pathological processes that 
affect the small blood vessels of the brain and are known to have ischaemic and 
haemorrhagic consequences (Pantoni 2010). SVD is responsible for about a fifth of all strokes 
worldwide and is the most common vascular cause of dementia (Wardlaw, Smith and 
Dichgans 2013; Wardlaw et al, 2013).  
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Approximately 80% of ICH is thought to be caused by SVDs, with hypertension-related small 
vessel disease and cerebral amyloid angiopathy (the build-up of an abnormal protein called 
amyloid in the blood vessels of the brain) being by far the two most common forms (Warlow 
et al, 2008; Pantoni 2010; Samarasekera et al, 2012).  However, diagnosing these during life 
is currently difficult and usually made based on risk factors (e.g. hypertension and age) and 
neuroimaging features (Wardlaw, Smith and Dichgans 2013).  
ICH has traditionally been classified as either ‘primary’ or ‘secondary’.  Primary ICH 
(accounting for 78-88% of cases) is attributed to the spontaneous rupture of small vessels 
commonly thought to be caused by chronic hypertension or CAA (Ikram, Wieberdink, and 
Koudstaal 2012; Smith and Venegas-Torres 2014).  Secondary ICH occurs in a minority of 
patients and is attributable to a variety of structural abnormalities including tumours, 
aneurysms, arteriovenous malformations or impaired coagulation (Qureshi, Mendelow and 
Hanley 2009; Smith and Venegas-Torres 2014).  
 
 Diagnosis  
The only reliable method of detecting ICH in life is early brain imaging (Al-Shahi Salman, 
Labovitz, and Stapf 2009). The widespread availability of computed tomography (CT) and 
rapid acquisition time makes it the ideal first-line diagnostic approach (Qureshi, Mendelow 
and Hanley 2009). CT not only defines the size, location and site of the haematoma, it also 
provides information about extension into the ventricular system, presence of surrounding 
oedema, and shifts in brain contents (Caplan 1992). Within minutes of symptom onset and 
up to one week thereafter, the ICH will appear hyperdense (white) in comparison to the brain 
parenchyma. Acute haematomas are very well defined on CT and have smooth borders. In 
patients who worsen abruptly, repeat CT may show enlargement of the ICH.  
Magnetic resonance imaging (MRI) with gradient echo can reliably differentiate infarction 
from haemorrhage more than one week after stroke onset and is more accurate at detecting 
micro-haemorrhages (Kidwell and Wintermark 2008). MRI can also distinguish ICH from 
haemorrhagic transformation of an infarct using diffusion-weighted imaging and detect 
chronic haemorrhages (Lovelock et al, 2009). However, the use of MRI continues to be limited 
by both its availability and the difficulty of using it in acutely unwell patients who may have 
metal implants, a pacemaker, or are unable to lie flat for the scan duration (Hand et al, 2005). 
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In addition, a Cochrane review comparing the diagnostic accuracy of MRI and CT for acute 
vascular lesions concluded that while the ability of CT to distinguish acute haemorrhagic 
lesions from non-stroke lesions is well established, the accuracy of MRI assessment of 
suspected acute stroke is still somewhat unclear (Brazzelli et al, 2009).   
 
 Management  
Guidelines recommend that patients with ICH should be managed in a stroke unit. Medical 
management includes intensive blood pressure lowering within six-hours of ICH onset, 
intermittent pneumatic compression of the legs in immobile patients with ICH, lowering 
intracranial pressure (if necessary), provision of hydration and nutrition, supportive care and 
the treatment of any medical complications i.e. seizure or infection (Broderick et al, 2007; 
Steiner et al, 2014; Hemphill et al, 2015). It is also recommended that subsequent blood 
pressure-lowering therapy is used for secondary prevention (Steiner et al, 2014). 
As a stroke survivor enters into the rehabilitation phase of their recovery, efforts continue to 
focus on the management of physical health and incorporate additional aspects e.g. self‐care, 
social functioning and interpersonal factors. The consequences of stroke can be far reaching 
and vary dramatically across different individuals. Besides reduced mobility and loss of 
physical functioning, research has shown stroke to impact upon individual’s mental health 
and cause changes in cognitive functioning (Haacke et al, 2006).  
 
 Mild cognitive impairment, dementia and vascular cognitive 
impairment  
 Mild cognitive impairment  
Cognitive impairment is not a singular concept. It incorporates multiple domains including 
attention (maintaining, dividing, shifting or focusing attention on a given stimulus or task, 
and the speed that information is processed); executive function (ability to plan, perform 
abstract reasoning, solve problems, focus despite distractions and shift focus when 
appropriate); visuospatial ability (visual search, drawing, construction); memory (ability to 
learn and recall new information); and language (either comprehension or expression) ( 
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Cumming, Marshall and Lazar 2013). Because the domains are not always independent of 
each other, classification is often difficult- for example, remembering what items you must 
buy at the shops is not just reliant on memory, but also on attention and language as well 
(Cumming, Marshall and Lazar 2013). The accepted ‘gold standard’ for detecting any 
cognitive disturbance is a full battery of neuropsychological tests covering all domains, where 
normative data are used to indicate domain-specific deficits. However, this is not always 
feasible.  
In 2011, the National Institute on Aging and Alzheimer’s Association charged a workgroup 
with the task of revising the core clinical criteria for the diagnosis of mild cognitive 
impairment (MCI) (see Box 1; Albert et al, 2011 p. 272-273). 
Box 1: Core clinical criteria for the diagnosis of MCI 
• Concerns regarding a change in cognition 
• Impairment in one or more cognitive domains 
• Preservation of independence in functional abilities 
• Not demented 
Mild cognitive impairment is generally used to describe the symptomatic pre-dementia 
phase of Alzheimer’s disease. The differentiation of dementia from MCI rests on the 
determination of whether there is significant interference in the ability to function at work 
or in usual daily activities. This is inherently a clinical judgment made by the clinician, based 
on the individual circumstances and the description of daily affairs obtained from the patient 
and a knowledgeable informant.     
 
 Dementia 
Dementia is a syndrome – usually of a chronic and progressive nature – in which there is 
deterioration in cognitive function beyond what might be expected from normal ageing. 
Dementia diagnoses are most commonly based on the Diagnostic and Statistical Manual of 
Mental Disorders IV (DSM-IV) criteria (American Psychological Association 1994). While 
dementia is normally characterised by a gradual decline in memory, this should also be 
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accompanied by disturbance in one of the following cognitive domains for a formal diagnosis 
to be given: language, praxis, gnosis, or executive functioning. For the DSM-IV criteria to be 
fulfilled, the impairment in cognitive function must be accompanied by a significant 
impairment in social or occupational functioning and represent a significant decline from a 
previous level of functioning (American Psychological Association, 1994). It should also be 
noted that memory impairment, although present in most people with dementia, is not an 
essential requirement. Rather, at least two cognitive domains must be impaired (Lopez et al, 
2000). However, in addition to revising the criteria for the diagnosis of mild cognitive 
impairment, the National Institute on Aging and Alzheimer’s Association workgroups also set 
out new clinical criteria for all-cause dementia (see Box 2; McKhann et al, 2011 p. 265-266).    
Box 2: Core clinical criteria for all-cause dementia 
Dementia can now be diagnosed when there are cognitive or behavioural symptoms 
that: 
1. Interfere with the ability to function at work or at usual activities; and 
2. Represent a decline from previous levels of functioning and performing; and 
3. Are not explained by delirium or major psychiatric disorder; 
4. Cognitive impairment is detected and diagnosed through a combination of 
(1) history-taking from the patient and a knowledgeable informant and (2) 
an objective cognitive assessment, either a ‘bedside’ mental status 
examination or neuropsychological testing. Neuropsychological testing 
should be performed when the routine history and bedside mental status 
examination cannot provide a confident diagnosis. 
5. The cognitive or behavioural impairment involves a minimum of two of the 
following domains: 
a. Impaired ability to acquire and remember new information—
symptoms include repetitive questions or conversations, misplacing 
personal belongings, forgetting events or appointments, getting 
lost on a familiar route. 
b. Impaired reasoning and handling of complex tasks, poor 
judgment—symptoms include poor understanding of safety risks, 
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inability to manage finances, poor decision-making ability, inability 
to plan complex or sequential activities. 
c. Impaired visuospatial abilities—symptoms include inability to 
recognize faces or common objects or to find objects in direct view 
despite good acuity, inability to operate simple implements, or 
orient clothing to the body. 
d. Impaired language functions (speaking, reading, writing)—
symptoms include difficulty thinking of common words while 
speaking, hesitations; speech, spelling, and writing errors. 
e. Changes in personality, behaviour, or comportment—symptoms 
include uncharacteristic mood fluctuations such as agitation, 
impaired motivation, initiative, apathy, loss of drive, social 
withdrawal, decreased interest in previous activities, loss of 
empathy, compulsive or obsessive behaviours, socially 
unacceptable behaviours. 
The new criteria were designed to be flexible enough to be used by both general healthcare 
providers without access to neuropsychological testing, advanced imaging and cerebral 
spinal fluid measures, as well as researchers. 
Alzheimer’s Disease (AD) is the most common form of dementia, accounting for up to 60-
70% of cases (Ferri et al, 2005; Kalaria et al, 2008). Pathologically, it is characterised by the 
accumulation of amyloid beta in the brain parenchyma (amyloid plaques) or in the blood 
vessels (cerebral amyloid angiopathy), in addition to the presence of neurofibrillary tangles 
(Querfurth and LaFerla 2010). Second in prevalence is vascular dementia (VaD), which is 
responsible for around 20% of cases and affects more than 140,000 people in the UK each 
year (Gorelick et al, 2011). 
 
 Vascular cognitive impairment  
A variety of classifications, diagnostic criteria, and descriptive syndromes are used to define 
cognitive impairment and dementia occurring after stroke. Vascular dementia has often been 
used as an umbrella term for a group of syndromes (usually relating to an abnormal executive 
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function that interferes with social or occupational functioning) caused by impaired blood 
flow to the brain and damage to the blood vessels resulting from events such as ischaemic or 
haemorrhagic strokes, and transient ischaemic attacks (TIA) (Khan et al, 2016).  
At the severe end of the cognitive spectrum, pooled dementia rates from studies of 
consecutive patients hospitalised with any type of stroke indicate that about one in ten 
patients have dementia before their first stroke, one in ten develop new-onset dementia 
after their first-ever stroke, and more than one in three have dementia after a recurrent 
stroke (Pendlebury and Rothwell 2009).The risk for poststroke dementia is known to be 
highest in the first year, with an estimated incidence of 20-30%, which is nine times greater 
than the risk for the general population (Pendlebury and Rothwell 2009). Prevalence rates 
for cognitive impairment after stroke are substantially higher. In the Canadian Study 
of Health and Aging, 64% of stroke survivors had cognitive impairment, compared to only 
21% of stroke-free controls (Jin et al, 2006). 
The Neuroepidemiology Branch of the National Institute of Neurological Disorders and Stroke 
(NINDS) convened an international workshop with support from the Association 
Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN) to develop a 
research criterion for the diagnosis of VaD (Roman et al, 1993). The NINDS-AIREN clinical 
diagnosis criteria for probable vascular dementia is the most commonly cited in the literature 
and was recommended by the National Institute for Health and Care Guidance (NICE 2006) 
(see Box 3; Roman et al, 1993). 
Box 3: NINDS-AIREN clinical diagnosis criteria for probable vascular dementia 
• Presence of dementia- this is characterised by impairment in memory plus 
impairment in two or more different cognitive domains (i.e. orientation, 
attention, language, visuospatial functions etc). This should be established 
through clinical examination and neuropsychological testing. Deficits should 
also be severe enough to interfere with daily activities. 
• Cerebrovascular Disease- defined by the presence of focal signs on 
neurological examination and by the presence of a relevant cerebrovascular 
disease on brain imaging (i.e. large vessel infarcts or extensive 
periventricular white matter lesions) 
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• A relationship between the above two disorders manifested or inferred by 
the presence of at least one of the following: onset of dementia within 3 
months of a recognised stroke, an abrupt deterioration in cognitive 
functions or fluctuating, stepwise progression of cognitive deficits.  
Traditionally, criteria for diagnosis of VaD are largely based on those used for AD, which does 
not take into consideration those cognitive deficits that are more commonly associated with 
cerebral vascular disease, such as attention and executive function (Jackman, Cumming and 
Miller 2016). In addition, the differentiation between VaD and cognitive impairment (not 
fulfilling criteria for dementia), is usually based on limitations in activities of daily living. In 
stroke survivors with substantial physical impairments, it may be difficult to assess changes 
in activities of daily living related specifically to cognitive problems (Ihle-Hansen et al, 2011). 
Consequently, the term vascular cognitive impairment (VCI) has come to be recognised as a 
far more appropriate concept than VaD (O’Brien et al 2003; Bowler 2005). VCI is defined as a 
syndrome of cognitive impairment associated with a vascular origin (clinical stroke or 
subclinical cerebrovascular insult), where the cognitive impairment affects at least one 
cognitive domain (Hachinski and Bowler 1993).  The term vascular cognitive impairment is 
used to encompass the full spectrum of cognitive deficits, from mild vascular cognitive 
impairment to vascular dementia (Gorelick et al 2011). 
In 2011, the American Heart Association and American Stroke Association formed a working 
group that issued a consensus paper proposing a new diagnostic criterion for vascular 
cognitive impairment (Gorelick et al, 2011; Chertkow et al, 2013). According to the paper, VCI 
should include all stages of cognitive disorders associated with cerebrovascular disease, from 
mild symptoms to dementia. Diagnostic criteria are therefore proposed for vascular 
dementia (probable and possible) and for vascular MCI (probable, possible, and unstable) 
(see Box 4; Gorelick et al, 2011).  
Box 4: Practical approach to the classification of dementia and vascular MCI 
• The diagnosis of dementia must be based on cognitive testing of a minimum 
of four domains (executive/attention, memory, language, and visuospatial 
functions), and requires a decline in cognitive function from a prior baseline 
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in at least two domains that are of sufficient severity to interfere with the 
person’s activities of daily living.   
• Probable vascular dementia requires the examining physician to determine 
that the cerebrovascular disease is the dominant, if not exclusive, pathology 
that accounts for the cognitive deficits.  
• The diagnostic criteria for possible vascular dementia are fulfilled if there is 
evidence of cognitive impairment and a cerebrovascular disease but there 
is no clear evidence of a relationship between the two (temporal, severity 
or cognitive pattern).  
• The diagnostic criteria for probable and possible vascular MCI parallel those 
of probable and possible vascular dementia, with the important exception 
that instrumental activities of daily living should be normal or only mildly 
impaired.  
• The concept of unstable vascular MCI was also introduced to account for 
individuals whose impairment may revert to normal during follow-up. 
Unlike earlier classifications, a diagnosis of VCI does not require the presence of significant 
memory impairment as this is neither the most pronounced nor consistently observed 
cognitive deficit observed after stroke (Cumming, Marshall and Lazar 2013). Vascular 
cognitive impairment can impact the patient’s mental ability, health and daily life, and is a 
major contributor to the burden caused by the long-term consequences of stroke due to 
intracerebral haemorrhage. 
 
 Quality of life vs health-related quality of life 
There is a growing consensus that health related quality of life (HRQOL) is an important 
outcome measure as it reflects the impact of the disease from the perspective of the 
individual and can provide researchers with a more holistic picture of stroke recovery. 
However, there remains some question as to how this concept is best defined and measured 




The term quality of life (QOL) is thought to have derived from the WHO definition of health:  
“a state of complete physical, mental and social well-being not merely the 
absence of disease” (World Health Organization 2014, p1) 
Although many definitions for QOL exist, one point of agreement in the literature is that it is 
a multidimensional construct, comprising several domains. One of the most widely cited 
definitions for QOL comes from the World Health Organization Quality of Life Group. Quality 
of life is defined as an: 
 “individuals’ perception of their position in life in the context of the culture and 
value systems in which they live and in relation to their goals, expectations, 
standards and concerns. It is a broad ranging concept affected in a complex 
way by the person's physical health, psychological state, level of independence, 
social relationships and their relationship to salient features of their 
environment” (WHOQOL Group 1998, p1570).  
This definition reflects the view that QOL refers to a subjective evaluation which is embedded 
in a cultural, social and environmental context. The individual's perception of quality is also 
key to quality of life assessment. Psychological processes, rather than circumstances alone, 
are central to an individual's experience of those aspects of life that contribute to its quality 
and to what extent. 
While QOL is an all-inclusive concept incorporating all factors that are part of an individual’s 
life, HRQOL includes only those factors that are part of an individual’s health (Torrance 1987). 
Health-related quality of life refers to the specific impact of an illness, injury or medical 
treatment on an individual's QOL (Drotar 1998). The term HRQOL is not well defined in the 
literature and most definitions do not sufficiently differentiate the term from quality of life. 
However, although there is no single accepted definition of HRQOL, there is a substantial 
body of literature devoted to discussing and identifying important domains to be included 
within this construct.  Spieth and Harris (1996) describe HRQOL as having four key domains: 
disease state and physical symptoms; functional status (the ability to perform a variety of 
age-appropriate daily activities); psychological functioning; and social functioning (the ability 
to maintain social relations). For this study, HRQOL will therefore be conceptualised as those 
areas of physical, psychological and social functioning that are likely to have been influenced 




This chapter has introduced the reader to the wider context of intracerebral haemorrhage, 
including its incidence, risk factors and diagnosis, and has set the scene for long-term 
management of this condition. An overview of the differences between mild cognitive 
impairment and dementia revealed that the concept of vascular cognitive impairment is the 
most appropriate term for any type of cognitive impairment (from mild cognitive impairment 
to dementia) that is associated with a vascular origin. This chapter then concluded with a 
brief discussion around the definitions for QOL and HRQOL, determining that health-related 
quality of life refers to the specific impact of an illness (such as intracerebral haemorrhage) 
















2. Intracerebral haemorrhage and cognitive decline: a review of 
the literature 
While narrative reviews have highlighted the link between ICH and cognitive decline, there 
have been no literature reviews of cognitive impairment and dementia before and after ICH. 
I have addressed this gap by identifying and gathering all the available primary research on 
cognitive impairment and ICH in adults using thorough search methods. The quality of the 
identified research has been critically evaluated against methodological criteria and the 
results of studies have been systematically brought together in order to provide the best 
possible answer to the research questions.  
 
 Introduction 
For any research to be justified, including literature reviews, the research questions must 
address what is important to patients (Pollock and Berge 2018). Cognitive impairment was 
recently identified as the first of the top ten research priorities relating to life after stroke by 
a priority setting project involving equal contributions from stroke survivors, carers, and 
health professionals (Pollock et al, 2012). Reliable data on long-term outcomes are needed 
to properly inform patients and their families, plan services for care following discharge from 
hospital and to help develop strategies to improve quality of life. 
Stroke and dementia are closely related: they have similar risk factors, and each increases 
the risk of the other. In the systematic review by Pendlebury and Rothwell (2009) (previously 
discussed in Section 1.2.3), dementia appeared to be more frequent after ICH, but there were 
no studies of patients with ICH alone to identify either the specific predictors or the influence 
of the location of ICH, which is a crude indicator of the types of underlying small vessel 
disease.  
Cognitive disorders are frequently seen after ICH yet until recently, very little was known 
about them as most studies had focused on ischaemic stroke survivors. Although three 
narrative reviews have highlighted the link between ICH and cognition, there have been no 
recent literature reviews of cognitive impairment and dementia before and after ICH (Murao, 
Rossi and Cordonnier 2013; Xiong et al, 2016; Planton et al, 2017a).     
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This literature review addresses the following research questions:  
What is the incidence of pre-ICH cognitive impairment and dementia? 
What is the prevalence of post-ICH cognitive impairment and dementia, in the short and 
long term? 




 Eligibility criteria 
Peer reviewed studies were considered eligible for the present review if they met the criteria 
set out in Box 5.  
Box 5: Eligibility criteria 
 Studies were considered eligible if they: 
(1) Assessed cognition in a cohort of patients with symptomatic intracerebral 
haemorrhage using a standardised measure or neuropsychological battery 
OR 
(2) Tested cognition in a group of stroke patients, including some with intracerebral 
haemorrhage, and presented the results according to stroke subtypes 
AND 
(3) Only included participants over 18 years  
(4) Were written in English 
(5) Had been published in a peer-reviewed journal  
Studies were excluded if they: 
(6) Were a case report, dissertation/thesis or article with no primary data i.e. reviews, 
editorials, abstracts etc. 
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 Search strategy 
Studies were identified by searching the databases PubMed, CINAHL, Medline and PsychINFO 
on December 5th, 2017 with the search terms in Box 6. No constraint was placed on year of 
publication. To keep the literature review as up-to-date as possible, a second search was 
performed in November 2018 to look for any studies that had been published in the previous 
year.  
Box 6: search terms 
• ‘cognition’, ‘cognitive’, ‘dementia’ or ‘neuropsychological’ AND  
•  ‘stroke’, ‘poststroke’, ‘prestroke’, ‘haemorrhag*’or ‘hemorrhag*’ NOT  
• ‘subarachnoid’, ‘ischemic’ or ‘ischaemic’.   
After duplicates had been removed, all remaining articles were evaluated based on title and 
abstract. The remaining studies were then read in full and critically evaluated based on 
exclusion and inclusion criteria. The reference lists of selected studies and review articles 
were also examined to find relevant articles that might complement the database search.  
 
 Search results 
The search strategy yielded 4252 articles. After 2747 duplicates had been removed, a further 
1357 studies were excluded after screening the titles and abstracts. Once the remaining 148 
had been read in full, 118 more articles were removed based on the eligibility criteria (the 
majority were removed as they did not present the results according to stroke subtypes). The 
screening of reference lists of included studies produced four additional articles, leaving a 
total of 34 articles for review. The second search, performed in November 2018, identified 
one more study for inclusion (Figure 2).  
Ten studies measured the incidence of dementia or cognitive impairment before ICH (see 
Table 1), 15 provided data on the prevalence of dementia after ICH (see Table 2), and 13 on 
the prevalence of cognitive impairment after ICH (see Table 3). In addition, nine of the studies 
gave details regarding the predictive factors for cognitive decline (see Table 4).  
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 Data synthesis and methodological quality assessment  
Results of the included studies were analysed by making qualitative, descriptive summaries. 
Where possible, this literature review was reported in accordance with the PRISMA 
guidelines (Appendix 1).  
The characteristics of the included articles are presented in Tables 1, 2 and 3. Data collection 
included study design, participant characteristics (including age, sex and number of 
participants), time since stroke, tools used to assess cognitive outcomes and results.  
The methodological quality of all selected studies was assessed using the Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) statement (Appendix 2). It 
consists of 22 items, where each included item was scored one point. Although studies were 
not excluded based on the STROBE quality assessment, it was used to add to the critical 
analysis (Appendix 3).  
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CAMCOG- Cambridge Cognitive Examination; CASI: Cognitive Abilities Screening Instruments; CDT- Clock Drawing Test; DSM-III/IV: Diagnostic and 
Statistical Manual of Mental Disorders, Third and Fourth editions; ICD-10: International Statistical Classification of Diseases and Related Health 
Problems, 10th revision;  MMSE: Mini Mental State Examination; NINDS-AIREN: National Institute of Neurological Disorders and Stroke (NINDS) and the 
Association Internationale pour la Recherche et l’Enseignement en Neurosciences (AIREN) criteria for VaD; NPB: Neuropsychological test battery; TICS: 
Telephone Interview for Cognitive Status; TMT A and B- Trail Making Test A and B; WMS-R: Wechsler Memory Scale-Revised. 
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Table 4: Risk factors for vascular cognitive disorders before and after ICH 
Author, year Is cognitive decline 
assessed pre- or post-ICH?  
Risk factors  
Viswanathan 
et al, 2008  




Pre-ICH In lobar intracerebral haemorrhage:   
Increasing age (OR 1.09 per year; 95% CI 1.02-1.15) 
Less than 8 years of education (OR 8.37; 95% CI 1.91-36.65) 
Cortical atrophy (OR 3.34 per step; 95% CI 1.40-7.96) 
In deep intracerebral haemorrhage:  
Old territorial vascular lesions (OR 4.52; 95% CI 1.18-17.42)  
Leucoaraiosis (OR 4.11 per step; 95% CI 1.73-9.75) 
Liable et al, 
2017 
Pre-ICH Previous stroke or TIA (OR 18.29; 95%-CI 1.945–172.033, p=.011)  
Hematoma volume (OR 0.90 per ml; 95%-CI 0.812–0.991, p=.033) 
Banjeree et al, 
2018 
Pre-ICH Meets modified Boston criteria for probable CAA (OR 4.01; 95% CI 1.53-10.51) 
Increasing CAA score (OR 1.42 per point increase; 95% CI 1.03-1.97) 
Cortical superficial siderosis (OR 4.08; 95% CI 1.28-13.05) 
Garcia et al, 
2013 
Post-ICH  Higher levels of disability at discharge (OR 3.5; 95% CI 1.7-6.9, p<.001) 
Haemorrhage volume (p =.07). 
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Author, year Is cognitive decline 
assessed pre- or post-ICH?  
Risk factors  
Tveiten et al, 
2014 
Post-ICH Age (OR 2.4 per 10 years; p=0.010) 




Post-ICH Previous stroke or transient ischemic attack (β [SE], −0.55 [0.23]; p<0.05) 
Pre-existing cognitive impairment (β [SE], −0.56 [0.25]; p <0.01) 
Severity of cortical atrophy (β [SE], −0.50 [0.19]; p <0.01) 
In patients without pre-existing cognitive impairment:  
Severity of cortical atrophy (β [SE], −0.38 [0.17]; p <0.05) 
Biffi et al, 2016 
 
Post-ICH Early onset dementia: 
Larger hematoma size (hazard ratio [HR], 1.47 per 10-mL increase; 95% CI, 1.09-1.97; p  < .001 for 
heterogeneity) 
Lobar ICH location (HR, 2.04; 95% CI, 1.06-3.91; p  = .02 for heterogeneity)   
Delayed onset dementia: 
Educational level (HR, 0.60; 95% CI, 0.40-0.89; p  < .001 for heterogeneity) 
Mood symptoms (HR, 1.29; 95% CI, 1.02-1.63; p  = .01 for heterogeneity) 
White matter disease (HR, 1.70; 95% CI, 1.07-2.71; p  = .04 for heterogeneity)   
Moulin et al, 
2016 
Post-ICH Whole cohort (lobar and deep): 
Lobar ICH location (subhazard ratio (SHR): 2.22, 95% CI: 1.30–3.79) 
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Author, year Is cognitive decline 
assessed pre- or post-ICH?  
Risk factors  
 Severe leukoaraiosis (SHR for score 3: 2.88, 95% CI: 1.63–5.07) 
History of previous stroke or TIA (SHR: 2.57, 95% CI: 1.43–4.62) older age (SHR per 10- year increase: 1.84, 
95% CI: 1.43–2.38)  
More severe stroke (as recorded by NIHSS) (SHR per 5- point increase: 1.20, 95% CI: 1.05–1.36)  
New stroke or TIA during follow-up (SHR: 3.22, 95% CI: 1.27–8.15) 
 
In subgroup of patients with lobar ICH: 
Severe leukoaraiosis (SHR for score ≥ 3: 2.70, 95% CI: 1.35–5.38) 
Older age (SHR per 10-year increase: 1.75, 95% CI: 1.01–1.11)  
NIHHS score (SHR 1 per 5-point increase: 1.42, 95% CI: 1.16–1.74)  
Increased cortical atrophy score (SHR per 1-point increase: 2.33, 95% CI: 1.25–4.35)  
Pre-existing cognitive impairment (SHR: 3.84, 95% CI: 1.79–8.20) 
 
In patients with brain MRI (lobar and deep): 
Disseminated superficial siderosis (SHR: 7.45, 95% CI: 4.27–12.99) 
Increasing cortical atrophy score (SHR per 1-point increase: 2.61, 95% CI: 1.70– 4.01) 
Higher number of cerebral microbleeds (five or more) (SHR for > 5: 2.33, 95% CI: 1.38–3.94)   
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Author, year Is cognitive decline 
assessed pre- or post-ICH?  
Risk factors  
In patients with brain MRI (lobar only): 
Disseminated superficial siderosis (SHR: 7.25, 95% CI: 3.76–13.97) 
Cortical atrophy (SHR per 1-point increase: 6.68, 95% CI: 2.29–19.50) 
Old macro-haemorrhages (SHR: 3.6, 95% CI: 1.74–7.44) 
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 Findings   
 Cognitive decline before ICH 
Until recent years, most of our knowledge on cognitive decline prior to stroke relied on 
cohorts which only or predominantly included ischaemic strokes (Pendlebury and Rothwell 
2009). Ten studies were found that reported data on pre-existing cognitive decline in patients 
with ICH. Six included intracerebral haemorrhage patients only, while the remaining 4 
included both ischaemic and haemorrhagic stroke sup-types. Pre-existing cognitive decline is 
usually estimated with the Informant Questionnaire of Cognitive Decline in the Elderly 
(IQCODE) (Jorm 1994). This questionnaire is rated by a relative who is asked to compare the 
participant’s ability to perform a list of daily cognitive tasks involving memory, praxis, 
calculation, or reasoning with his or her baseline 10 years prior to the index event. Of the ten 
studies that assessed the frequency of pre-existing cognitive decline in patients with ICH, all 
used the IQCODE.  
In the four studies that reported data on a sub-set of patients with ICH, 940 participants were 
included (116 with ICH and 824 with ischaemic stroke), where the number of participants 
with ICH ranged from 13-46. The small numbers of ICH survivors may be somewhat explained 
by the low frequency (10-15% of all strokes) and high mortality rate (approximately 40% in 
the first month) of ICH.  Prevalence of dementia prior to stroke was 9-24% before 
intracerebral haemorrhage, and 12-23% before an ischaemic stroke (Henon et al, 1997; Barba 
et al, 2001; Klimkowicz et al, 2002; Lefebvre et al, 2005).  
To date, six studies have examined the frequency of pre-existing cognitive decline in cohorts 
purely comprised of intracerebral haemorrhage participants. Four assessed pre-existing 
cognitive impairment (Smith et al, 2004; Rost et al, 2008; Viswanathan et al, 2008; Banjeree 
et al, 2018), and two gave figures for both pre-existing cognitive impairment and dementia 
(Cordonnier et al, 2010; Laible et al, 2017).  
In a recent prospective study which focused on pre-existing cognitive impairment and 
dementia in a consecutive cohort of patients with ICH, cognitive status was assessed within 
48 hours of stroke onset using the short version of the IQCODE (Cordonnier et al, 2010). 
Patients who scored between 53 and 63 were classified as having cognitive impairment 
without dementia, and patients who scored over 63 were thought to have pre-existing 
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dementia. Of 417 consecutive patients, 14% (58 patients) were considered to have cognitive 
impairment before ICH and 16% (65 patients) had pre-existing dementia. Among patients 
with lobar ICH, the prevalence of pre-existing dementia was 23%, compared to 12% in 
patients who had deep haemorrhages, and 9% in the fossa ICH group. In a similar study, Laible 
et al (2017) recruited a cohort of 89 ICH patients in the acute phase of stroke. IQCODE 
indicated cognitive impairment in 16 (18%) patients prior to their ICH, of which 8 (9%) were 
found to have pre-existing dementia.  
Three other studies describing levels of cognitive impairment before ICH have found a 
prevalence of 15% in a cohort of 629 patients (Rost et al, 2008); 20% in a cohort of 49 ICH 
patients meeting the Boston criteria1 for probable or possible CAA (Viswanathan et al, 2008); 
and 23% in a cohort of 182 lobar ICH patients aged 55 years and above (Smith et al, 2004). 
While Smith et al (2004) found more severe white matter disease as seen on CT to be 
independently associated with cognitive impairment before ICH, in the study by Viswanathan 
et al (2008), chronic tissue disruption (as measured by mean apparent diffusion coefficient 
(ADC) on MRI) was the only variable strongly associated with pre-existing cognitive decline. 
Although Viswanathan et al (2008) were unable to find a correlation between MRI markers 
of CAA and pre-existing decline other than mean ADC, this may reflect the small sample size. 
A recent study from Banjeree et al (2018) aimed to investigate the association between 
cognitive impairment before ICH and MRI markers of cerebral amyloid angiopathy. A total of 
166 patients with neuro-imaging confirmed ICH were included in the study. In analysis 
adjusted for clinical and demographic variables, cognitive impairment before ICH was 
statistically significantly associated with meeting the modified Boston criteria for probable 
CAA at presentation, a higher composite CAA score and cortical superficial siderosis.  
Conclusion: In the studies that reported data on a sub-set of patients with ICH, prevalence of 
dementia prior to stroke was similar in both ICH and ischaemic stroke subgroups, with up to 
one in four patients suffering from pre-existing dementia. Studies examining the frequency 
 
1A system that uses clinical, imaging and pathological information to categorise the 
probability of cerebral amyloid angiopathy into 'definite', 'probable' and 'possible' (Knudsen 
et al, 2001) 
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of pre-existing cognitive decline in cohorts purely comprised of intracerebral haemorrhage 
participants found the prevalence of pre-existing cognitive decline to be 14-25%, and pre-
existing dementia 9-16%.  Risk factors for cognitive decline prior to ICH included 
neuroimaging markers for CAA.  
 
 Dementia after ICH 
Fifteen studies have reported data on dementia after ICH. Three included intracerebral 
haemorrhage patients only, while the remaining 12 included both ischaemic and 
haemorrhagic stroke sup-types.  
Within the twelve studies that reported data on dementia after stroke in a small subgroup of 
patients with ICH, 5,005 participants were included (504 with ICH and 4,501 with ischaemic 
stroke), where the number of participants with ICH ranged from 4-266 (de Koning et al, 1998; 
Barba et al, 2000; Madureira, Guerreiro and Ferro 2001; Henon et al, 2001; Tang et al, 2004; 
Altieri et al, 2004; de Koning et al, 2005; Khedr et al, 2009; Ihle-Hansen et al, 2011; Bejot et 
al, 2011; Arauz et al, 2014; Chaudhari et al, 2014).  
Within these studies, the incidence of dementia after stroke was 5-44% for ICH patients, and 
6-77% for ischaemic stroke patients. However, five studies did not exclude pre-existing 
cognitive decline, allowing for a possible overestimation in the prevalence of new-onset 
dementia. In addition, the timing and methods for cognitive assessments varied. One study 
assessed cognition in the first month after stroke; nine between 3 months and 1 year; and 
two between 1 and 4 years. With regards to the methods of assessment: 9 studies performed 
detailed cognitive testing using a comprehensive neuropsychological test battery and the 
remaining three studies used a variety of brief cognitive assessments.          
To date, only three studies dedicated to patients with ICH have reported data on dementia 
prevalence (Garcia et al, 2013; Moulin et al, 2016; Biffi et al 2016). In a single centre 
retrospective study, among the 78 ICH survivors who were recruited, 48 underwent a 
comprehensive neuropsychological assessment (Garcia et al, 2013). At a mean follow-up 
time of 41 months, dementia was observed in roughly one in four patients according to the 
DSM-IV (23%). In bivariate analysis, possible risk factors for dementia were haemorrhage 
volume, residency in a nursing home and higher levels of disability (Rankin score of more 
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than 1). Cognitive impairment without dementia was seen in 37 patients (77%) and was 
diagnosed when patients showed a significant impairment in one cognitive domain without 
significant impairment to activities of daily living.  Although this study is of value, only one 
patient was identified as having pre-existing dementia. It is likely that this number was 
underestimated due to the use of a retrospective, cross-sectional design.  
A recent prospective observational study with a median follow-up of 6 years recruited a 
cohort of 218 ICH survivors without pre-existing dementia (Moulin et al, 2016). The incidence 
of new-onset dementia was 14% within the first year, 20% at 2 years, 24.5% at three years, 
and 28% at 4 years. Interestingly, the incidence of new-onset dementia was more than two 
times higher in patients with lobar (23·4%) versus non-lobar (9·2%) intracerebral 
haemorrhage. This difference emerged when patients were first assessed at 6 months after 
stroke onset, suggesting that the initial stroke may have been the main contributor to 
dementia soon after onset. For patients who developed dementia later during follow-up, 
dementia incidence rates were similar between lobar and non-lobar ICH. This is likely to be 
attributable to the underlying small vessel diseases (Al-Shahi Salman et al, 2016).  
In addition to lobar location of the ICH, multivariable analysis in the whole cohort identified 
severe leukoariosis, history of previous stroke or TIA, older age, more severe stroke (as 
recorded by NIHSS) and the occurrence of any new stroke or TIA during follow-up as 
independent risk factors for new-onset dementia.  
Moulin et al (2016) also investigated radiographical biomarkers in patients with available 
brain MRI data (188 patients) and found that disseminated superficial siderosis, increasing 
cortical atrophy score and a higher number of cerebral microbleeds (five or more), were 
independently associated with dementia. When this analysis was repeated in the subgroup 
of patients with lobar ICH, the results revealed that disseminated superficial siderosis, 
cortical atrophy and old macro-haemorrhages were risk factors for new-onset dementia. 
Although the results were fairly consistent between the whole cohort of patients with MRI 
and those with lobar ICH, we were not told whether small vessel disease biomarkers on brain 
MRI differed between lobar and non-lobar intracerebral haemorrhage (Al-Shahi Salman et al, 
2016). 
Most recently, Biffi et al (2016) recruited 738 participants without pre-existing dementia to 
a longitudinal study comparing risk factors for early and delayed dementia after ICH. 
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Cognitive performance was measured using the modified Telephone Interview for Cognitive 
Status (TICS- a brief test of cognitive function that can be performed over a telephone 
interview) test at 3 and 6 months after ICH, and then every 6 months thereafter in a subset 
of patients for whom long-term follow-up data were available (mean follow-up duration of 
47 months). In this study, dementia was characterised by a low TICS score or an ICD-9 code 
(a system used by physicians to classify and code diagnoses and symptoms) consistent with 
dementia. Early dementia was defined as an onset within the first 6 months after ICH, with 
delayed dementia being an onset beyond that time. Among the 738 patients, 140 (19%) 
developed dementia within the first 6 months. Patients without dementia at 6 months (435 
patients) were then followed up longitudinally with an estimated yearly incidence of 
dementia of 5.8%. Two hundred and seventy-nine of the 738 (37.8%) participants developed 
dementia at some point during follow-up. Most notable however were the differing risk 
factors for early vs late dementia. Large haematoma size and lobar location of ICH were 
identified as risk factors for early (but not delayed) incident dementia, reflecting the findings 
of Moulin et al (2016) which suggested that the initial stroke may have been the main 
contributor to early onset dementia. Level of education, white matter disease (as seen on 
CT) and history of a mood disorder, were important in predicting delayed dementia. Although 
the definition of dementia may have resulted in an overestimation of its incidence, these 
findings emphasise that dementia, or at the very least cognitive decline, is a common 
complication after ICH. Risk of delayed onset dementia had little to no association with the 
acute bleeding event. The delayed onset in a large percentage of individuals suggest that ICH 
may be a marker of an underlying process as opposed to an event that precipitates worsened 
decline.   
 Conclusion: Within the twelve studies that reported data on dementia after stroke in a small 
subgroup of patients with ICH, the incidence of dementia after stroke was higher in the 
ischaemic stroke subgroup. In the three studies dedicated to patients with ICH, dementia was 
observed in 23-38% of patients (mean follow-up time of 4 years). In one of the studies, the 
incidence of new-onset dementia was more than two times higher in patients with lobar 
versus non-lobar intracerebral haemorrhage. Risk factors for dementia after ICH suggest that 
that the initial stroke may have been the main contributor to early onset dementia while late-




 Cognitive impairment after ICH 
Ten additional papers were identified that investigated the prevalence and risk factors for 
cognitive impairment after stroke in ICH patients (Patel et al, 2002; Tang et al, 2006; Nys et 
al, 2007; Zhang et al,, 2012; Douiri, Rudd and Wolfe, 2013; Tveiten et al, 2014; Jacquin et al, 
2014; Qu et al, 2015; Benedictus et al, 2015; Planton et al, 2017b).  Seven of these studies 
included both ischaemic and haemorrhagic stroke sub-types, while the remaining three only 
recruited participants with ICH.  
From the seven studies investigating the prevalence of cognitive impairment after an 
ischaemic or haemorrhagic stroke, a total of 3,794 participants were recruited (400 with ICH 
and 3,394 with ischaemic strokes). Prevalence of cognitive impairment ranged from 25-87% 
after ICH, and 22-80% after ischaemic stroke. Once again, timing and methods of assessment 
varied between studies. One study assessed cognition at 1-2 weeks; five assessed 
participants at 3 months; and one at 4.5 years after the index event. While two studies relied 
solely on brief cognitive assessments for their diagnosis of cognitive impairment, one study 
made use of a full neuropsychological test battery and four studies used a combination of 
brief assessments. Two studies did not exclude pre-existing dementia prior to assessment.  
In addition to the study by Garcia et al (2013) (described above), only three further studies 
could be found that investigated the frequencies and patterns of cognitive impairment after 
stroke in a dedicated ICH cohort (Tveiten et al, 2014; Benedictus et al, 2014; Planton et al, 
2017b). In a Norwegian study which aimed to assess long-term functional outcome after ICH, 
among the 44 patients with ICH that could be assessed with the Montreal Cognitive 
Assessment (MoCA), 61% reported cognitive impairment during follow-up (median follow-
up time 3.8 years) (Tveiten et al, 2014). Factors independently associated with cognitive 
impairment were age and lobar ICH location. However, data on cognition before the ICH were 
not available. 
A prospective study was recently conducted to determine prognostic factors for cognitive 
decline in ICH patients (Benedictus et al, 2015). At 6 months after stroke onset, 167 patients 
without pre-existing dementia were followed up for a median time of 4 years. Thirty-seven 
percent of patients exhibited cognitive decline during follow-up, where the annual change in 
Mini Mental State Examination (MMSE) scores was used as a marker of cognitive loss. 
Multivariate analysis showed that previous stroke or TIA, pre-existing cognitive impairment 
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and severity of cortical atrophy were all independent prognostic factors for cognitive decline. 
In patients without pre-existing cognitive impairment (139 patients), cerebral cortical 
atrophy was the only prognostic factor for cognitive decline after ICH. Interestingly, ICH 
characteristics (i.e. volume, location, multiple ICHs) were not associated with cognitive 
decline. Instead, the authors demonstrated that the risk of cognitive decline after ICH was 
associated with factors already present before the ICH occured.  One of the limitations of this 
study was the use of the MMSE as an outcome measure. Although the MMSE is a widely 
accepted test for the evaluation of cognition in the elderly, it may lack the sensitivity to assess 
for vascular cognitive impairment.    
Finally, a recent study by Planton et al (2017b) aimed to investigate the frequency and 
patterns of vascular cognitive disorders in patients with CAA related and deep ICH. They 
recruited 20 lobar ICH patients with possible or probable CAA (according to the modified 
Boston criteria), and 20 deep ICH patients. Mild (decline in one or more cognitive domains, 
with test performance between 1 and 2 standard deviations below the norm) and major 
(decline in one or more cognitive domains, with test performance 2 or more standard 
deviations below the norm) vascular cognitive disorders were observed respectively in 87.5% 
and 2.5% of all ICH patients. Every patient in the CAA group had mild vascular cognitive 
disorders. However, no significant difference was observed in cognitive functioning between 
the two ICH groups.  
Conclusion: From the seven studies investigating the prevalence of cognitive impairment 
after an ischaemic or haemorrhagic stroke, prevalence of cognitive impairment was similar 
in both ICH and ischaemic stroke subgroups, where up to four-fifths of patients had cognitive 
impairment after their stroke. Of the four studies that could be found that investigated 
cognitive impairment after stroke in a dedicated ICH cohort, the frequency of cognitive 
impairment ranged from 37-88%. An assessment of risk factors among this group indicated 
that the risk of cognitive decline after ICH was associated with factors already present before 







From the available literature on cognitive decline before ICH, data suggest that pre-existing 
cognitive impairment and dementia are not uncommon. The finding that the prevalence of 
pre-existing dementia was seen more frequently in patients with lobar ICH is an interesting 
one. In the study by Cordonnier et al (2010), available post-mortem data from 4 patients with 
pre-existing dementia and lobar haemorrhages confirmed definite CAA associated with 
Alzheimer’s Disease pathology. In the one autopsied patient with pre-existing dementia and 
deep ICH, severe small vessel disease was found without Alzheimer’s Disease or CAA, 
enabling a diagnosis of pure vascular dementia. Although only 5 patients with pre-existing 
dementia were autopsied, these findings support the notion that pre-existing dementia may 
be the consequence of the different underlying pathologies; a vascular process in non-lobar 
ICH and Alzheimer’s Disease pathology with CAA in lobar ICH. These findings are echoed in 
the study from Banjeree et al (2018) who found that MRI neuroimaging markers of CAA were 
associated with pre-ICH cognitive impairment. This would appear to provide evidence that 
the small vessel disruption caused by CAA makes an important contribution to pre-existing 
cognitive impairment.   
From the studies assessing risk factors for cognitive impairment and dementia after ICH, most 
factors were already present when the ICH occurred.  Although there may be a haematoma 
volume effect on cognition in the acute stage, in the long-term it seems to be a process of 
ongoing cognitive impairment. The underlying small vessel disease that caused the bleeding, 
rather than the bleed itself, may therefore be responsible for future development of 
cognitive decline. 
This literature review benefited from thorough ascertainment of a large number of relevant 
studies, using multiple electronic databases, in an attempt to be comprehensive and avoid 
reporting bias. Studies underwent a comprehensive critical appraisal and judgement relating 
to whether there were any potential risks of bias within the study. The average 
methodological quality score was 20, with most studies attaining a methodological score of 
between 20 and 22, suggesting that the quality and reporting of included studies was at a 
high standard.  
In the most recent narrative review from Planton et al (2017a), the authors concluded that 
future ICH outcome research should include longitudinal and extensive cognitive 
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examinations, which separate the acute bleeding events from any potential underlying 
disease process. The researchers also emphasised the need for future studies to investigate 
behavioural, mood and quality of life data in ICH, as these are currently lacking.   
In addition to the above, there have been no qualitative studies designed specifically to 
examine cognitive decline after ICH. Performance on cognitive assessments is not likely to 
capture the full experience of cognitive impairment. Qualitative interviews with ICH survivors 
and their carers could help provide much needed insight into the lived experience of 

















3. The influence of cognitive impairment on health-related 
quality of life after stroke: a review of the literature 
Although many studies have sought to investigate the potential impact that cognitive 
impairment can have on health-related quality of life after stroke, an overview of this 
literature is still lacking. I have addressed this gap by identifying and gathering all the 
available primary research investigating the relationship between cognitive impairment and 
HRQOL after stroke using thorough search methods. The quality of the identified research 
has been critically evaluated against methodological criteria and the results of studies have 
been systematically brought together in order to provide the best possible answer to the 
research question.  
 
 Introduction 
Traditionally, studies researching the long-term consequences of stroke have focused their 
attention on clinical outcomes such as recurrent stroke and survival. Although this is of great 
importance to physicians and other healthcare professionals, in recent years, researchers 
have begun to select outcomes that matter most to patients and their families (Pollock et al, 
2012; Carod-Artal et al, 2000; Rincon 2013). Health-related quality of life  refers to those 
aspects of quality of life affected by disease. HRQOL can be drastically reduced after stroke 
given its sudden nature and the inability of patients and their families to adjust and cope with 
the long-term complications. There is a growing consensus that HRQOL is an important 
outcome as it reflects the impact of the disease from the perspective of the individual and 
can provide researchers with a more holistic picture of stroke recovery (Christensen, Mayer 
and Ferran 2009).  
Many factors are thought to influence quality of life after stroke. Studies assessing HRQOL in 
stroke patients have identified: depression, fatigue, social support, functional status, motor 
impairment, anxiety, disability, dementia, neglect, stroke severity, age, incontinence, female 
sex, social participation, reduced activities of daily living, side of lesion, number of co-
morbidities and cognitive impairment as determinants of poor quality of life (King, 1996; 
Carod-Artal et al, 2000; Sturm et al, 2004; Haacke et al, 2006; Patel et al, 2007; Franceschini 
et al, 2010; Hilari et al, 2010; Howitt et al, 2011; Meyer et al, 2010; Kreiter et al, 2013; Tjahjadi 
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et al, 2013; Dhamoon et al, 2014; Chen-Min et al, 2015). Although many studies have sought 
to investigate the impact of cognitive impairment on HRQOL after stroke, an overview of this 
literature is still lacking. The only available review describing the influence of cognitive 
impairment on HRQOL in this cohort did not focus on stroke, but rather neurological disease 
in general, and consequently missed some of the relevant studies (Mitchell et al, 2010). 
Although the focus of this thesis is intracerebral haemorrhage, due to the lack of available 
literature (no studies could be found assessing the relationship between cognitive 
impairment and HRQOL with a dedicated intracerebral haemorrhage cohort), this review has 
included all stroke sub-types. This literature review therefore addresses the following 
research question:  
What is the relationship between cognitive impairment and HRQOL after stroke?  
 
 Methods 
 Eligibility criteria 
Peer reviewed studies were considered eligible for the present review if they met the criteria 
set out in Box 7.  
Box 7: Eligibility criteria 
Studies were considered eligible if: 
(1) More than 50% of the study population had a stroke  
(2) All participants were over 18 years  
(3) One of the outcomes was HRQOL, assessed using a standardised measure  
(4) One of the determinants studied had to give an indication of cognitive 
impairment, assessed with a standardised measure or neuropsychological 
battery 
(5) The article was written in English  
(6) They were published in a peer-reviewed journal  
Studies were excluded if they: 
(7) Were a case report, dissertation/thesis or article with no primary data i.e. 
reviews, editorials, abstracts etc 
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 Search strategy 
Studies were identified by searching the databases PubMed, Embase, CINAHL and PsychINFO 
on September 11, 2017. No constraint was placed on year of publication. The search 
combined a ‘stroke’ domain with a ‘HRQOL’ outcome and ‘cognitive impairment’ 
determinant (see Box 8). 
Box 8: Search terms 
• cognitive impairment OR memory OR dementia OR cognit* OR MMSE OR mini-
mental state examination (Abstract) AND 
• stroke OR strokes OR CVA OR CVAs OR vascular accident OR vascular accidents OR 
cerebrovascular OR brain infarction OR brain infarctions OR cerebral infarction OR 
cerebral infarctions OR ischemic OR ischaemic OR haemorrhage OR hemorrhage 
OR poststroke OR poststroke (Title) AND 
• quality of life OR QOL OR life quality OR life qualities OR health-related quality of 
life OR HRQOL OR perceived health OR health status OR wellbeing OR well-being 
(Abstract) 
After duplicates had been removed, all remaining articles were evaluated based on title and 
abstract. The remaining studies were then read in full and critically evaluated based on 
exclusion and inclusion criteria. The reference lists of selected studies were also examined to 
find relevant articles that might complement the database search.  
 
 Search results  
The search strategy yielded 2402 articles. After 1202 duplicates had been removed, a further 
1089 studies were excluded after screening the titles and abstracts. Once the remaining 111 
had been read in full, 63 more articles were removed based on the eligibility criteria. The 
screening of reference lists of included studies produced six additional articles, leaving a total 
of 54 articles for review (Figure 3). 32 studies measured global cognitive functioning against 
overall HRQOL score (see Table 5), while the remaining 22 studies assessed cognitive and/or 




 Data synthesis and methodological quality assessment 
Results of the included studies were analysed by making qualitative, descriptive summaries.  
Where possible, this review has been reported in accordance with the PRISMA guidelines 
(Appendix 1). 
The characteristics of the included articles are presented in Tables 5 and 6. Data collection 
included study design, participant characteristics (including age, sex and number of 
participants), time since stroke onset (follow-up), outcome measures and results.  
The methodological quality of all selected studies was assessed using the Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) statement (Appendix 2). Each 
item was scored one point, with the maximum possible score being 22. Although studies 
were not excluded based on the STROBE quality assessment, it was used to add to the critical 
analysis (Appendix 4).  
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Removed duplicates  
(n = 1202) 
Total (n = 1200) 












Total (n = 111) 
Removed after screening 
title/abstract  
(n = 1089) 
Total (n = 48) 
Total (n = 54) 
Removed after screening 
full-text (n = 63) 
 
Added after screening 
references  
(n = 6) 
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and setting   






(β) or odds ratio (OR)  
STROBE 











Home assessment   
249 68.6  
(± 9.9) 
57% 3 months SIS v2.0 MoCA r = 0.421 









163 67.5  
(± 10.7) 









1572 69  
(± 12) 
60% 90 days EQ-5D MMSE 
TICS 
r = 0.507 (MMSE) 









and setting   






(β) or odds ratio (OR)  
STROBE 












Outpatient   
77 57.3  
(± 17.2) 
52% NR SS-QOL MMSE r = 0.4  























71% nr SS-QOL-12 
SS-QOL-8 
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STROBE 














Home assessment  
56 72.1  
(± 13.9) 
73% 3 and 12 
months 
AQOL NPB β = -0.103 















MMSE β = 0.05 
p = 0.04 
20 
Dhamoon, 





2870 63.4  
(± 10.7) 
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528 68.0  
(± 11.9) 
54% 2 and 12 
months 
EQ-5D  MMSE β = 0.0009 



















77 71.7  
(± 11.3) 
45% 4 years EQ-5D 
EQ VAS   
HUI2/3 
MMSE β = 0.016 (HUI2)  
β = 0.026 (HUI3) 
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(β) or odds ratio (OR)  
STROBE 





























52 67.1  
(±13.9) 
48% 3 years  WHOQOL-
BREF 
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STROBE 














35 55.3  
(± 3.8) 
71% 3, 6 and 
12 
months 









97 63.2  
(± 14.6) 






188 72.3  
(± 9.4) 





AMT β = -0.114 








113 49.4  
(± 13.0) 
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(β) or odds ratio (OR)  
STROBE 















6 and 12 
months 









91 61.6  
(± 13.2) 
52% 1 week 
and 7.5 
months  
SS-QOL  NPB  β = -0.261 









100  69  
(± 7) 
72% 3 months EQ-5D NPB r = 0.29 
p <0.05 (poststroke 
dementia) 
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(β) or odds ratio (OR)  
STROBE 












99 53.6  
(± 12.2) 
17% 3 and 12 
months  


















MoCA r = -0.479 










125 61.8  
(± 10.4) 
61% 1 and 3 
months 
SF-36 CNS OR = 5.72 
p = 0.008 (1) 
OR = 3.17 
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(β) or odds ratio (OR)  
STROBE 














114 58.2  
(± 14.2) 
68% NR SS-QOL MMSE β = 0.047 
p <0.001  
15 
Scott, R.B 
UK 2008  
Randomised, 
controlled trial;  
SAH; 
Outpatient 











232 52  
(± 13) 
29% 3 and 12 
months 







and setting   






(β) or odds ratio (OR)  
STROBE 












17 76.3  
(± 10.5) 
47% NR Japanese 













1181 52.3 NR 1 year SIP NPB OR = 8.4 (adjusted) 
p < 0.001 
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190 72.5  
(± 8.7) 
67% 15.6 years  SF-36 
EQ-5D 





AMT- Abbreviated Mental Test; AQOL- Assessment of QOL scale; CAMCOG-Cambridge Cognitive Examination for the elderly; CNS- Canadian 
Neurological Scale; CSI-D- Community screening instrument for dementia; EQ-5D- EuroQOL-5D; EQ VAS- EuroQOL visual analogue scale; FLP- Functional 
Limitations Profile; HUI 2/3- Health Utility Index 2 and 3; MoCA- Montreal Cognitive Assessment; MMSE- Mini-Mental State Exam; NM scale- Nishimura’s 
Mental State Scale for the Elderly; NPB- Neuropsychological battery; NR- Not reported; NS- Not significant; SAQOL-39- Stroke and Aphasia Quality of 
Life Scale-39; SF-36- Short Form- 36; SIP- Sickness Impact Profile; SIS- Stroke Impact Scale; SS-QOL- Stroke Specific-QOL; TICS- Telephone Interview for 
Cognitive Status; VAS- Visual analogue scale; WAIS-R- Weschler Adult Intelligence scale; WHOQOL-BREF- World Health Organization Quality of Life-









































52% 5 years SF-36  NPB Only visual memory (r = 0.163) 
and language (r = 0.121) domains 
were significantly related to SF-36 
mental component score in 










100 53.9  
(±13.4) 







Attention, executive functioning, 
learning potential and verbal 
memory were not significantly 































153 70.6 49% 1, 3 and 6 
months  
SF-36  MMSE Self-perceived health status was 
not strongly related to cognitive 
function. However, significant 
associations were found between 
the following: 
-MMSE at 1 month and emotional 
role  
-MMSE at 3 months and general 
and mental health (MH)  
-MMSE at 6 months and MH and 
vitality  
One-month poststroke 30% 
(n=45) of stroke patients had 
abnormal cognitive function 






































SIS v3.0 MMSE SIS communication (β = 0.36, 
p<0.001) and memory (β = 0.18, 














44% 5 years SF-36  NPB Visual memory (r = 0.562*); 
Language (r= 0.549); 
Visuoperceptual (r= 0.462); 
Executive (r= 0.590*); 
Information processing (r= 
0.584*) were all correlated with 
SF-36 (*p<0.01) 
21 
Clarke, P  
Canada 2002 
Longitudinal; 282  75.9  
(± 5.1) 
46% NR Ryff 
measure 
MMSE Stroke survivors with lower 






























lower score on the ‘sense of 
purpose in life’ domain than 
those with higher cognitive 







26 49 23% 1 year  SF-36  
GHQ-30 
NPB In patients with cognitive 
impairment, physical functioning 
(p = 0.04), role physical (p = 
0.004) and general health (p = 
0.001) domains of the SF-36 were 
significantly reduced compared 
to the means of the study 
population. Reduced scores on 
the GHQ-30 well-being domain (p 























the participants with poor 







106 54.6  
(±11.3) 
63% 72 days 
and 10 
months  
SIP NPB In univariate analysis, several 
cognitive tasks- mainly those that 
measured spatiotemporal and/or 
sequential aspects of behaviour- 
administered at 2 
months poststroke were 
predictive of HRQOL at 10 
months. Trail Making test (part B) 
emerged as an independent 
predictor of HRQOL in regression 




































SS-QOL MMSE Using the Chi-squared Automatic 
Interaction Detector method, 
MMSE was not a predictor of SS-









422 64.5  
(± 10) 
58% 2 weeks  WHOQOL
-BREF 
MMSE In the acute phase of stroke, 
impaired cognitive function was 
independently associated with 
lower HRQOL in three domains: 
physical factors (β = 0.44; p < 
0.01), psychological factors (β = 
0.42; p < 0.05) and environmental 






























274  74.3 56% 4 and 16 
months  
SF-36  MMSE In stepwise linear regression, 
MMSE was associated with the 
Bodily Pain domain of the SF-36 










50 55.3  
(± 8.2) 
62% 1 and 3 
months 
SIS 2.0 MMSE MMSE score was strongly 
correlated with the memory (r = 
0.47) and communication (r = 










85 65  
(±12.5) 
58% 3 and 12 
months 
SF-36  MMSE No significant correlation 
between the RAND-36 sub-scales 





























247 70.5  
(±11.6) 





MMSE In multilevel multivariate 
analysis, MMSE was not found to 
be a significant factor 
contributing to change in any of 
















RBANS Using inpatient RBANS 
visuospatial/ constructional, 
delayed memory, and attention 
Indexes, multiple regression 
predicted 46% of the variance in 
the cognitive Functional 
Independent Measure (FIM) at 
follow-up and 22% of the 






























43% 3 and 13 
months 
SF-36  MMSE  Cognitive disability did not make 
a significant contribution to the 
patient’s mental or physical QOL 
(sub-scores of SF-36) in 
regression analysis.   
33% of patients were classified as 
cognitive impaired at 3 months 








397 NR 53% 1 and 3 
years 
SF-36  MMSE Cognitive impairment was an 
independent predictor for worse 
mental (β = -2.70) and physical (β 
= -3.04) health summary scores at 
1 year and worse physical (β = -
8.32) health summary scores at 3 































147 59.9  
(±13.7) 
52% 3 months HRQOLISP MoCA  
V-NB 
Health-related quality of life was 
lowest among poststroke 
dementia subjects, followed by 
vascular cognitive impairment 
without dementia and then 
stroke survivors without vascular 
cognitive impairment. This trend 
was most obvious in the 
psychosocial, cognitive, and eco-
social domains of the HRQOLISP 
questionnaire but not in the 
physical domain. 73% of stroke 
participants demonstrated 
cognitive impairment on the 























cognitive impairment without 




























NPB Impaired cognitive function 
correlated significantly with all 
QOL domains, most strongly with 
social participation and weakest 
with depressive mood (r = 0.21 
(BI) r = 0.63 (FAI) r = 0.31 (LiSat-9) 
p < 0.01; r = -0.24 (CES-D) p<0.05) 
In regression analysis, the 
predictive value of cognitive 
functioning diminishes after 

























characteristics and motor 
impairment.  
Regression analysis OR (without 
adjusting for confounders): 2.03 
p<.01 (BI); 0.64 p<.01 (FAI); 0.31 




























CAMCOG In regression analysis, at one-year 
poststroke, perception (β = -
0.160) was the cognitive variable 
most strongly correlated to 
health status. In addition, 
orientation was correlated with 
the total score (β = -0.151), 
physical domain (β = -0.151) and 





























and memory to the physical 
dimension (β = 0.164).  
At three years poststroke, 
perception (β = -0.187) was once 
again correlated with the SIP 
total score and physical 
dimension (β = -0.180), and 
language was correlated with the 











EQ-5D NPB Highly significant differences 
were found in the means of face 
recognition tests for patients 
with no problems on HRQOL vs 























This indicates that long-term 
outcomes are dependent on well 










27 56  
(± 16) 






NPB No significant relation was found 
between cognitive functioning 
and HRQOL by means of a linear 
regression conducted with 
different cognitive domain 
scores of the SF-36. 
22 
CAMCOG-Cambridge Cognitive Examination for the elderly; EQ-5D- EuroQOL-5D; GHQ-30- General Health Questionnaire; HRQOLISP- Health Related 
Quality of Life in Stroke Patients; MoCA- Montreal Cognitive Assessment; MMSE- Mini-Mental State Exam; NPB- Neuropsychological battery; NR- Not 
reported; RBANS- Repeatable Battery for Assessment of Neuro-psychological Symptoms; SF-36- Short Form-36; SIP- Sickness Impact Profile; SIS- Stroke 
Impact Scale; SS-QOL- Stroke Specific-QOL; VAS- Visual analogue scale; V-NP- Vascular Neurological Battery; WHOQOL-BREF- World Health Organization 




 Characteristics of included studies 
Fifty-four studies have reported data on the association between cognitive impairment and 
health-related quality of life after stroke (13,217 patients [mean age 48-76]), with the 
number of participants ranging from 17 to 2870. Twenty-five longitudinal cohort studies; 
seventeen cross-sectional; seven case-control; and five randomised controlled trials were 
included in this review. Of these studies, nine included ischaemic strokes only; ten studied 
subarachnoid haemorrhage; one focused on patients who had a TIA or minor stroke; and 
three were unspecified. The remaining 31 studies included both ischaemic and haemorrhagic 
stroke participants however, data could not be extracted on the stroke subtypes.  To date, 
no studies assessing the relationship between cognitive impairment and HRQOL have been 
conducted within a dedicated intracerebral haemorrhage cohort. The relevance of this is that 
the results of the studies in this review may not be generalisable to ICH, the least treatable 
and most disabling type of stroke.   
Follow-up time of included studies varied significantly, from 1 week to 15 years after stroke 
onset. The settings for these studies also differed at follow-up: three were hospital based; 10 
were conducted in the patient’s home; 10 within rehabilitation centres; 27 were based in 
outpatient departments; 3 were conducted over the telephone; and one was assessed 
through a community questionnaire. 
Results are also difficult to compare due to the different cognitive assessment strategies that 
were employed. Whilst the majority utilised general screening measures such as the MMSE, 
MOCA or TICS to assess for cognitive impairment, sixteen studies used comprehensive 
neuropsychological test batteries and assessments. A variety of measures were also used to 
assess HRQOL outcomes, from a simple unidimensional visual analogue scale, to generic 
measures of health-related quality of life such as the EuroQOL-5D (EQ-5D), to more in-depth 
and stroke specific assessments such as the Stroke Specific Quality of Life scale (SS-QOL). It 
is also worth noting that some of the HRQOL scales included specific items on cognition (i.e. 
SS-QOL and Stroke Impact Scale (SIS)), making the associations seem somewhat circular 
(Cumming et al, 2014).  
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Of the 32 studies that assessed global cognition against total score on the HRQOL measure, 
25 revealed significant relationships between cognitive impairment and health-related 
quality of life. In addition to this, a further four studies revealed significant associations 
between measures of individual cognitive domains and overall HRQOL. 
 Studies showing an association between global cognitive impairment and 
HRQOL 
A significant association between global cognitive impairment and HRQOL was reported by 
25 studies in this review. While some studies only measured bivariate relationships (Adamit 
et al, 2015; Alvarez-Sabin et al, 2016; Ankolekar et al, 2014; Canuto, Nogueira and de Araujo 
2016; Park et 1l, 2013; Scott et al, 2008; Springer et al, 2009; Takemasa et al 2016), those 
using multivariate analysis often found that the significant relationships in bivariate analysis 
were no longer significant in regression analysis (Fatoye et al, 2007; Gurcay et al, 2009; Hilari 
et al 2010; Peixoto et al, 2017). An example of this was the study by Hilari et al (2010) which 
was one of the first to specifically look at the HRQOL of people living with aphasia. Eighty-
three participants with chronic aphasia were assessed at a mean time of 3.5 years after their 
stroke. Although HRQOL was significantly poorer in participants with lower cognitive levels, 
in the regression model, emotional distress, involvement in home and outdoor activities, 
extent of communication disability and number of comorbid conditions explained 52% of the 
variance.  
Several studies found significant associations between cognitive impairment and lower 
HRQOL in the first 3-9 months after stroke onset (Adamit et al, 2015; Ankolekar et al, 2014; 
Chen-Min et al, 2015; Dhamoon et al, 2010; Dhamoon et al, 2014; Mayer et al, 2002; Nys et 
al, 2007; Park et al, 2013; Rachpukdee et al, 2013; Gurcay et al, 2009). One of the largest 
studies of cognition after acute stroke was a randomised controlled trial assessing the 
management of blood pressure in previously independent ischaemic and haemorrhagic 
patients (Ankolekar et al, 2014). 1572 participants were assessed over the telephone 3 
months after stoke onset with modified versions of the MMSE and TICS. By 90 days, cognitive 
impairment was present in 38% of participants, where both measures of cognition were 
significantly related to reduced health-related quality of life on the EQ-5D. Although the 
multiple exclusion criteria of the randomised controlled trial will have limited eligibility, 
patients were enrolled from 18 different countries, across 5 continents, giving it great 
external validity and generalisability. Similar results were obtained by Adamit et al (2015), 
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who assessed 249 participants with mild ischaemic strokes in their homes at 3 months post-
event. Despite being able to perform basic activities of daily living independently, 67% of 
patients scored less than 26 on the MOCA, indicating possible cognitive decline. In addition, 
there were significant correlations between lower scores on the MOCA and most domains 
on the Stroke Impact Scale (a stroke-specific, self-report, health status measure). Patients 
suffering from mild strokes may often be overlooked by health care systems and 
rehabilitations programmes as they are likely to be functionally independent. Given that two-
thirds of participants had some level of cognitive dysfunction, this study emphasises the 
necessity of follow-up. A major strength of this study was that participants were evaluated 
at home, in their natural environment.  
Four studies indicated that cognitive impairment in the first 1-3 months after stroke was an 
independent predictor for lower HRQOL at 6-12 months (Cumming et al, 2014; Lee et al, 
2009; Nys et al, 2007; Passier et al, 2012). In the first of these studies, Nys et al (2007) 
concluded that cognitive impairment in the early phase of stroke (first month) is an 
independent risk factor for reduced health-related quality of life after 6 months. As well as 
long-term depressive symptoms being independently predicted by cognitive impairment at 
baseline, patients with cognitive impairment demonstrated lower HRQOL scores at 6 months 
poststroke than those without. Despite participants having a high level of cognitive function, 
in stepwise regression analysis Lee et al (2009)  found that cognitive scores at one month 
could predict HRQOL at 6 months. Although HRQOL was measured using a single item tool, 
the results suggest that clinicians need to observe for early signs of mild cognitive impairment 
to enhance poststroke quality of life. In addition, among stroke patients who were living at 
home, Passier et al (2012) and Cumming et al (2014) both showed that cognitive functioning 
at 3 months was an important predictor of HRQOL at 1 year.   
Five studies assessed patients at 12 months after their stroke and found associations 
between lower cognitive scores and lower global HRQOL. Of these, two studies recruited 
patients who had either an ischaemic and haemorrhagic stroke (Franceschini et al, 2010; 
Peixoto et al, 2017), and three recruited SAH patients (Scott et al, 2008; Springer et al, 2009; 
Taufique et al, 2016). In addition, a further four studies evaluated the longer-term effects (2-
4 years) of an ischaemic or haemorrhagic stroke (Alvarez-Sabin et al, 2016; Haacke et al, 
2006; Hilari et al, 2010; Safaz et al, 2016). In a randomised controlled trial assessing the effect 
of citicoline treatment on health-related quality of life and cognitive performance in patients 
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with a first ischemic stroke, global cognitive impairment was associated with poorer HRQOL 
at 2 years (0.55 vs 0.66 in utility; p = 0.015; where 1 represents the patient without any health 
problems and 0 the worst health status) (Alvarez-Sabin et al, 2016). Twenty-three percent of 
patients were classified within the group with poor or very poor quality of life (utility < 0.5) 
however, patients treated with the study drug had less cognitive impairment at 2 years (28% 
v 39%).  
Conclusion: Twenty-five studies reported a significant association between global cognitive 
impairment and HRQOL. While most studies only measured bivariate relationships, those 
using multivariate analysis often found that the significant relationships in bivariate analysis 
were no longer significant in regression analysis. Ten studies found significant associations 
between cognitive impairment and lower HRQOL in the first 3-9 months after stroke onset, 
and a further four studies indicated that cognitive impairment in the first 1-3 months after 
stroke was an independent predictor for lower HRQOL at 6-12 months. In addition, nine 
studies assessed patients 1-4 years after their stroke and found associations between lower 
cognitive scores and lower global HRQOL. These results suggest that health-related quality 
of life is consistently impaired in patients suffering from cognitive impairment after stroke 
and that it is a problem that begins early after stroke onset and continues to be present in 
the long-term. 
 
 Studies showing no association between global cognitive impairment and 
HRQOL 
Only seven studies did not find a significant impact of cognitive impairment on patient’s 
health-related quality of life (Chou 2015; Howitt et al, 2011; Huang et al, 2010; Jonkman, 
Weerd and Vrijens 1998; Kwa, Limburg and Hann 1996; Meyer et al, 2010; van Wijk et al, 
2007). Kwa, Limburg and Hann (1996) conducted the first study to specifically examine the 
influence of cognition on the health-related quality of life in 129 patients, two years after 
their ischaemic stroke. Cognitive function was assessed with the Cambridge Cognitive 
Examination for the elderly (CAMCOG- a concise neuropsychological test for the assessment 
of cognitive impairment in elderly people) and HRQOL with a visual analogue scale. In 
multivariate analysis, cognitive function was not found to be significantly associated with 
health-related quality of life. However, it should be noted that the patient sample was 
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restricted to a relatively well group of stroke survivors, making the results less transferable 
to the wider stroke population. In a similar study investigating long-term health-related 
quality of life of patients in Tanzania, Howitt et al (2011) assessed patients 1-5 years (mean 
3 years) after their incident stroke. Lower levels of health-related quality of life were 
associated with depression, reduced social interaction and physical disability and motor 
function. Although cognitive function played less of a role than motor function in predicting 
health-related quality of life, findings could be related to the inability of those with significant 
cognitive impairment to provide accurate information. In addition, many of the participants 
struggled to rate their emotions and health status on a rating scale.  
Another study worth noting is that conducted by Jonkman, Weerd and Vrijens (1998), who 
evaluated the different factors which were deemed to be important for health-related 
quality of life in the 3-12 months following an ischaemic stroke. Health-related quality of life 
scores, as measured by the Sickness Impact Profile (SIP- assesses quality of life in patients 
who have sustained a stroke), improved in the 3-12 months after the stroke but were not 
correlated with cognitive disturbances in regression analysis. The sample was confined to a 
relatively young group of stroke survivors (aged between 25 and 70 years), none of which 
returned to their original occupational level. As a result, the authors have suggested that the 
patients may have been less confronted by their decrease in cognitive abilities than if they 
had returned to their previous occupational capacity.  
Conclusion: Although seven studies did not find a significant impact of cognitive impairment 
on patient’s HRQOL, some of these studies were confined to a younger and relatively well 
group of stroke survivors.  
 
 Studies showing an association between individual cognitive domains and 
overall HRQOL 
From the 22 studies that investigated cognitive/HRQOL domains (as measured by 
standardised assessment tools or tests batteries), only four revealed a significant association 
between individual cognitive domains and overall HRQOL (Chahal, Barker-Collo and Feigin 
2011; Hochstenbach et al, 2001; Verhoeven et al, 2011a; Vilkki et al, 2012).  
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In a selective sample of 106 patients who were all younger than 70 at stroke-onset and lived 
at home, Hochstenbach et al (2001) were the first researchers to show that several cognitive 
tasks- mostly in the attention domain- administered at 2 months poststroke, were predictive 
of health-related quality of life at 10 months. However, some of the significant univariate 
relationships were no longer significant in regression analyses. Multivariate analysis showed 
that poor health-related quality of life was more likely if patients had a poor result on the 
Trail Making Test (TMT) Part B (requiring speed of processing and visual scanning). A possible 
explanation for these results is that poor performance on the TMT Part B is an indication of 
difficulty in performing under time pressures, as well as being able to adequately shift mental 
states. The authors argued that these abilities are crucial to performing many daily life 
activities such as preparing dinner, going shopping, doing housework etc.  
In accordance with these results, Nys et al (2007) concluded that among all cognitive 
disorders, visual perceptual/construction ability was the cognitive domain with the strongest 
link to health-related quality of life. Likewise, in addition to visual memory and language, 
Chahal, Barker-Collo and Feignin (2011) found that impairments in visual perceptual ability, 
executive functioning and speed of information processing impacted long-term (5 years 
poststroke) functional outcomes and HRQOL of SAH survivors. In regression analysis at one- 
and three-years poststroke, CAMCOG scores were significant predictors of long-term health 
status in patients with stroke (Verhoeven et al, 2011a). As before, visual perception was the 
cognitive variable most strongly correlated to HRQOL. All these studies gave some indication 
that executive function and visuospatial ability are closely related to HRQOL after stroke. 
Because the tasks used to assess these abilities are typically speed-dependent, these results 
may therefore be mediated by a more generalised speed of processing capability.  
In light of this research, Cumming et al (2014) aimed to assess whether speed of processing 
in the acute stage after stroke onset would be independently related to HRQOL at 12 months. 
In addition to their finding that cognitive impairment at 3 months poststroke was associated 
with lower HRQOL at 12 months (even when covariates were taken into account), poorer 
attention and visuospatial ability were significantly and independently related to lower long-
term HRQOL. Of those participants that were tested acutely (n=33), the researchers found 
that faster choice reaction times at 2 weeks poststroke was significantly associated with 
better HRQOL at 12 months, suggesting that straightforward speed of processing tasks (such 
as the Trail Making B) may be more sensitive to the extent of brain damage than other 
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neuropsychological tasks. However, the sample was made up of mild and moderate stroke 
patients and is therefore not generalisable to more severely impaired stroke survivors.  
In contrast to these results, Vilkki et al (2012) found that of all cognitive domains tested 1 
year after SAH, the only predictive variable for HRQOL 11 years after stroke was the face 
recognition test. This indicates that long-term outcomes are dependent on well preserved 
learning and memory functions.  
Conclusion: From the 22 studies that investigated cognitive/HRQOL domains, only four 
revealed a significant association between individual cognitive domains and overall HRQOL. 
From these studies, executive functioning, speed of information processing and visual 




Health-related quality of life is the closest thing we have to a central and universally 
important health outcome measure. Fifty-four published studies were reviewed in which the 
effect of cognitive impairment on health-related quality of life was explored after stroke. The 
results of the previous studies are difficult to compare. The assessment of cognitive 
impairment ranged from general screening measures such as the MMSE, to the use of a full 
and comprehensive neuropsychological test battery covering various cognitive domains. In 
addition, the researchers used a variety of measures to assess health-related quality of life, 
where assessments took place between one week and 15 years after stroke onset.  
Despite these methodological challenges, previous research indicates that cognitive 
impairment after stroke can have profound consequences to the patient’s health-related 
quality of life. Of the 32 studies that assessed global cognitive impairment against overall 
HRQOL, 25 showed a significant association. The available evidence suggests that health-
related quality of life is consistently impaired in patients suffering from a cognitive 
dysfunction and that it is a problem that begins early after stroke onset and continues to be 
present in the long-term. From the studies which investigated cognitive/HRQOL domains, 
executive functioning (particularly speed of information processing and attention) and 
visuospatial ability were found to be closely related to HRQOL after stroke.  
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This literature review benefited from thorough ascertainment of a large number of relevant 
studies, using multiple electronic databases, in an attempt to be comprehensive and avoid 
reporting bias. The use of a broad review question has the advantage that the findings are 
applicable to a wider range of settings and populations, with less opportunity for chance 
findings (Pollock and Berge 2018). Studies underwent a comprehensive critical appraisal and 
judgement relating to whether there were any potential risks of bias within the study. The 
average methodological quality score was 19, with most studies attaining a methodological 
score of between 19 and 22, suggesting that the quality of included studies was at a high 
standard. 
Although the literature indicates that a relationship exists, the exact nature of the 
relationship remains unclear. Cognitive impairment and health-related quality of life are 
complex issues that have multiple interacting determinants. There is more to health-related 
quality of life than someone’s cognitive ability or neurological impairment. To explore the 
relationship between objective (i.e. MOCA) and subjective measures (i.e. EuroQOL-5D), and 
to identify other potential factors that may be closely linked to someone’s HRQOL, mixed 
method studies are required. Not only would this add to the existing understanding of the 
impact and meaning of stroke, qualitative interviews would allow us to further understand 
how stroke patients adjust and adapt to their situation. Whilst there have been several 
qualitative studies on quality of life after stroke, none of these focussed on patients with 
cognitive impairment. In addition, no quantitative studies have examined cognition and its 
resultant impact on health-related quality of life within a dedicated ICH cohort. This research 
is important as it may contribute to rehabilitation in terms of raising awareness and 
educating professionals, family members and carers on the long-terms consequences of ICH 




4. Research design 
This chapter begins by setting out the aims of the research. To help orientate the reader, an 
overview of the different studies that are components of this research has been provided. 
The chapter will then go on to explain the research design that has been adopted; this 
involves an examination of the theoretical underpinnings of the methodology, as well as an 
explanation of why this design was deemed most suitable for meeting the research aims. The 
chapter concludes with an exploration of ethical considerations and details on patient 
involvement in the research process.      
 
 Research aim and objectives 
The overall aim of this research study is to explore the outcomes and experiences of people 
living with cognitive impairment and intracerebral haemorrhage. 
To meet this aim, three research objectives were developed. These are:  
a) To study the prevalence of pre-existing dementia and cognitive impairment in 
patients with ICH, and to quantify their incidence at specific time points thereafter,  
b) To investigate the demographic, clinical, radiographic and functional outcomes 
associated with the occurrence of cognitive impairment following an ICH, and  
c) Evaluate the experience of life after ICH with cognitive impairment.   
 
 Orientation to research studies linked to this thesis  
 LATCH  
The Lothian Audit of the Treatment of Cerebral Haemorrhage (LATCH) identified all residents 
in the Lothian Health board region of Scotland, who were aged ≥16 years at the time they 
were diagnosed, with first-ever or recurrent ICH. Adults with exclusively extra-axial 
intracranial haemorrhage (haemorrhages that are external to the brain parenchyma) or ICH 
definitely attributable to trauma or haemorrhagic transformation of an ischaemic stroke 
were excluded.  
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Incident ICH cases were identified using multiple overlapping sources of case ascertainment 
(full details of which have been provided by Samaresekera et al, 2015). The NHS Lothian 
Caldicott Guardian approved the use and transfer of patient identifiable information for 
LATCH. Patients in NHS Lothian were informed about the use of their data for audit, and 
information leaflets about LATCH were distributed to inform patients and their carers about 
their right to opt out. The team collected data on demographics, medical history, and 
medication use at time of ICH diagnosis by interviewing patients, their families or carers at 
the time of presentation and reviewing primary care and hospital records. 
Using the LATCH database, I carried out a retrospective analysis (henceforth referred to as 
LATCH COG) of all patients diagnosed with ICH in the Lothian region between June 2010 and 
May 2013 inclusive, with available CT data (n=404). Analyses of an anonymised dataset, 
extracted from the audit database held on NHS and University servers, did not require NHS 
ethics approval. The primary aim of this analysis was to give a crude measure of the 
prevalence of dementia and cognitive decline before an ICH and quantify their incidence at 
specific time points thereafter (research objective (a)). 
 
 LINCHPIN 
Patients with ICH who were identified by LATCH had the opportunity to participate in the 
Lothian IntraCerebral Hemorrhage, Pathology, Imaging and Neurological Outcome 
(LINCHPIN) study. This was my supervisor’s (Professor Rustam Al-Shahi Salman) prospective 
community-based research study examining the causes of ICH using clinical assessments, 
brain MRI, blood samples and research autopsy in case of death. The Scotland A Research 
Ethics Committee (10/MRE00/23) approved LINCHPIN. Written informed consent was 
obtained by the Chief Investigator or Senior Research Nurse from all participants, or their 
nearest relative when participants did not have mental capacity. Data collection started on 
1st June 2010 and ended on 31st December 2016.  
At the time that I was conducting my PhD, the LINCHPIN research team was primarily made 
up of four members, two of which were my supervisors: Chief Investigator (Professor Rustam 




 LINCHPIN COG  
LINCHPIN COG is a prospective, observational cohort sub-study of cognitive impairment in 
patients who had an intracerebral haemorrhage. Six-month survivors of ICH who had already 
consented to participate in the LINCHPIN study were given the opportunity to take part in a 
more detailed assessment of their cognition and quality of life at six months and 1-2 years 
following their ICH. The sub-study was approved by the Scotland A Research Ethics 
Committee on the 6th March 2015 in the form of a substantial amendment (Appendix 5). NHS 
Lothian Research and Development approval was then awarded on the 12th March 2015 
(Appendix 6).  
Data collection for LINCHPIN COG started in March 2015 and was completed in February 
2018. In order to avoid selection bias, I aimed to consecutively assess all patients who 
survived to 6 months that had consented to LINCHPIN. This sometimes meant visiting 
patients in nursing homes or on a hospital ward, with the family’s consent. For patients who 
were unable to be cognitively assessed, for example as a result of severe aphasia, visual 
impairment or neurological impairment, I relied on those tools that could be completed by 
the caregiver or family member. Analysis was carried out to investigate the frequency of 
cognitive impairment before and after ICH and any clinical, demographic, radiographic or 
functional outcome associations with its occurrence (research objective (b)). 
 
 Qualitative interviews 
To help further understand the different ways in which cognitive impairment can impact a 
person’s life following an ICH, semi-structured qualitative interviews were conducted with 
six LINCHPIN COG participants with varying levels of cognitive decline at 6-24 months after 
their ICH. During these interviews, the participants discussed how they and their family 
members had been able to adjust and adapt to the long-term consequences of their ICH 






 Study setting 
For all studies mentioned above, patients were included if they were resident in the region 
served by the NHS Lothian Health Board. The region has three main hospitals (Royal Infirmary 
of Edinburgh, Western General Hospital and St John’s Hospital), all of which have a specialist 
stroke unit.   
 
 Design   
When designing a research study, there are numerous approaches to choose from. When 
seeking to understand the experiences of people living with cognitive impairment after a 
chronic disabling condition like ICH, although a purely quantitative or qualitative approach to 
the research could have been taken, mixing methods was likely to provide me with the most 
comprehensive picture. While many of the quantitative studies on stroke have relied on 
objective measures of functional outcome and health-related quality of life, qualitative 
research has focused on the complexities of how participants make sense of their experience 
(Clarke 2009). As such, quantitative results can tell us how many patients experience 
cognitive impairment and decreased HRQOL after their ICH, whereas qualitative findings can 
help shed light on the underlying process by which health-related quality of life is maintained 
in some patients and lost in others. Both approaches can be seen to make separate, yet 
equally important, contributions to our understanding of the stroke experience.  
 
 Mixed Methodology  
The use of both qualitative and quantitative approaches in a single study has been the subject 
of considerable controversy and remains a relatively uncommon practice in the study of 
health and illness (Creswell 2011). The underlying problem when trying to combine these 
two strategies comes from the conflicts of different paradigms. Some authors believe that 
paradigms have rigid boundaries that cannot be mixed, and that the applications of 
qualitative and quantitative methods rely on a different set of assumptions about the world 
and the ways of learning about it (Johnson and Onwuegbuzie 2004). Whilst quantitative 
research falls within the positivist paradigm (which assumes that the world is stable and 
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predictable, with a single reality), qualitative research is thought to fall within the 
constructivist paradigm (which assumes that the world is made up of multiple socially 
constructed realities that need to be interpreted). However, a growing number of academics 
advocate for the mixing of methods and maintain that: 
 “both views of the nature of reality are compatible and essential to 
understand the human experience” (Haase and Myers 1988, p.132; 
Morgan 1998).  
This aligns with my own perspective that reality is something that can be measured and 
generalised yet is unique to everyone.    
For the purposes of this thesis, the definition of mixed methods that has been chosen is from 
Creswell and Clark (2007, p.5): 
“Mixed methods research is a research design with philosophical assumptions 
as well as methods of inquiry.  As a methodology, it involves philosophical 
assumptions that guide the direction of the collection and analysis… As a 
method, it focuses on collecting, analysing, and mixing both quantitative and 
qualitative data in a single study… Its central premise is that the use of 
qualitative and qualitative approaches, in combination, provides a better 
understanding of research problems than either approach alone.” 
 
 Theoretical underpinnings 
When designing a study, it is important for the researcher to think about their philosophical 
assumptions and how these might guide inquiry and fit into the methods of their research. 
Researchers bring a worldview to their study (also referred to as paradigm) that is composed 
of beliefs and assumptions about the nature of knowledge and provides a guide that can be 
used to ground their research (Creswell and Clark 2011). The choice of research questions 
and methods is therefore a reflection of the researcher’s philosophical understanding of the 
world, even if it is not made explicit.    
Pragmatism, a worldview which is often associated with mixed methods, focuses on the 
problem to be researched and provides a basis for a position that has been stated as the 
“dictatorship of the research question” (Tashakkori and Teddlie 2010, p.21).  Pragmatic 
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researchers believe that it is the research question that should drive the design and methods 
of a study and reject the forced choice between traditional constructivist and positivist ways 
of knowing in order to look at what is meaningful from both (Biesta 2010). A similar argument 
was made by Howe (1988) who suggested that researchers should “forge ahead with ‘what 
works’” (p. 15).  Rather than using metaphysical concepts such as ‘truth’ and ‘reality’, 
pragmatism accepts that there are both singular and multiple realities that are open to 
inquiry and orientates itself to solving practical problems in the real world (Biesta 2010). As 
stated by Casebeer and Verhoef (1997), we should view: 
 “qualitative and quantitative methods as part of a continuum of research 
techniques, all of which are appropriate depending on the research 
objective” (p.132).   
Pragmatic researchers see the value of mixing methods as it extends our understanding of a 
phenomenon using multiple perspectives. This emphasis also points to the underlying belief 
in complementarity research that qualitative and quantitative approaches can be combined 
to ‘compliment’ the advantages and disadvantages present within each (Shannon-Baker 
2015).   
 
 Complementarity 
A mixed methods approach has been chosen for its complimentary abilities (Greene, Caracelli 
and Graham 1989). The key goal for studies seeking complementarity is to: 
 “measure overlapping but also different facets of a phenomenon, yielding an 
enriched, elaborated understanding of the phenomenon” (Greene, Caracelli 
and Graham 1989, p.258) 
Complementarity refers to enhancement or clarification, where the quantitative and 
qualitative substudies represent different pieces of the puzzle.  By undertaking qualitative 
interviews, I hoped to illustrate and explain the results of the quantitative assessments by 
allowing the participants to elaborate on their experiences in their own words. As stated by 
Creswell and Clark (2011, p. 63), adding a qualitative element allows researchers to “put meat 
on the bones of dry quantitative findings”. Mixing methods avoids the limitations of a single 
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approach and allows the researcher to use the methodological tools that are best suited to 
addressing the research questions. By approaching the study of cognitive impairment and 
ICH from both philosophical perspectives, a greater depth of knowledge can be obtained 
about the stroke experience.   
 
 Explanatory sequential design 
Although there are many options when designing a mixed methods study in terms of the 
timing and priority given to the two different strands of inquiry, I decided to choose an 
explanatory sequential design. Using this design, the researcher starts with the collection and 
analysis of quantitative data, which has the priority for addressing the research questions. 
This is then followed by the subsequent collection and analysis of qualitative data. The 
researcher then interprets how the qualitative results help to explain the initial quantitative 
findings (see Figure 4). As is the case for the present study, this design can be used when the 
researcher wants to use quantitative results about participant characteristics to guide 
purposeful sampling for a qualitative phase (Tashakkori and Teddlie 1998). The 
straightforward nature of this design allows the study to be reported in distinct phases, a 
quantitative section followed by a qualitative section, with a final discussion that brings the 
results together (Creswell et al, 2003).  
 


















 Ethical considerations 
Conducting research with stroke survivors is surrounded by a multitude of ethical quandaries, 
each of which will be discussed separately below:  
• Inclusion of adults without mental capacity 
• Assessment of mental capacity  
• Consent form adults without mental capacity  
• Withdrawal of consent 
• Inclusion of adults with aphasia 
• Interviewing participants who are cognitively impaired 
• Potential distress to participants 
• Duration of interview 
• Confidentiality 
• Data protection 
• Possible risk to me as a researcher  
The majority of the ethical considerations discussed apply to LINCHPIN COG however, issues 
around confidentiality and data protection also apply to LATCH COG.  
 
 Inclusion of adults without mental capacity 
Due to the nature of LINCHPIN COG, it involved the recruitment of some participants who 
did not have the mental capacity to give informed consent. It was felt that the inclusion of 
adults who were unable to consent for themselves was important for a number of reasons. 
Firstly, this group have been poorly represented in previous studies of cognition after ICH. 
The study would also be extremely biased if I excluded adults with incapacity and I would 
underestimate the frequency of cognitive impairment and dementia. Most importantly 
however, I wanted the results of the study to be generalisible to the entire population of 
patients with intracerebral haemorrhage. 
In order to protect individuals from any harm, the following steps were taken when recruiting 
adults who lacked the capacity to consent: 
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• Because of the vulnerability of adults without mental capacity, I had a discussion with 
the participant’s nearest relative (with the support of the Senior Research Nurse) to 
assess their suitability to take part in the research, before the decision to consent was 
made. It was made explicit that relatives had the right to withdraw the participant from 
the study at any time, without the care of their relative being affected. 
• My view of consent was not as the result of a single interview but as an ongoing 
process. I encouraged relatives to discuss participation with other family members 
before reaching a decision.  
• The consent process was tailored to each individual participant. Provision was made 
for the participant potentially regaining capacity, in which case he/she was then asked 
whether they wished to continue participating in the study.  
In patients who were so mentally incapacitated that they could not complete any of the 
quantitative assessments of cognitive function, only the National Institutes of Health Stroke 
Scale was carried out with the participant to assess the level of physical impairment. Their 
relative was then asked to fill out two questionnaires on the participant’s behalf. 
 
 Assessment of mental capacity 
Capacity to consent to research participation differs from capacity to consent to treatment. 
In order to decide whether an individual had capacity to make a decision, I needed to 
consider whether: 
1. The person had a mental disorder (which includes mental illness, learning disability, 
dementia and acquired brain injury), or severe communication difficulty because of 
a physical disability (such as stroke or severe sensory impairment)? And, if so, 
2. Had it made the person unable to make the decision or decisions in hand? 
For the purposes of the Adults with Incapacity (Scotland) Act 2000, to prove that a participant 
had mental capacity I needed to show that the individual had the capacity to consent to 
participation in the research at the time that the consent was required to be made. In order 
to show that an individual had the mental capacity to consent, I needed to prove that the 
participant could (British Medical Association 2016): 
92 
 
1. Understand information- did the participant understand what the research was 
about? 
2. Retain information- could the person hold the information in their mind long 
enough to use it to make a decision? 
3. Use or weigh up the information 
4. Communicate their decision 
If the answer was no to elements one to three then, on the balance of probabilities, the 
participant was deemed to be unable to reach a decision themselves. 
 
 Consent from adults without mental capacity 
Mental incapacity is an inability to comprehend and retain information necessary to make 
the decision, and/or an inability to weigh up the information in the process of making the 
decision (Mental Capacity Act 2005). Participants who were unable to consent were likely to 
be those admitted with intracerebral haemorrhage causing an impairment of consciousness 
or language. Potential participants who were unable to give informed consent were enrolled 
into LINCHPIN COG if their proxy (usually the nearest relative) provided consent (see Box 9 
for the Mental Health Act 1983 definition of relative).  
Box 9: Mental Health Act 1983 definition of relative 
The Mental Health Act 1983 defines the term relative as any of the following persons: 
(a) husband or wife (or civil partner) 
(b) son or daughter; 
(c) father or mother; 
(d) brother or sister; 
(e) grandparent; 
(f) grandchild; 
(g) uncle or aunt; 
(h) nephew or niece. 
 The general rule is that the nearest relative is the person who comes highest on the list.  
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Nearest relatives were asked to consider any previous wishes that the participant may have 
verbally or otherwise expressed about their participation in research. I was guided in the 
timing of consent by the participant, their relatives and the clinical situation, and encouraged 
relatives to discuss participation with other family members before reaching a decision.  
Although some of the participants were cognitively impaired, an inability to consent was not 
assumed. If an individual was cognitively impaired, I worked alongside the participant, 
respecting those areas of functioning where the participant had retained competency. By 
viewing consent as an ongoing process, I re-checked the participant’s willingness to remain 
involved in the study, particularly where consent had been taken two weeks prior to 
assessment.  
Participants who initially lacked the capacity to consent but later regained it had the 
opportunity to provide consent themselves, overriding any wishes previously expressed by 
their representative. In such an event I provided information about the study and sought 
their consent at an appropriate time, ensuring that a member of their family was present 
where possible. 
 
 Withdrawal of consent 
Participants were withdrawn if:  
• Having consented to participate in the study, the participant changed their mind and 
no longer wished to participate.  
• Where participants lacked the capacity to consent to entering the study and consent 
had been given by their nearest relative, they could be withdrawn if the person who 
had given consent changed their mind and no longer wanted them to take part in the 
study.  
• A participant having been entered into the study with consent given by their nearest 





 Inclusion of adults with aphasia 
Stroke often results in impairment in expressive language. Previous studies on stroke related 
cognitive impairment tended to use specific inclusion criteria where patients with aphasia 
were often excluded (Pendlebury and Rothwell 2009). Exclusion of those participants with 
aphasia is often undertaken due to the methodological issues encountered when trying to 
assess cognition in such patients (Pendlebury et al, 2015). However, excluding participants 
with aphasia limits the generalisability of findings. To ensure that findings were applicable to 
the wider ICH population, I endeavoured to include patients with expressive language 
impairments. Due to the inherent difficulties of assessing capacity in patients with 
communication difficulties, written consent was taken from the participant’s nearest 
relative.  
Where possible, the same assessment tools were used as for those without aphasia. When 
conducting the qualitative interviews, adjustments were made to accommodate language 
difficulties depending on the needs of the participant. Adjustments included the option of 
having a close family member present for support and to help with clarification, providing 
extra time for responses and additional breaks as necessary.  
 
 Interviewing participants who are cognitively impaired 
Although interviewing those who are cognitively impaired can be challenging at times, such 
individuals have important views and perspectives that should not be excluded (Lloyd, 
Gatherer and Kalsy 2006).  Qualitative research requires effective communication to optimise 
participant responses. One strategy for this is to conduct interviews in a place that is familiar 
and comfortable, for example the participant’s home. I also ensured that interview questions 
were structured using terminology that was understandable to the participant, allowing 






 Potential distress to participants  
It was predicted that the qualitative interview may have elicited upsetting memories for 
some participants as they recalled their experiences and the impact the stroke had on their 
lives. In addition, some of the quantitative questionnaires asked questions about mood, 
anxiety and depression. It was acknowledged that this may cause distress and participants 
were informed that they did not have to complete the questionnaires if they found them 
upsetting.  
On the few occasions were participants became upset, I managed participant distress firstly 
by reassuring the participant and acknowledging that they were upset (e.g. ‘Are you okay’, 
‘Would you like to stop the interview for a while?’), and then by talking through whatever it 
was that had caused them to become distressed. In all cases, participants were happy to 
continue with the interviews or questionnaires after pausing for a short time.  
The cognitive and functional assessments were also identified as having the potential to lead 
to distress for stroke participants, particularly where they lacked insight into the extent of 
their impairments. Participants were offered a short break if required and were given the 
option to discontinue whatever research activity was being performed at the time.  
Consent was sought from all participants to contact their GP with a summary of the cognitive 
and functional outcome assessments. If it became apparent during any of the study visits 
that a patient was suffering from mental health issues or expressed suicidal thoughts, this 
was highlighted in the letter to the GP.  
 
 Duration of interview 
Both the quantitative and qualitative interviews were expected to take between 60-90 
minutes each. Stroke survivors often experience fatigue and it was possible that some of the 
participants would find this a long time to concentrate. Participants were given the choice of 
setting for the interview – in their own home or in a clinic setting, to make them most 
comfortable. Participants were also made aware that they could stop testing for breaks or 
could complete the assessments over two appointments.    
96 
 
 Confidentiality  
As part of this study, patients gave consent for the LATCH/LINCHPIN research team to access 
their identifiable data. The identifiable information was processed by the research team 
which included medical, computing and administrative staff, all of whom had a duty of 
confidentiality to the participants and were either NHS employees or had NHS honorary 
contracts.  
Only appropriately trained and authorised members of the research team had access to 
participants' personal data during the study. The consent form specified that any information 
collected would be kept confidential by the University of Edinburgh research team and only 
made available to other researchers in a form which preserved anonymity. 
Audio recordings of the qualitative interviews were made on an encrypted digital dictaphone 
and downloaded onto the secure NHS server. These files were password protected and 
labelled with a participant number. Once downloaded, original recordings were deleted from 
the dictaphone. 
To ensure anonymity and confidentiality of personal data, transcripts were given a 
participant number and did not contain names or contact details. Due to the nature of this 
research, direct quotations have been used in the dissemination of the findings. A sufficient 
degree of anonymity has been ensured by removing all obvious descriptors and identifiable 
information from the extracts used. When anonymising data, I was sensitive to changing 
anything that might have been considered identifiable without detracting from the richness 
of the content or changing it so much that it altered the meaning substantially (Guenther 
2009).  Participants were informed that descriptive data or direct quotations in an 
anonymous form would be used in dissemination. 
 
 Data protection 
The research team complied with the Data Protection Act 1998 when sharing or processing 
data within the NHS and other organisations involved in the research. Study data were 
accessible via databases on two separate servers. Identifiable data could only be handled by 
authorised staff members (Chief Investigator, research nurses and support staff with NHS 
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contracts) via a password protected, secure database on the NHS server. The NHS database 
handles and stores the identifiable data (patient name, address, postcode, CHI, date of birth, 
phone numbers, email). This data can only be accessed from an NHS Lothian PC, within the 
NHS network, by staff members that have been given the appropriate permissions. 
Anonymised data were also stored on the University server, which could only be only 
accessed via a password protected secure database. The University server contains the 
pseudo-anonymised research and audit data, where all the data relates to the LINCHPIN ID, 
the university system primary numeric identifier.  
Paper and other manual files are stored in a locked filling cabinet in a secure area for the 
purposes of future communication with the participant and their doctor as appropriate. Only 
the LATCH/LINCHPIN research team, with NHS contracts and a duty of confidentiality, have 
access to the data. 
  
 Possible risk to me as researcher  
Many of the interviews took place in the participant’s own homes, which meant that I was 
visiting these participants on my own. A lone working procedure was therefore followed to 
minimise any risk and to ensure my own safety when visiting participants outside the hospital 
setting (see Box 10).  
 
Box 10: Lone working procedure 
Pre-study visit: Researcher to inform a nominated person (supervisor or other identified 
member of staff within the LINCHPIN research team) of the planned study visit, and give 
details of date, location, start time and estimated finish time 
During study visit: Nominated person aware of study visit; both researcher and nominated 
person to be contactable by telephone 
Post-study visit: Researcher to contact nominated person once study visit is complete. If 
no contact is made within the expected time, nominated person will contact researcher 
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 Patient involvement in research  
I involved a group of patient representatives (the Research to Understand Stroke due to 
Haemorrhage Patient Reference Group (RUSH PRG)) during the design of this study. At the 
time, the RUSH PRG was comprised of 3 stroke survivors- 2 women and 1 man- two of whom 
had had an intracerebral haemorrhage. They provided valuable assistance in the 
development of study materials and reviewed and commented upon the information sheet 
and consent forms for this study.  
 
 Overview of remaining chapters 
This thesis will now be divided into separate methodology and results chapters (Chapters 5-
10), each containing study-specific sections based upon the three research objectives. 
Chapter 11 will then provide a summary of the principal findings, drawing them together with 






5. Methodology: LATCH COG 
The Lothian Audit of the Treatment of Cerebral Haemorrhage (LATCH) is a prospective, 
population-based cohort study that identified all residents in the Lothian Health board region 
of Scotland who were diagnosed with first-ever or recurrent ICH (confirmed by brain imaging 
or pathology), between June 1st 2010 and May 31st 2013 inclusive. In order to study the 
prevalence of pre-existing dementia and cognitive impairment in patients with ICH, and to 
quantify their incidence at specific time points thereafter (objective (a)), I carried out a 
retrospective analysis of LATCH (henceforth referred to as LATCH COG). This chapter contains 
a detailed discussion of the methods used to collect and analyse data. Strengths and 
limitations are included at the end of this chapter to aid the reader in interpreting the clinical 
implications and generalisability of the findings.   
 
 Research objective and questions  
The overall aim of LATCH COG was to:  
• Study the prevalence of pre-existing dementia and cognitive impairment in patients 
with ICH, and to quantify their incidence at specific time points thereafter. 
To meet this aim, the following research questions were developed:   
1. What is the prevalence of pre-existing cognitive impairment and dementia in 
patients who have had an ICH? 
2. What factors are associated with pre-existing cognitive impairment and dementia in 
patients who have had an ICH? 
3. What is the incidence of new-onset cognitive impairment and dementia within 1-5 
years of ICH? 
4. What factors are associated with new-onset cognitive impairment and dementia in 
patients who have had an ICH? 
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5. How accurate is the GP electronic medical record for identifying cognitive 
impairment and/or dementia, compared to a reference standard of the 
IQCODE? 
 
 Selection of Participants 
Participants were included in LATCH COG if they met the inclusion criteria outlined in Box 11.  
Box 11: LATCH COG inclusion criteria 
Participants were eligible if they were:  
• Diagnosed as having first-ever ‘primary’ ICH (not secondary to an underlying 
tumour, intracranial vascular malformation or venous thrombosis etc): 
ICH was defined as the abrupt symptomatic onset of severe 
headache, altered level of consciousness, or focal 
neurological deficit, anatomically referable to a focal 
collection of blood within the brain parenchyma as observed 
on brain imaging (by a neuroradiologist with an interest in 
stroke) or at autopsy, which was not attributable to prior 
trauma or haemorrhagic conversion of a cerebral infarction 
• Adults, aged 16 or over at time of diagnosis 
• Seen as an inpatient or neurovascular outpatient at Western General Hospital, 
Royal Infirmary Edinburgh or St John’s Hospital 
• Resident in the NHS Lothian Healthboard region 
• Included in the Lothian Audit of the Treatment of Cerebral Haemorrhage  
• Diagnosed with ICH between June 2010 and May 2013   





Participants were excluded from LATCH COG if they met any of the exclusion criteria outlined 
in Box 12.  
Box 12: LATCH COG exclusion criteria 
Participants were excluded if they had:  
• ICH definitely attributable to trauma 
• Exclusively extra-axial intracranial haemorrhage (i.e. subarachnoid, subdural, or 
extradural). However, patients with intraparenchymal haemorrhage that 
extended into other compartments could be included. 
• ICH into a tumour, from a proven intracranial vascular malformation, due to 
venous sinus thrombosis, or which proves to be a haemorrhagic transformation of 
a cerebral infarction after further imaging or autopsy. 
• Recurrent ICH 
• Opted out of LATCH 
 
 Methods 
Patients meeting the eligibility criteria above were identified using the LATCH database. 
LATCH is an audit of the care of adults who were affected by ICH. As part of this audit, the 
team collected copies of the patient’s primary care records, including GP summaries, at 
baseline and during follow-up. In clinical practice, GP summaries are used in order to give an 
indication of the patient’s significant co-morbidities, home or telephone consultations, 
repeat prescriptions, a list of medications from the last 3 months, any allergies or 
intolerances, and any related health history i.e. blood pressure, height, weight, history of 
smoking etc. Once the patient had died, the team collected copies of the patient’s hospital 






 Demographic characteristics and medical history 
In addition to collecting data on age and sex, the LATCH research team recorded history of 
previous stroke or TIA, hypertension, diabetes and atrial fibrillation. Classification for each of 
these was based on whether the participant had been diagnosed prior to their index ICH and 
if it was recorded in their primary care or hospital notes. Participants were classified as having 
hypertension if either a history of hypertension had been documented in their medical 
records or if they were taking antihypertensive medications at the time of their ICH. Pre-
existing level of dependency was evaluated using the modified Rankin scale, where patients 
with a score of >2 were considered dependent (van Swieten et al 1988).      
 
 Follow-up 
Multiple sources of follow-up included an annual review of patient’s primary care and 
hospital records, annual questionnaires that were sent to the patient’s GP to determine level 
of dependency (according to the modified Rankin Scale) and whether there had been any 
recurrent stroke or new diagnosis of dementia, and review of death certificates (if 
applicable). 
 
 Evaluation of cognitive impairment and dementia 
Primary care and hospital records for each patient were reviewed for the presence of 
dementia or cognitive impairment before and after their index ICH. This involved hand-
searching of the entire record including individual consultations, clinic letters and 
hospitalisation documentation. Diagnosis was often recorded in hospital notes or clinic 
letters but not the primary care diagnosis list. In some cases, diagnosis was made on the basis 
of cognitive impairment that was apparent from hand-searching of the medical record 
including individual primary care consultations, hospital physician consultations and nursing 





 Definitions  
The diagnosis of dementia was confirmed following the criteria set out in Box 13, recorded 
in either the hospital or primary care records. 
Box 13: Criteria for the diagnosis of dementia 
Diagnosis of dementia was confirmed if there was:  
1. Evidence that the DSM-IV criteria have been fulfilled (American Psychiatric Association, 
1994): 
• Documented evidence of previously normal cognitive and social function,  
• Decline of cognitive and social function that was irreversible with medical or 
psychiatric treatment, 
• Evidence of memory impairment,  
• Dementia that causes significant impairment in social or occupational functioning 
and represents a significant decline from previous level of functioning,  
• Documented evidence of one or more of the following cognitive disturbances: 
aphasia, apraxia, agnosia or disturbance in executive function.  
2. A READ code used in the GP electronic record diagnostic summary that implied 
dementia (Dementia Partnerships 2012; Table 7) 
3. A prescription of medication intended to enhance cognition (i.e. cholinesterase 
inhibitors) (Table 8)  
The diagnosis of cognitive impairment was confirmed following the criteria set out in Box 14, 
recorded in either the hospital or primary care records.  
Box 14: Criteria for the diagnosis of cognitive impairment 
Diagnosis of cognitive impairment was confirmed if there was: 
1. Evidence that the following conditions for Mild Cognitive Impairment have been met 
(Albert et al, 2011): 
• Concerns regarding a change in cognition, 
104 
 
• Impairment in one or more cognitive domains, 
• Preservation of independence in functional abilities, 
• not demented. 
2. A READ code used in the GP electronic record diagnostic summary that indicates a non-
specific cognitive problem, for example: memory loss symptom, mental disorder, cognitive 
impairment, cognitive decline, confusional state, memory disturbance or memory loss of 
elderly. 
If there was no mention of any of the above, the patient was categorised as having no history 
of dementia. The classifications for dementia on the study database were as follows:  
1. Diagnosis of dementia;  
2. Cognitive impairment (no dementia); or  
3. No history of dementia.  
Table 7: Dementia specific READ Codes  
READ Code Description 
E012.11, Eu10711 Alcoholic dementia NOS 
Eu00z11 Alzheimer’s dementia unspecified 
Eu00111 Alzheimer’s disease type 1 
Eu00013 Alzheimer’s disease type 2 
Eu004, Eu01.11 Arteriosclerotic dementia 
E004100 Arteriosclerotic dementia with delirium  
E004200 Arteriosclerotic dementia with paranoia 
E004300 Arteriosclerotic dementia with depression 
E004z00 Arteriosclerotic dementia NOS 
Eu00, F110.00 Dementia in Alzheimer’s Disease 
Eu000, F110000 Dementia in Alzheimer’s Disease with early onset 
Eu001, F110100 Dementia in Alzheimer’s Disease with late onset 
Eu00200 Dementia in Alzheimer’s Disease, atypical or mixed type 
Eu00z Dementia in Alzheimer’s Disease, unspecified 
Eu021 Dementia in Creutzfeldt-Jacob Disease 
Eu022 Dementia in Huntington’s Disease 
Eu023 Dementia in Parkinson’s Disease 
Eu024 Dementia in Human Immunodeficiency Virus (HIV) Disease  
E02y1 Drug-induced dementia 
Eu025, F116.00 Lewy body dementia 
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READ Code Description 
Eu013 Mixed cortical and subcortical vascular dementia 
Eu011, Eu004.11 Multi-infarct dementia 
E012.00 Other alcoholic dementia 
Fyu3000 Other Alzheimer’s disease 
Eu01y Other vascular dementia 
Eu020, F111.00 Pick’s disease/ Frontotemporal dementia  
Eu00011 Presenile dementia; Alzheimer’s Type 
Eu00012 Primary degenerative dementia; Alzheimer’s type; presenile onset  
EU00113 Primary degenerative dementia of Alzheimer’s type; senile onset 
Eu00112 Senile dementia; Alzheimer’s type 
Eu012 Subcortical vascular dementia 
Eu01.00 Vascular Dementia 
Eu010 Vascular dementia of acute onset 
Eu01z Vascular dementia, unspecified 
 
Table 8: List of medications to enhance cognition 
Dementia and cognitive impairment were defined as pre- or post-event according to whether 
the diagnosis was made before or after the index ICH. The term cognitive decline is used in 
this thesis when referring to a grouping of patients with either cognitive impairment or 
dementia. 
Based on evidence that less than half of people with dementia in the UK are ever formally 
diagnosed with dementia, GP summaries held in the LATCH audit records were 
supplemented by IQCODE questionnaires for the sub-set of patients who were also in the 
LINCHPIN research study (Iliffe et al 2009; Connolly et al 2011). The IQCODE can be very 
useful in the screening and evaluation of dementia. This questionnaire is rated by a relative, 
who is asked to compare the participant’s ability to perform a list of daily tasks requiring 
memory and other intellectual abilities with his or her baseline 10 years prior to the index 
Medication Brand Name 
Donepezil Aricept, Aricept Evess 
Galantamine Reminyl, Reminyl XL 
Rivastigmine Exelon 
Memantine hydrochloride Exiba 
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event. IQCODE scores between 53 and 63 were classified as cognitive impairment with no 
dementia, and pre-existing dementia was recorded as an IQCODE score of 64 and above 
(Jorm 1994). The IQCODE allowed for the validation of the medical records-based 
assessments for the presence of cognitive impairment and/or dementia before ICH.  
 
 Radiological assessment 
Brain CT scans were available for all patients on admission. At least one neuroradiologist 
evaluated CT images with a standardised pro forma derived from previous largescale stroke 
studies (Rodrigues et al, 2018). Using the CT scans, the following data were recorded:  
• location of haemorrhage (lobar or non-lobar) 
• haemorrhage volume 
• presence or absence of old vascular lesions (lacunes) 
• severity of anterior and posterior white matter lucencies (3-point rating scale with a 
higher score denoting more severe white matter lucencies (van Swieten et al, 1990)) 
• severity of central (deep) or cortical cerebral atrophy (3-point rating scale where a 
higher score denotes a more severe atrophy (Sato et al, 2016) 
• composite SVD score (one point for each of the following: >1 lacune, severe white 
matter lucencies and severe atrophy) 
 
 Definition of lobar and non-lobar ICH 
ICH location was defined as either ‘lobar’ or ‘non-lobar’. At least one experienced consultant 
neuroradiologist reviewed diagnostic brain imaging and classified ICH location as ‘non-lobar’ 
if an adult had a single infratentorial ICH (located in the brainstem or cerebellum), a single 
supratentorial deep ICH (located in the basal ganglia, internal or external capsule or thalamus 
without extension to a lobar area), or multiple ICHs in solely non-lobar locations (either 





 Hematoma volume 
Hematoma volume was calculated using the first CT brain scan after the adult’s presentation 
with ICH using the ABC/2 method where: A is the largest diameter of ICH on in the axial plane 
(cm); B is the largest diameter at 90 degrees to A on the same slice (cm) and; C is the depth 
of the haemorrhage as measured by the number of axial CT slices on which the ICH is visible 
(cm) (Newman 2007). 
 
 Composite CT SVD score 
A team of researchers from the Third International Stroke Trial created an aggregate small 
vessel disease score by summing white matter changes, presence of lacunes and brain 
atrophy scores. White matter changes were rated with the Van Swieten Scale, where the 
posterior (range 0-2) and anterior (range 0-2) scores were combined into a 5-point ordinal 
scale (0-4) (van Swieten et al, 1990). The presence and number of lacunes was recorded 
and brain atrophy was defined as central (deep) or cortical and rated with a 3-point ordinal 
scale as: none, moderate, or severe (Sato et al, 2016). One point was assigned for each of the 
following if present: severe lucencies (Van Swieten Scale = 2) in anterior or posterior white 
matter, lacunes >1, and severe (=2) central or cortical atrophy. The combined 4-point ordinal 
score therefore assessed the global burden of small vessel disease from 0 (no imaging 
features of severe SVD) to 3 (imaging features of SVD scored as severe for each imaging 
variable) (Arba et al, 2017). 
 
 Edinburgh CAA criteria 
For patients who had a lobar ICH, the Edinburgh CT and genetic diagnostic criteria for CAA 
was also available (Rodrigues et al, 2018). The Edinburgh CAA criteria can predict the 
likelihood of underlying moderate/severe CAA. For the Edinburgh CAA criteria (CT only), 
scores were based on the absence or presence of subarachnoid haemorrhages and finger-
like projections (elongated extensions arising from the haematoma, longer than they are 
wide, regardless of whether they extended to the cortex or not). For the Edinburgh CAA 
criteria (CT and APOE genotype), scores were based on the absence or presence of 
subarachnoid haemorrhages, finger-like projections and possession of the Apolipoprotein E 
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(APOE) e4 allele2. A low score signified that none of the features were present and a high 
score signified that at least two- or both for the CT only criteria- of the features were present.  
 
 Statistical Analysis 
SPSS statistical software was used to conduct statistical analyses. The analysis of data were 
carried out separately for each of the research questions as outlined below.  
1. What is the prevalence of pre-existing cognitive impairment and dementia in patients 
who have had an ICH? 
Using descriptive statistics, the prevalence of cognitive impairment with no dementia and 
pre-existing dementia is described with 95% confidence intervals (CI).  
2. What factors are associated with pre-existing cognitive impairment and dementia in 
patients who have had an ICH? 
According to the scale of variances, differences in clinical as well as imaging features between 
the three ICH groups (‘no cognitive decline, ‘pre-existing cognitive impairment (no 
dementia)’ and ‘pre-existing dementia’) were compared with bivariate analyses (Pearson Chi-
square tests or Kruskal-Wallis tests where appropriate). Continuous data are reported as 
medians and inter-quartile range (IQR). Categorical data are presented as frequencies and 
percentages.  
To determine which of the variables above were potential risk factors, separate binomial 
logistic regressions were performed for those with pre-existing cognitive decline (cognitive 
impairment or dementia) and pre-existing dementia only (7-10 events per variable).  
 
 
2 For APOE genotype analysis, the research team obtained DNA from peripheral blood 
samples or cerebellar tissue stored in the LINCHPIN brain bank. APOE genotype was classified 
as APOE ε4 possession if they had at least one ε4 allele. 
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3. What is the incidence of new-onset cognitive decline and dementia within 1-5 years of 
ICH? 
After the exclusion of prestroke cognitive decline, Kaplan-Meier survival analyses (Kaplan and 
Meier 1958) was used to determine the proportion of patients surviving free of cognitive 
decline or dementia 1-5 years after their ICH. 
4. What factors are associated with new-onset cognitive decline and dementia in patients 
who have had an ICH? 
To investigate differences in survival distributions between baseline characteristics and those 
at risk of developing new-onset cognitive decline (cognitive impairment or dementia) within 
5 years of their stroke, univariate analysis was conducted using the log-rank test (Savage 
1956). Using Cox proportional hazards regression models (Cox 1972), separate multivariate 
analysis was then performed to explore independent factors on the presence of new-onset 
cognitive decline and new-onset dementia (7-10 outcome events per predictor variable). 
5. How accurate is the GP electronic medical record for identifying cognitive decline and/or 
dementia, compared to a reference standard of the IQCODE? 
Using descriptive statistics, patient’s pre-ICH cognitive status according to their electronic 
medical records were compared with the results of the IQCODE. 
 
 Strengths and limitations  
Strengths of the study include its prospective, community-based design, with multiple 
overlapping sources of case ascertainment and comprehensive data collection. The study is 
based on an unselected cohort of consecutive patients, in a representative population.  The 
LATCH research team examined exclusively a cohort of ICH patients and used standardised 
data collection. 
In stroke cohorts, death occurring during follow-up can be a serious competing risk. 
Therefore, I decided to take this into account during the survival analysis. 
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The main strength of this study is the detailed neuroimaging description of structural markers 
of CAA and SVD in the context of pre- and post-ICH cognitive decline. However, a major 
limitation is that it did not include MRI data to support the diagnosis of any underlying CAA.  
Another limitation is that there were no standardised assessments of cognitive impairment. 
Pre-existing and new-onset cognitive impairment and dementia were classified based on 
medical records alone. Although I tried to correct for this by hand searching of the entire GP 
consultation record including individual consultation records and all hospital clinic and 
discharge letters to look for evidence of cognitive impairment satisfying the DSM-IV criteria 
for dementia, given that dementia is consistently underdiagnosed in primary care settings, 
the prevalence of cognitive impairment and dementia may be higher than that demonstrated 




6.  Results: LATCH COG 
 Study population 
The study population consisted of 404 patients (219 females; 54%; 95% CI 49-59%) with a 
median age of 77 years (interquartile range 68-84), all of which had available CT data from 
the time of their index ICH. Within the seven-year follow-up period, 312 patients died (77%; 
95% CI 73-81%). One hundred and ninety-nine patients had a lobar haemorrhage (49%; 95% 
CI 44-54%) and 205 patients had a non-lobar haemorrhage (51%; 95% CI 46-56%). 
 
 Prevalence of pre-existing cognitive decline and dementia  
Ninety-three patients had pre-existing cognitive decline (23%; 95% CI 19-27%).  
Forty-one patients (10%; 95% CI 7-14%) had cognitive impairment with no dementia. The 
prevalence of cognitive impairment with no dementia was 11% in the lobar group (22 
patients; 95% CI 7-16%) and 9% in the non-lobar ICH group (19 patients; 95% CI 6-14%).  
Fifty-two patients met the criteria for pre-existing dementia (13%; 95% CI 10-17%). The 
prevalence of pre-existing dementia was 19% in the lobar group (37 patients; 95% CI 13-25%) 
and 7% in the non-lobar ICH group (15 patients; 95% CI 4-12%).  
 
 Factors associated with pre-existing cognitive decline and dementia  
The following variables include known predictors of dementia for stroke patients and the 
elderly population in general and were available for analysis (Baumgart et al, 2015; Zulkifly 
et al, 2016): age, sex, hypertension, diabetes, atrial fibrillation, previous ischaemic stroke or 
TIA, modified Rankin score, ICH location (lobar vs non-lobar), haemorrhage volume, presence 
of old vascular lesions, presence of anterior or posterior white matter lucencies, rating of 
central and cortical atrophy and composite SVD score. For the subgroup of patients where 
data were available, the Edinburgh CAA criteria (CT only) and Edinburgh CAA criteria (CT and 
APOE genotype) variables were also selected.   
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Differences in clinical as well as CT imaging features between the three ICH groups (‘no 
cognitive decline, ‘Pre-existing cognitive impairment (no dementia)’ and ‘pre-existing 
dementia’) were compared with univariate analyses to test for significance. 
To determine whether there were statistically significant differences between the three ICH 
groups and the continuous and ordinal variables, the Kruskall-Wallis test was conducted 
(data were not normally distributed according to the Shapiro-Wilk Test). To determine 
whether there was a difference in distributions between the categorical variables and the 
three ICH groups, a Chi-squared test was conducted. If any cells had an expected count of 
less than 5, a Fisher’s exact test was applied.  
Continuous data are reported as medians and interquartile ranges and categorical data 
presented as frequencies and percentages. Any missing data are made explicit when 
presenting results. The majority of missing data are related to analysis using the Edinburgh 
CAA criteria as this only applied to patients who had a lobar ICH. In addition, information 
relating to genotyping was only available for patients who had consented to the LINCHPIN 
study. 
When conducting multiple analyses on the same dependent variable, the chance of 
committing a Type I error- rejecting the null hypothesis when you should not- increases, thus 
increasing the likelihood of observing a significant result by pure chance. To correct for this, 
or protect from Type I error, a Bonferroni correction was conducted (Bland and Altman 1995). 
The new p-value will be the alpha-value (αoriginal = .05) divided by the number of 
comparisons (15): (αaltered = .05/15) = .003. To determine if any of the 15 comparisons is 
statistically significant, the p-value must be p ≤ .003 (see Tables 9 and 10 for results of 









Table 9: Characteristics of patients with no cognitive decline, with pre-existing cognitive 
impairment (no dementia) and with pre-existing dementia  
 No cognitive 
decline 





(n= 41) (%) 
Pre-existing 
dementia 
(n= 52) (%) 
p 
Demographics     
   Agea  75 (65-83) 80 (74-85) 82 (78-87) <.0001 
   Female sex 163 (52) 22 (54) 34 (65) .220 
Vascular Risk Factors     
   Hypertension 207 (67) 28 (68) 31 (60) .584 
   Diabetesb 34 (11) 7 (17) 5 (10) .478 
Medical History     
   Atrial Fibrillation 68 (22) 6 (15) 15 (29) .257 
   Previous ischaemic stroke or 
TIA 
67 (22) 15 (37) 14 (27) .088 
Functional Status     
   modified Rankina 1 (0-2) 2 (1-3) 3 (2-3) <.0001 
Radiological data     
   ICH Location    .002 
      Non-lobar 171 (55) 19 (46) 15 (29)  
      Lobar 140 (45) 22 (54) 37 (71)  
   Volume (ml)a 18 (5-48) 16 (4-61) 40 (14-90) .003 
   Old vascular lesion 127 (41) 22 (54) 24 (46) .259 
   Anterior wm lucencies scorea 1 (1) 1 (1-2) 2 (1-2) <.001 
   Posterior wm lucencies scorea 1 (0-2) 2 (1-2) 2 (1-2) <.001 
   Central atrophy scorea 1 (0-1) 1 (1-2) 1 (1) <.001 
   Cortical atrophy scorea  1 (0-1) 1 (1-2) 1 (1-2) .080 
   Composite SVD scorea 1 (0-2) 1 (1-2) 1 (1-2) .001 





Table 10: Edinburgh CAA criteria data for lobar ICH patients with no cognitive decline, with 
cognitive impairment (no dementia) and with pre-existing dementia 
 No cognitive 
decline 








(n= 37) (%) 
p 
   Edinburgh CAA criteria (CT only)a    .005 
       Low 44 (31) 7 (32) 3 (8)  
       Intermediate 73 (52) 10 (45) 19 (51)  
       High 23 (16) 5 (23) 15 (41)  
   Edinburgh CAA criteria (CT &     
    APOE)ab 
   .797 
       Low 11 (8) 2 (9) 1 (3)  
       Intermediate 23 (16) 5 (23) 4 (11)  
       High 19 (14) 3 (14) 6 (16)  
a Fisher’s Exact test; b Missing data for 125 patients   
After testing that the distribution of scores was similar for all groups (as assessed by visual 
inspection of boxplots), both median age (χ2(2) = 29.967; p = <.001) and haemorrhage volume 
(χ2(2) = 11.445; p = 0.003) were statistically significant between the three ICH groups. Where 
a statistically significant difference was found, pairwise comparisons were then performed 
using Dunn’s (1964) procedure with a Bonferroni correction for multiple comparisons with 
those variables. Adjusted p-values and median values are presented below.  
Post hoc analysis revealed statistically significant differences in median age between: 
• ‘no cognitive decline’ (75.0) and ‘pre-existing cognitive impairment (no dementia)’ 
(80.0) (p = 0.049) 
• ‘no cognitive decline’ (75.0) and ‘pre-existing dementia’ (82.0) (p = <.0001)  




• ‘pre-existing cognitive impairment (no dementia)’ (15.6) and ‘pre-existing dementia’ 
(40.2) (p = 0.033)  
• ‘no cognitive decline’ (17.7) and ‘pre-existing dementia’ (40.2) (p = 0.003)  
For those variables where the distribution of scores was not similar for all groups (as assessed 
by visual inspection of boxplots), a comparison of distributions was made. The distribution of 
anterior (χ2(2) = 33.379; p = <0.001)  and posterior (χ2(2) = 17.176; p = <0.001)  white matter 
lucencies scores, central atrophy scores (χ2(2) = 19.847; p = <0.001), SVD scores (χ2(2) = 
14.461; p = 0.001) and modified Rankin scores (χ2(2) = 79.995; p = <0.001) were statistically 
significant between the three ICH groups. Where a statistically significant difference was 
found, pairwise comparisons were then performed using Dunn’s (1964) procedure with a 
Bonferroni correction for multiple comparisons with those variables. Adjusted p-values are 
presented below. 
Post hoc analysis revealed statistically significant differences in anterior white matter 
lucencies scores between: 
• ‘no cognitive decline’ and ‘pre-existing cognitive impairment (no dementia)’ (p = 
0.002), 
• ‘no cognitive decline’ and ‘pre-existing dementia’ (p = <.0001)  
Post hoc analysis revealed statistically significant differences in posterior white matter 
lucencies scores between:  
• ‘no cognitive decline’ and ‘pre-existing cognitive impairment (no dementia)’ (p = 
0.019)  
• ‘no cognitive decline’ and ‘pre-existing dementia’ (p = 0.002)  
Post hoc analysis revealed statistically significant differences in central atrophy scores 
between:   
• ‘no cognitive decline’ and ‘pre-existing cognitive impairment (no dementia)’ (p = 
0.006) 
• ‘no cognitive decline’ and ‘pre-existing dementia’ (p = 0.001)  
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Post hoc analysis revealed statistically significant differences in small vessel disease scores 
between:  
• ‘no cognitive decline’ and ‘pre-existing cognitive impairment (no dementia)’ (p = 
0.030)  
• ‘no cognitive decline’ and ‘pre-existing dementia’ (p = 0.006)  
Post hoc analysis revealed statistically significant differences in modified Rankin scores 
between:  
• ‘no cognitive decline’ and ‘pre-existing cognitive impairment (no dementia)’ (p = 
0.001)  
• ‘no cognitive decline’ and ‘diagnosis of dementia’ (p = <.001)  
• ‘pre-existing cognitive impairment (no dementia)’ and ‘pre-existing dementia’ 
groups (p = 0.003) 
For those categorical variables where a statistically significant difference was shown, 
Cramer’s V test was then run to provide an estimate of the effect size. See Box 15 for 
suggested guidelines on how to interpret Cramer’s V (Cohen 1998).  
Box 15: Cramer's V magnitude of effect size 




Statistically significant differences were found between the following variables and the three 
ICH groups: ICH location (χ2(4) = 12.531; p= 0.002) and Edinburgh CAA criteria (CT only) (χ2(4) 
= 14.397; p = 0.005). The effect size was small for both variables, where Cramer’s V = 0.176 
for ICH location and 0.188 for Edinburgh CAA criteria (CT only).  
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To determine which of the variables above were potential risk factors, separate binomial 
logistic regressions were performed for those with pre-existing cognitive decline (cognitive 
impairment or dementia) and pre-existing dementia only (7-10 events per variable). The 
following variables, chosen from the results of the literature review (Section 2.2, Table 4), 
were included in the logistic regression model for cognitive decline: age, sex, location of the 
haemorrhage (lobar vs non-lobar), haemorrhage volume, presence of old vascular lesions, 
presence of anterior and posterior white matter lucencies, rating of central and cortical 
atrophy and composite SVD score.  
To ensure that the assumptions of the logistic regression were met, a test for multicollinearity 
was first performed. The Variance Inflation Factor (VIF) values were well below 10 
(suggesting that the variance of the regression coefficient had not been inflated due to 
multicollinearity in the model) and the tolerance statistics all above 0.2 (indicating a low 
threat of multicollinearity) (Myers 1990; Menard 1995). Linearity of the continuous variables 
with respect to the logit of the dependent variable was also assessed via the Box-Tidwell 
procedure (Box and Tidwell 1962). Based on this assessment, both continuous independent 
variables (age and haematoma volume) were found to be linearly related to the logit of the 
dependent variable. To assess for outliers, patients with studentized residual values greater 
than 2.5 were inspected to determine whether they needed to be removed from the analysis. 
There were five studentized residuals with values between 2.715 and 9.388 standard 
deviations which were kept in the analysis after inspecting that the Cook’s distance and 
leverage values were within a normal range.    
The logistic regression model was statistically significant, χ2(10) = 71.474, p = <0.001. The 
model explained 25% (Nagelkerke R2) of the variance in pre-existing cognitive decline and 
correctly classified 76% of cases. Sensitivity was 16% and specificity was 94%. According to 
the Hosmer-Lemeshow test, the model is also a good fit (p = 0.748) as it is not statistically 
significant.   
The area under the ROC curve (Figure 5) was .779 (95% CI .731-.828), which is an acceptable 
level of discrimination according to Hosmer, Lemeshow and Sturdivant (2013). Here, 
discrimination is the ability of the logistic regression model to distinguish between those 
patients with and without the event of interest (i.e. be able to predict who had, or did not 
have, pre-existing cognitive decline).   
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Of the ten predictor variables, only four were statistically significant: age, lobar ICH location, 
haemorrhage volume and presence of central atrophy (Table 11).  
Figure 5: ROC curve for pre-existing cognitive decline 
 















Age, per 1-year increase  .004 1.05 1.02 1.08 
Female sex .901 1.04 .60 1.78 
Lobar haemorrhage .003 2.32 1.34 4.02 
Haematoma volume, per 1ml 
increase 
.017 1.01 1.00 1.01 
Old vascular lesion .523 1.20 .69 2.06 
Anterior white matter 
lucencies 
.546 1.34 .49 3.90 
Posterior white matter 
lucencies 
.313 1.53 .67 3.46 
Central atrophy .001 4.50 1.81 11.16 
Cortical atrophy .981 .99 .51 1.92 
SVD score >0 .122 1.80  .86  3.78 
119 
 
Patients who had a lobar ICH were twice as likely to exhibit pre-existing cognitive decline 
than those who had a non-lobar ICH, and patients with central atrophy were over 4 times 
more likely to exhibit cognitive decline than those without. Increasing age was also 
associated with an increased likelihood of patients having cognitive decline prior to their 
stroke, as was a larger haemorrhage volume.     
The following variables, chosen from the results of the literature review (Section 2.2, Table 
4) were included in the logistic regression model for dementia only: age, sex, location of the 
haemorrhage (lobar vs non-lobar), haemorrhage volume, presence of central atrophy and 
composite small vessel disease score. 
To ensure that the assumptions of the logistic regression were met, a test for multicollinearity 
was first performed. The VIF values were well below 10 (Menard 1995) and the tolerance 
statistics all above 0.2 (Myers 1990). Linearity of the continuous variables with respect to the 
logit of the dependent variable was also assessed via the Box-Tidwell procedure (Box and 
Tidwell 1962). Based on this assessment, both continuous independent variables (age and 
haematoma volume) were found to be linearly related to the logit of the dependent variable. 
To assess for outliers, patients with studentized residual values greater than 2.5 were 
inspected to determine whether they needed to be removed from the analysis. There were 
thirteen studentized residuals with values between 2.637 and 4.345 standard deviations, 
which were kept in the analysis after inspecting that the Cook’s distance and leverage values 
were within a normal range. 
The logistic regression model was statistically significant, χ2(6) = 63.967, p = <0.001. The 
model explained 27% (Nagelkerke R2) of the variance in pre-existing dementia and correctly 
classified 87% of cases. Sensitivity was 8% and specificity was 99%. According to the Hosmer-
Lemeshow test, the model is also a good fit (p = 0.472).  The area under the ROC curve (Figure 
6) was .821 (95% CI .771-.872), which is excellent level of discrimination according to Hosmer, 







Figure 6: ROC curve for pre-existing dementia 
 
Of the six predictor variables, five were statistically significant: lobar ICH location, presence 
of central atrophy, composite SVD score >0, haemorrhage volume and age (Table 12).  















Female sex  .528 1.24 .634 2.43 
Age, per 1-year increase .001 1.07 1.03 1.12 
Lobar haemorrhage  .002 3.06 1.51 6.22 
Haematoma volume, per 1ml 
increase 
.004 1.01 1.00 1.02 
SVD score > 0 .028 2.71 1.11 6.60 
Central atrophy .002 8.23 2.15 31.57 
Patients who had a lobar ICH were 3 times more likely to exhibit pre-existing dementia than 
those who had a non-lobar ICH, while patients with evidence of central atrophy were 8 times 
more likely to exhibit dementia before their stroke than those without. Increasing age and 
haemorrhage volume were also associated with an increased likelihood of patients having 
dementia prior to their stroke, as were patients with evidence of small vessel disease.  
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 Incidence of new-onset cognitive decline and dementia within 1-5 
years of first-ever ICH 
After excluding patients with prestroke cognitive impairment and dementia from the cohort 
above, Kaplan-Meier survival analyses methods were used to determine the proportion of 
patients surviving free of cognitive decline (cognitive impairment or dementia) after their ICH 
(Kaplan and Meier 1958). A separate analysis was then conducted to determine the 
proportion of patients surviving free of dementia. For every year of follow-up, the Kaplan-
Meier method estimates the probability of patients surviving free of cognitive decline past 
that given time-point, taking into consideration the presence of censored cases (i.e. patients 
who die or are lost to follow-up).    
Of the 404 patients, 93 were excluded from this part of the analysis due to pre-existing 
cognitive decline. The study population for the survival analysis is therefore 311 patients (163 
[52%] are female), with a median age of 75 years (IQR 65-83). 140 patients had a lobar 
haemorrhage (45%; 95% CI 40-51%), 171 patients had a non-lobar haemorrhage (55%; 95% 
CI 49-61%) (see Table 13 and 14 for baseline characteristics of patients without pre-existing 
cognitive decline).   
 
Table 13: Baseline characteristics of study population, excluding those with prestroke 
cognitive decline 
 No evidence of 
cognitive decline 
(n= 249) (%) 
New-onset cognitive 
impairment or 




Demographics    
   Age 76 (65-83) 75 (66-81) 79 (74-84) 
   Female sex 131 (53) 32 (52) 17 (65) 
Vascular Risk Factors    
   Hypertension 167 (67) 40 (65) 17 (65) 
   Diabetes 27 (11) 7 (11) 3 (12) 
Medical History    
   Atrial Fibrillation 54 (22) 14 (23) 6 (23) 
   Previous ischaemic stroke   
    or TIA 
54 (22) 13 (21) 8 (31) 
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 No evidence of 
cognitive decline 
(n= 249) (%) 
New-onset cognitive 
impairment or 




Functional Status    
   modified Rankin >2 39 (16) 9 (15) 6 (23) 
Radiological data    
   ICH Location    
           Non-lobar 144 (58) 27 (44) 10 (39) 
       Lobar   105 (42) 35 (57) 16 (62) 
   Volume (ml) 21 (6-55) 11 (3-24)  8 (2-31) 
   Old vascular lesion 101 (41) 26 (42) 13 (50) 
   Anterior wm lucencies    0 62 (25) 11 (18) 2 (8) 
                                            1 125 (50) 41 (66) 19 (73) 
                                            2 62 (25) 10 (16) 5 (19) 
   Posterior wm lucencies  0            91 (37) 21 (34) 4 (15) 
                                               1 54 (22) 16 (26) 9 (35) 
                                               2 104 (42) 25 (40) 13 (50) 
   Central atrophy score     0 75 (30) 19 (31) 7 (27) 
                                           1 141 (57) 37 (60) 16 (62) 
                                               2 33 (13) 6 (10) 3 (12) 
   Cortical atrophy score     0 70 (28) 17 (27) 4 (15) 
                                                1 127 (51) 37 (60) 17 (65) 
                                                2 52 (21) 8 (13) 5 (19) 
    Composite SVD score      0 95 (38) 27 (44) 9 (35) 
                                                1 90 (36) 21 (34) 9 (35) 
                                                2 53 (21) 11 (18) 6 (23) 







Table 14: Edinburgh CAA criteria data for lobar ICH patients, excluding those with prestroke 
cognitive decline  
 No evidence of 
cognitive decline  
(n= 105) (%) 
New-onset cognitive 
impairment or 




Edinburgh CAA criteria (CT only)    
      Low     32 (30) 12 (34) 6 (38) 
      Intermediate    54 (51) 19 (54) 8 (50) 
      High 19 (18) 4 (11) 2 (13) 
  Edinburgh CAA criteria (CT &     
  APOE)a 
   
       Low 9 (9) 2 (6) 1 (6) 
       Intermediate 14 (13) 9 (26) 4 (25) 
       High 13 (12) 6 (17) 1 (6) 
aMissing data for 97 patients 
During the first 5 years of follow-up, 60 patients developed new-onset cognitive decline and 
222 died (including 30 patients who died after the diagnosis of new-onset cognitive decline). 
Cumulative survival rates for patients remaining free of cognitive decline were 82% in the 
first year, and reached 76% at 2 years, 74% at 3 years, 69% at 4 years and 65% at 5 years (see 
Figure 7).  




During the first 5 years of follow-up, 24 patients developed new-onset dementia. Cumulative 
survival rates for patients remaining free of dementia were 95% in the first year, and reached 
92% at 2 years, 91% at 3 years, 87% at 4 years and 84% at 5 years (see Figure 8).  
Figure 8: Survival curve for new-onset dementia 
 
 Factors associated with new-onset cognitive decline and dementia  
To investigate differences in survival distributions between baseline characteristics and those 
at risk of developing new-onset cognitive decline within 5 years of their stroke, univariate 
analysis was conducted using the log-rank test (Savage 1956). The log-rank tests the 
hypothesis that there is no difference in survival times between the groups being studied at 
any of the time points. The log rank test compares the observed and expected number of 
events for each group using the same test statistic as the Chi-squared test, although the 
calculations for the expected frequencies are different. Log-rank tests can only be run with 
categorical variables as such, any continuous variables had to be categorised. Age and 
haematoma volume were both dichotomised around the median.  
One of the assumptions of the Kaplan-Meier method is that censorship (those who do not 
experience the event) is similar in all groups tested. It is assumed that censoring is not related 
to time and that the pattern of censoring is the same in all groups.  Failure to meet this 
assumption can lead to false conclusions being drawn. To detect censoring in each of the 
variables, I examined the percentage of censored cases per group to determine whether 
there was a similar amount of censorship. 
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I could not detect statistically significant results when investigating the differences in survival 
distributions between baseline characteristics and patients with new-onset cognitive decline 
(Table 15).  
Table 15: Associations of new-onset cognitive decline with baseline characteristics  
 n No. of 
events 
𝑥2 p 
Demographics and medical history     
Age, >75 75 (65-83) 26 .294 .588 
Female sex 163 (52%) 30 .511 .475 
Hypertension 207 (67%) 39 .120 .729 
Diabetes 34 (11%) 7 1.455 .228 
Atrial Fibrillation 68 (22%) 14 .674 .412 
Previous ischaemic stroke or TIA 67 (22%) 12 .020 .888 
Functional status     
modified Rankin >2a 48 (16%) 9 1.871 .171 
Radiological data     
ICH Location   2.888 .089 
Non-lobar 171 (55%) 26   
Lobar 140 (45%) 34   
Volume, >18ml 17.7 (5-48.2) 19 .055 .814 
Old vascular lesion 127 (41%) 26 1.050 .306 
Anterior wm lucencies score >0 238 (77%) 50 3.935 .047 
Posterior wm lucencies score >0 199 (64%) 40 3.562 .059 
Central atrophy score >0 217 (70%) 43 1.009 .315 
Cortical atrophy score >0 224 (72%) 43 .104 .747 
Composite SVD score >0 189 (61%) 33 .559 .455 
Edinburgh CAA criteria (CT only)b  
    Intermediate/High 
95 (31%) 21 .042 .837 
Edinburgh CAA criteria (CT & APOE)c  
    Intermediate/High 
42 (14%) 14 1.622 .203 
Data are n (%) or median (IQR). a Missing data for 3 patients; b Missing data for 171 patients 
(lobar ICH only); c Missing data for 258 patients (lobar ICH only)  
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However, log-rank tests determined that there were statistically significant differences 
between those with new-onset dementia and patients who were older in age (χ2(1) = 9.543; 
p = .002) and had posterior white matter lucencies (χ2(1) = 11.942; p = 0.001) (Table 16; 
Figures 9 and 10).    
Table 16: Associations of new-onset dementia with baseline characteristics  
 n No. of events 𝑥2 p 
Demographics and medical history      
Age, >75 75 (65-83) 15 9.543 .002 
Female sex 163 (52%) 15 .967 .325 
Hypertension 207 (67%) 16 .146 .702 
Diabetes 34 (11%) 3 1.030 .310 
Atrial Fibrillation 68 (22%) 6 .793 .373 
Previous ischaemic stroke or TIA 67 (22%) 7 1.904 .168 
Functional Status     
modified Rankin >2a 48 (16%) 6 8.215 .004 
Radiological data     
ICH Location   2.965 .085 
Non-lobar 171 (55%) 9   
Lobar 140 (45%) 15   
Volume, >18ml 17.7 (5-48.2) 8 .213 .645 
Old vascular lesion 127 (41%) 12 1.025 .311 
Anterior wm lucencies score >0 238 (77%) 23 7.065 .008 
Posterior wm lucencies score >0 199 (64%) 21 11.942 .001 
Central atrophy score >0 217 (70%) 19 3.030 .082 
Cortical atrophy score >0 224 (72%) 20 2.695 .101 
Composite SVD score >0 189 (61%) 15 2.520 .112 
Edinburgh CAA criteria (CT only)b  









Edinburgh CAA criteria (CT & APOE)c  









Data are n (%) or median (IQR). a Missing data for 3 patients; b Missing data for 171 patients 
(lobar ICH only); c Missing data for 258 patients (lobar ICH only)  
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Figure 9: Cumulative survival rates for new-onset dementia according to age 
 
Figure 10: Cumulative survival rates for new-onset dementia in patients with and without 
posterior white matter lucencies 
 
Using Cox proportional hazards regression model, separate multivariate analysis was then 
performed to explore independent factors on the presence of new-onset cognitive decline 
and new-onset dementia only (7-10 outcome events per predictor variable). The Cox’s 
regression procedure is similar to logistic regression and enables the difference between 
survival times of particular groups of patients to be tested, while allowing for other factors. 
The main output of the Cox regression model is the hazard ratio (HR), which is given for each 
independent predictor variable. For example, when comparing those who have had a lobar 
ICH to those who have had a non-lobar ICH, the hazard is the probability of the event (e.g. 
new-onset cognitive decline) occurring within a defined time interval, and the hazard ratio is 
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the ratio between the hazard of the event in the lobar group and the hazard of the event in 
the non-lobar group.  
A key assumption of the Cox regression method is that of proportional hazards. This means 
that the survival curves for the groups must have hazard functions that are proportional over 
time. In order to test this assumption, survival curves were plotted for each of the variables 
to be tested in multivariate analysis and a visual inspection made to ensure that the survival 
curves did not cross. 
The following variables, chosen from the results literature review (Section 2.2, Table 4), were 
included in the regression model for new-onset cognitive decline: age, sex, location of the 
haemorrhage, haemorrhage volume, presence of white matter lucencies (anterior and 
posterior) and composite SVD score >0. The Cox’s regression model for new-onset cognitive 
decline was not statistically significant, p = 0.111.  
The following variables included in the logistic regression model for new-onset dementia only 
were age, sex and location of haemorrhage. The Cox’s regression model for new-onset 
dementia was statistically significant, p = <0.001. The only independent risk factor for new-
onset dementia was increasing age (HR per 1-year increase 1.085; 95% CI 1.039-1.133) (Table 
17).  



















Age, per 1-year increase  .000 1.085 1.039 1.133 
Female sex .277 .599 .237 1.509 
Lobar haemorrhage  .149 1.851 .802 4.275 
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 The problem of competing risks 
A competing risk is an event that modifies the chance of the event of interest occurring. In 
the LATCH cohort, death is a major competing risk as it can prevent the observation of new-
onset cognitive decline (e.g. a patient may have started to develop cognitive decline, but they 
died before it was diagnosed by their GP). In this study, death might not only prevent the 
outcome of interest from occurring, it may also strongly alter its probability.  
The primary aim of this PhD is to investigate the long-term outcomes of ICH. We know that 
over 40% of patients die within the first month of their ICH, after which the risk of death 
significantly decreases (Fogelholm et al, 2005). As such, log-rank tests and Cox regression 
models were re-run after excluding those patients who died within the first 30 days after 
their index ICH.   
Of the original cohort of 404 patients, 93 were excluded from this part of the analysis due to 
pre-existing cognitive decline, and a further 143 were excluded due to death within the first 
30 days. The study population for the survival analysis is therefore 168 patients (94 [56%] are 
female), with a median age of 74 years (IQR 61-82). 82 patients had a lobar haemorrhage 
(49%; 95% CI 41-57%) and 86 patients had a non-lobar haemorrhage (51%; 95% CI 43-59%).  
During the first 5 years of follow-up, 47 patients who survived longer than 30-days after their 
stroke developed new-onset cognitive decline and 22 developed new-onset dementia. I 
could not detect statistically significant results when investigating the differences in survival 
distributions between baseline characteristics and patients with new-onset cognitive decline 










Table 18: Associations of new-onset cognitive with baseline characteristics in patients who 
survive past 30 days 
 n No. of events 𝑥2 p 
Demographics     
Age, >74 83 (49%) 26 4.808 .028 
Female sex 94 (56%) 27 .130 .718 
Vascular Risk Factors     
Hypertension 107 (64%) 30 .055 .815 
Diabetes 15 (9%) 7 4.803 .028 
Medical History     
Atrial Fibrillation 36 (21%) 12 1.541 .214 
Previous ischaemic stroke or TIA 32 (19%) 10 .193 .661 
Functional Status     
modified Rankin >2 21 (13%) 8 4.218 .040 
Radiological data     
ICH Location   6.422 .011 
Non-lobar 86 (51%) 17   
Lobar 82 (49%) 30   
Volume, >10ml 79 (47%) 24 .579 .447 
Old vascular lesion 72 (43%) 20 .031 .860 
Anterior wm lucencies score >0 127 (76%) 40 4.711 .030 
Posterior wm lucencies score >0 99 (59%) 32 4.440 .035 
Central atrophy score >0 116 (69%) 36 3.075 .080 
Cortical atrophy score >0 121 (72%) 35 .648 .421 
Composite SVD score >0 91 (54%) 27 1.676 .195 
Edinburgh CAA criteria (CT only)a  









Edinburgh CAA criteria (CT & APOE)b  









Data are n (%) or median (IQR). a Missing data for 87 patients (lobar ICH only); b Missing data 
for 127 patients (lobar ICH only) 
However, log-rank tests also determined that there were statistically significant differences 
between those with new-onset dementia and patients who were older in age (χ2(1) = 12.158; 
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p = <.001), had a modified Rankin score >2 (χ2(1) = 9.383; p = 0.002) and the presence of 
posterior (χ2(1) = 10.328; p = 0.001) white matter lucencies (Table 19 and Figures 11-13). 
Table 19: Associations of new-onset dementia with baseline characteristics in patients who 
survive past 30 days 
 N No. of events 𝑥2 p 
Demographics     
Age, >74 83 (49%) 16 12.158 <.001 
Female sex 94 (56%) 15 1.710 .191 
Medical History      
Hypertension 107 (64%) 15 .417 .519 
Diabetes 15 (9%) 3 1.107 .293 
Atrial Fibrillation 36 (21%) 6 1.190 .275 
Previous ischaemic stroke or TIA 32 (19%) 6 1.094 .296 
Functional Status     
modified Rankin >2 21 (13%) 6 9.383 .002 
Radiological data     
ICH Location   1.389 .239 
Non-lobar 86 (51%) 9   
Lobar 82 (49%) 13   
Volume, >10ml 79 (47%) 11 .100 .752 
Old vascular lesion 72 (43%) 11 .874 .350 
Anterior wm lucencies score >0 127 (76%) 21 6.358 .012 
Posterior wm lucencies score >0 99 (59%) 19 10.328 .001 
Central atrophy score >0 116 (69%) 17 1.838 .175 
Cortical atrophy score >0 121 (72%) 19 3.349 .067 
Composite SVD score >0 91 (54%) 14 2.588 .108 
Edinburgh CAA criteria (CT only)a  









Edinburgh CAA criteria (CT & APOE)b  









Data are n (%) or median (IQR). a Missing data for 87 patients (lobar ICH only); b Missing data 
for 127 patients (lobar ICH only) 
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Figure 11: Cumulative survival rates for new-onset dementia in patients who survive past 30 
days according to age 
 
Figure 12: Cumulative survival rates for new-onset dementia in patients who survive past 30 









Figure 13: Cumulative survival rates for new-onset dementia in patients who survive past 
30 days with and without posterior white matter lucencies 
 
The following variables, chosen from the results of the literature review (Section 2.2, Table 
4), were included in the regression model for new-onset cognitive decline: age, sex, location 
of the haemorrhage, presence of white matter lucencies (anterior and posterior) and 
composite SVD score >0. The Cox’s regression model for new-onset cognitive decline was 
statistically significant, p = .010 (Table 20).  
Table 20: Results of Cox regression model of new-onset cognitive decline in patients who 










95% CI for Hazard 
Ratio 
Lower Upper 
Age, per 1-year increase  .092 1.025 .996 1.054 
Female sex .321 .720 .376 1.379 
Lobar haemorrhage .011 2.184 1.193 4.000 
Anterior white matter lucencies .167 1.958 .755 5.078 
Posterior white matter lucencies  .600 1.241 .554 2.781 
Small vessel disease score >0 .993 .997 .500 1.989 
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The only independent risk factors for new onset cognitive decline was lobar ICH location (HR 
2.184; 95% CI 1.193-4.000).   
The following variables included in the logistic regression model for new-onset dementia only 
were age, sex and location of haemorrhage. The Cox’s regression model for new-onset 
dementia was statistically significant, p = .001. The only independent risk factor for new-
onset dementia was increasing age (HR per 1-year increase 1.083; 95% CI 1.034-1.134) (Table 
21).  
Table 21: Results of Cox regression model of new-onset dementia in patients who survive 
past 30-days 
 
 Accuracy of GP electronic medical record for identifying cognitive 
decline and/or dementia 
Using descriptive statistics with those LATCH patients who also consented to the LINCHPIN 
study, I compared patient’s pre-ICH cognitive status according to their medical records with 
the results of the IQCODE (IQCODE scores between 53 and 63 will be indicative of cognitive 
impairment with no dementia, and pre-existing dementia will recorded as a score of 64 and 
above) (Table 22).  
In total, 132 patients had an IQCODE recorded. Of those patients with an IQCODE score 
indicating no history of cognitive decline (74 patients; 56%; 95% CI 47-65%), only 2 were 
recorded as having a history of cognitive decline in baseline characteristics, and none were 










95% CI for Hazard 
Ratio 
Lower Upper 
Age, per 1-year increase .001 1.083 1.034 1.134 
Female sex .520 .718 .262 1.969 
Lobar haemorrhage  .361 1.490 .633 3.508 
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Of those patients with an IQCODE score indicative of pre-existing cognitive decline (37 
patients; 28%; 95% CI 21-37%), 27 were recorded as having no history of cognitive decline in 
baseline characteristics, 6 as having cognitive decline and 4 as having dementia.  
Lastly, of those patients with an IQCODE suggestive of pre-existing dementia (21 patients; 
16%; 95% CI 10-23%), 4 were recorded as having no history of cognitive decline, 6 as having 
a cognitive impairment and 11 as having dementia.  




<53 53-63 (suggestive of 
cognitive 
impairment) 
>63 (suggestive of 
dementia) 
No History of cognitive 
decline 
72 27 4 
History of cognitive 
impairment   
2 6 6 
History of dementia  0 4 11 
 
 
 Summary of results 
Cognitive decline and stroke are closely related. This study has given a crude indicator of the 
prevalence of pre-existing and new-onset cognitive decline, and its associated risk factors. 
Using data from LATCH COG, I found that roughly 1 in 4 (23%) patients had cognitive decline 
prior to their ICH. Forty-one patients (10%) had cognitive impairment with no dementia. Fifty-
two patients met the criteria for pre-existing dementia (13%).  
In univariate analysis, CT neuroimaging markers of cerebral amyloid angiopathy and small 
vessel disease were associated with pre-existing cognitive decline (lobar ICH location, 
anterior and posterior white matter lesions, central (deep) atrophy score, CT composite SVD 
score and Edinburgh CAA criteria (CT only)). Increasing age, modified Rankin score (level of 
dependency) and haemorrhage volume were also associated with pre-existing cognitive 
decline.   
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In logistic regression analysis, patients who had a lobar ICH were twice as likely to exhibit 
pre-existing cognitive decline and 3 times more likely to exhibit pre-existing dementia than 
those who had a non-lobar ICH. Patients with central (deep) atrophy were over 4 times more 
likely to exhibit cognitive decline and 8 times more likely to exhibit dementia before their 
stroke than those without. In line with this, severity of white matter changes was associated 
with pre-existing dementia. Patients with a compositive SVD score >0 (suggesting they have 
at least one feature of SVD) were over twice as likely to have pre-existing dementia, 
suggesting a neurodegenerative process. Increasing age and larger haemorrhage volume 
were also associated with increased likelihood of patients having pre-existing cognitive 
decline and dementia.  
During the first 5 years of follow-up of LATCH COG, of the 168 patients who survived longer 
than 30-days after their ICH, 47 patients developed new-onset cognitive decline (cognitive 
impairment and dementia). Cumulative survival rates for patients remaining free of cognitive 
decline were 82% in the first year and reached 65% at 5 years. Cumulative survival rates for 
patients remaining free of dementia were 95% in the first year after ICH and 84% after 5 
years.   
In univariate analysis of LATCH COG, presence of posterior white matter lucencies was 
associated with new-onset dementia, indicating an association with markers of small vessel 
disease. In Cox regression analysis, patients who had a lobar ICH were twice as likely to 
exhibit new-onset cognitive decline than those who had a non-lobar ICH.  In those who 
survived past 30 days, the incidence of new-onset cognitive decline was 37% in patients with 
lobar ICH and 20% in patients with non-lobar ICH.  
When the IQCODE was compared to medical records for the detection of pre-existing 
cognitive impairment or dementia, in patients with an IQCODE score indicative of cognitive 
impairment, 73% had no record of cognitive impairment on their medical/GP records. In 
patients with IQCODE score indicative of dementia, 19% had no record of cognitive decline 
and 29% as having cognitive impairment (without dementia).   
Due to the retrospective design of this study, it is likely that I have given a conservative 
estimate of the frequency of cognitive decline. This study was therefore followed-up with a 




7. Methodology: LINCHPIN COG 
I set up a prospective, population-based cohort sub-study in adults with first-ever ICH from 
LINCHPIN. Participants were given the opportunity to have their cognition and functional 
outcomes assessed at 6 and 12-24 months after their stroke. I measured pre-existing 
cognitive decline using the IQCODE informant questionnaire, and collected basic 
demographic data, vascular risk factors, stroke severity, level of dependency, and 
neuroimaging features on computed tomography and magnetic resonance imaging. The 
primary outcome was new-onset cognitive impairment (defined as MoCA score <26) at 6 
months, when I also measured functional outcomes (depression, fatigue, health-related 
quality of life). This chapter includes a detailed discussion of the method used to collect and 
analyse data. Strengths and limitations are included at the end of this chapter to aid the 
reader in interpreting the generalisability and clinical implications of the findings.   
 
 Research objective and questions  
The overall aim of LINCHPIN COG was to:  
• Investigate the demographic, clinical, radiographic and functional outcomes 
associated with the occurrence of cognitive impairment following an ICH. 
To meet this aim, the following research questions were developed:   
1. What is the prevalence of pre-existing cognitive impairment and dementia in patients who 
have had their first-ever ICH? 
2. What is the incidence of new-onset cognitive impairment in patients who have had their 
first-ever ICH at 6 months after their stroke? Is there a difference in cognitive assessment 
scores between 6 and 12-24 months? 
3. How do the scores on MMSE, MoCA and ACE-III compare when assessing cognition in 
patients who have an ICH at 6 months after their stroke? 
4. What factors (demographic, clinical and radiographic) are associated with new-onset 
cognitive impairment at 6 months in patients who have had an ICH?  
5. Is cognitive impairment at 6 months correlated with assessments of functional outcome? 
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 Selection of participants 
Participants were included in LINCHPIN COG if they met the inclusion criteria outlined in Box 
16.  
Box 16: LINCHPIN COG inclusion criteria 
Participants were eligible if they were:  
• Diagnosed as having first-ever ‘primary’ ICH (not secondary to an underlying 
tumour, intracranial vascular malformation or venous thrombosis etc): 
ICH was defined as the abrupt symptomatic onset of severe headache, 
altered level of consciousness, or focal neurological deficit, 
anatomically referable to a focal collection of blood within the brain 
parenchyma as observed on brain imaging (by a neuroradiologist with 
an interest in stroke) or at autopsy, which was not attributable to prior 
trauma or haemorrhagic conversion of a cerebral infarction 
• Adults, aged 18 or over at time of diagnosis 
• Seen as an inpatient or neurovascular outpatient at Western General 
Hospital, Royal Infirmary Edinburgh or St John’s Hospital 
• Resident in the NHS Lothian healthboard region 
• Diagnosed with ICH between August 2014- July 2016 
Participants were excluded from LINCHPIN COG if they met any of the exclusion criteria 
outlined in Box 17.  
Box 17: LINCHPIN COG exclusion criteria 
Participants were excluded if they had:  
• ICH definitely attributable to trauma 
• Exclusively extra-axial intracranial haemorrhage (i.e. subarachnoid, 
subdural, or extradural). However, patients with intraparenchymal 
haemorrhage that extended into other compartments could be included 
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• ICH into a tumour, from a proven intracranial vascular malformation, due to 
venous sinus thrombosis, or which proves to be a haemorrhagic 
transformation of a cerebral infarction after further imaging or autopsy. 
• Refused consent to LINCHPIN  
 
 Methods 
Participants were recruited from the ethically approved LINCHPIN study, which was a 
prospective cohort study examining the causes of ICH using clinical assessments, brain MRI, 
blood samples and research autopsy in case of death. Eligible participants were approached 
by a member of the LINCHPIN research team before, or soon after, hospital discharge (or 
later, if that was more appropriate for the patient) to ascertain whether they would be 
interested in participating in the study. The participant or nearest relative were given an 
information leaflet and time to consider the study and ask any questions that they may have 
before signing a consent form.  
Six-month survivors who had consented to participate in LINCHPIN were given the 
opportunity to take part in a more detailed assessment of their cognition and functional 
outcomes at 6 and 12-24 months after their stroke.  This part of the study ran for three years, 
from March 2015-February 2018 inclusive. LINCHPIN participants were approached with a 
separate consent form and information leaflet at 6 months post-ICH (see Appendix 7 and 8). 
Where possible, patients were also followed-up at 12-24 months after the index ICH. 
I assessed the suitability of LINCHPIN research participants for this sub-study by contact with 
them or their nearest relative, where I offered them the opportunity to be assessed at home 
if preferred.  I believed that it was important to include those patients who were unable to 
be assessed in a clinic setting because their cognitive function may be more severely affected, 
and not including them in the study would bias the assessment of cognitive function after 
ICH. 
Consent was sought from patients for the assessments outlined in the Schedule of 
Evaluations (Table 23 and 24; Appendix 9: LINCHPIN COG participant assessments). 
Participants were assessed in a structured, face-to-face interview, lasting approximately 60-
90 minutes.  
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Table 23: Schedule of evaluations for those with mental capacity 
Assessment Visit 1: 6 months post-ICH Visit 2: 12-24 months post-
ICH 
Informed Consent Form  X  
Patient Demographics X X 
EuroQOL-5D X X 
Patient Health 
Questionnaire-2 (PHQ-9 if 
relevant) 
X X 
SF-36 vitality scale X X 
Clinical Dementia Rating 
scale  
X X 
National Adult Reading Test X  
ACE-III X X 
MMSE X X 
MoCA X X 
NIHSS X X 
 
Table 24: Schedule of evaluations for those without mental capacity 
Assessment Visit 1: 6 months post-ICH Visit 2: 12-24 months post-
ICH 
Informed Consent Form  X  
Patient Demographics X X 
EuroQOL X X 
Clinical Dementia Rating 
scale  
X X 







 Cognitive Assessment 
There is no ideal way of assessing cognition after stroke.  Many patients may not be able 
participate in a full neuropsychological assessment covering all cognitive domains and 
screening tools such as the MMSE may miss subtle cognitive decline and dementia 
(Pendlebury and Rothwell 2009). 
When performing quantitative assessments of cognition, the assessment tools differed 
according to the patient’s mental capacity (see Tables 23 and 24 for further details). To 
measure the occurrence of cognitive impairment in participants, the following assessment 
tools were selected: 
• Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)  
• Clinical Dementia Rating Scale (CDR) 
• Addenbrooke’s Cognitive Examination-III (ACE-III) 
• Mini-Mental State Examination (MMSE) 
• Montreal Cognitive Assessment (MoCA) 
 
IQCODE 
The systematic assessment of pre-existing cognitive impairment and dementia was 
conducted using the short version of the IQCODE (Jorm 1994). This questionnaire, which is 
rated by a close friend or relative, consists of 16 questions regarding the changes experienced 
by the patient over the last 10 years in aspects of daily behaviour requiring memory and 
other intellectual abilities. IQCODE scores between 53 and 63 were classified as cognitive 
impairment with no dementia, and pre-existing dementia was recorded as an IQCODE score 
of 64 and above (Jorm 1994).   
 
Clinical Dementia Rating Scale 
The Clinical Dementia Rating (CDR) scale is a staging instrument for dementia and has good 
reliability when used by non-physicians (McCulla et al, 1989). In a recent systematic review 
of clinical staging scales, the CDR scale was recognised as the best-evidenced scale in terms 
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of its reliability and validity (Rikkert et al, 2011). In a study looking at the validity of the CDR 
for the detection and staging of dementia, sensitivity for the detection of questionable 
dementia and actual dementia cases was 86% and specificity was 80% in relation to the gold 
standard (DSM III-R diagnostic criteria) (Chaves et al, 2007).  
The Clinical Dementia Rating scale (CDR) was used to rate the level of cognitive impairment 
in all participants, both with and without mental capacity, as it is based on caregiver accounts 
of problems in daily functional and cognitive tasks (Morris 1993). The CDR scale allows the 
researcher to assess the level of cognitive impairment from none (0) to severe (3).  
Patients with mental capacity were also assessed for cognitive impairment using the ACE-III, 
MMSE and MoCA. 
 
Addenbrooke’s Cognitive Examination 
In a review by Pendlebury et al (2012), the Addenbrooke’s Cognitive Examination–Revised 
(ACE-R), which included the MMSE, was recommended as a useful tool for measuring 
cognition in the stroke population.  
The ACE-R is a brief test that assesses five cognitive domains: attention/orientation, memory, 
verbal fluency, language and visuospatial abilities. The total score is out of 100, with higher 
scores indicating better cognitive functioning. In the review mentioned above, sensitivity and 
specificity were optimal for mild cognitive impairment with a cut-off score of less than 94 
(sensitivity 83% and specificity 73%). In a further systematic review looking at the accuracy 
and clinical utility of the ACE-R, the evidence suggested that it can provide information on a 
range of cognitive domains and can differentiate well between those with and those without 
cognitive impairment (Crawford et al, 2012).  
Copyright issues have meant that the ACE-R has now been discontinued. The successor to 
this well validated test, the ACE-III, is similar in style to the ACE-R and provides scores in five 
sub-domains. Although this test has not yet been validated for use with stroke patients, the 
results of a recent study provided objective validation of the ACE-III as a screening tool for 
cognitive deficits in Alzheimer’s disease (Hseih et al, 2013). In addition, total scores on the 
ACE-III are highly correlated to the ACE-R with similar specificity and sensitivity values for the 
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same cut-offs. In this study, the cut-off score of 94 was used for the detection of mild 
cognitive impairment, as recommended by Pendlebury et al (2012). 
 
Mini-Mental State Examination 
The MMSE is a brief screening tool for cognitive impairment and dementia (Folstein, Folstein 
and McHugh 1975). Although two recent reviews have highlighted the inability of the MMSE 
to detect mild cognitive impairment, when compared to the ACE-R and MoCA, the MMSE 
performed similarly in detecting multi-domain impairments among stroke patients 
(Pendlebury et al, 2012). Blake et al (2002) examined the sensitivity and specificity of the 
MMSE for detecting cognitive impairment after stroke. The study identified an optimum cut-
off of <24, with good specificity (88%) and moderate sensitivity (62%). The MMSE takes 
approximately 10 minutes to administer and is scored out of 30.  
 
Montreal Cognitive Assessment 
The MoCA was developed as a quick screening tool for MCI and dementia and assesses the 
following cognitive domains: visuospatial/executive functioning, naming, memory, attention, 
language, abstraction, delayed recall and orientation. In a recent population-based study of 
transient ischaemic attack and stroke, the MMSE and MOCA were administered to patients 
at a 6-month follow-up (Webb et al, 2014). In this study, the MoCA picked up considerably 
more abnormalities than the MMSE. 
The MoCA only takes 10 minutes to administer, with a total possible score out of 30. In a 
further publication from the study mentioned above, the MoCA was recommended as a 
screening tool for cognitive impairment, where sensitivity and specificity for cognitive 
impairment were optimal with a score of <26 (sensitivity 87% and specificity 63%) 
(Pendlebury et al, 2012).  In a recent systemic literature review of the use of cognitive 
screening tools after stroke, five studies investigated the sensitivity and specificity of the 
MoCA. Of these five studies, four reported adequate levels of reliability and validity for the 




 Functional outcome 
To determine the association between cognitive impairment and functional outcomes after 
intracerebral haemorrhage, the following questionnaires and assessments were used: 
• EuroQOL (EQ-5D) 
• Patient Health Questionnaire 2 (PHQ-2) 
• Short Form-36 (SF-36) vitality scale 
• National Institutes of Health Stroke Scale (NIHSS) 
While the EuroQOL is a global measure of health-related quality of life, the PHQ-2 is a brief 
screening tool for depression. In order to assess levels of fatigue, the SF-36 vitality scale has 
been chosen as it consists of 4 questions and is well validated for use with stroke patients. 
To gain an indication of neurological outcome in all participants, the National Institutes of 
Health Stroke Scale was chosen.  
 
EuroQOL-5D 
Throughout the literature, a multitude of both generic and stroke specific QOL measures 
have been developed. Based on my review of the literature (Chapter 3), previous studies 
have tended to select the EQ-5D or SF-36 as a generic measure of health-related quality of 
life, with no clear preference for which tool should be used with stroke patients. Both tools 
appear to measure broadly similar domains of health and have qualitatively similar test-
retest reliability (Dorman et al, 1998; Dorman, Dennis and Sandercock, 1999). Despite their 
similarities and usefulness, the SF-36 is substantially longer than the EQ-5D. In order to keep 
the burden to participants as low as possible, the EQ-5D has been selected due to its length 
and ease of use (Dorman et al, 1997).  The EQ-5D provides a reliable assessment of HRQOL 
in the general population and has been well validated in patients with stroke (van Agt et al, 
2004; Dorman et al, 1997). 
In addition to a Visual Analogue Scale (VAS), which takes a score of 100 for perfect health 
and 0 for dead, the EQ-5D has 5 subscales that assess: mobility, self-care, usual activities, 
pain and anxiety/depression. Each of these domains is scored on five levels of severity: no 
problems; slight problems; moderate problems; severe problems; and unable. The EQ-5D 
utility score integrates the ratings of the five dimensions into a single score, calculated using 
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population-based preference weights for each subscale. In the present analysis, I used the 
weights obtained from the UK population.  A utility score is calculated to express HRQOL 
quantitatively as a fraction of perfect health with a score of 1 representing perfect health, a 
score of 0 representing death, and negative scores representing health scores considered 
worse than death. When patients were not able to answer the questionnaire themselves, 
proxy responders such as a relative or caregiver, were asked to rate the patient’s HRQOL. The 
EQ-5D has previously been validated for use in proxy responders (Dorman et al, 1997). 
EQ-5D scores from the general population were used as reference data. The EQ-VAS 
population norm for the UK is 83 (age 75+ is 74) and the EQ-5D utility score is 0.856 (age 75+ 
is 0.734) (Janssen and Szende 2014). As the data on the EQ-5D dimension are ordinal, 
information is often presented as the proportion of the population reporting problems on 
each level of severity, for each dimension. However, because the number of people reporting 
severe problems is usually very small in population surveys, it is common for results to be 
presented in a dichotomised fashion using categories ‘no problems’ and ‘problems’ for each 
of the dimensions (Janssen and Szende 2014). The population norms for the percentage of 
people in the UK (all ages) reporting problems within each of the 5 domains is as follows: 




In a review which aimed to determine the accuracy of common screening tools in recognising 
depression in stroke patients, because the authors found no significant differences between 
measures, the Patient Health Questionnaire-2 (PHQ-2) was recommended as it is free and 
only has two items (Turner et al, 2012). The PHQ-2 enquires about the frequency of 
depressed mood over the past 2 weeks (Kroenke, Spitzer and Williams, 2003). The PHQ-2 
score ranges from 0-6 and asks how often in the last 2 weeks the patient has been bothered 
by the following problems:  
1. little pleasure or interest in doing things? 
2. feeling down, depressed or hopeless? 
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While the construct and criterion validity make it an attractive measure for depression 
screening (Kroenke, Spitzer and Williams, 2003), a cut-off score of 2 or more has a sensitivity 
of 0.75 and specificity of 0.76 (de Man-van et al, 2012).  
Although this two-item scale has psychometric support as a screening tool, those scoring 2 
or more were administered a further 7 items, to complete the full 9-item version (de Man-
van et al, 2012).  The PHQ-9 discriminates well between participants with any versus no 
depressive disorder, as well as between participants with and without major depression. The 
PHQ-9 performs best with a cut-off score of 10 or more, with 91% sensitivity and 89% 
specificity for major depression, and 78% sensitivity and 96% specificity for any depression 
diagnosis (Williams et al, 2005). 
 
SF-36 Vitality Scale 
Fatigue was measured using the vitality component of the SF-36 (Ware et al, 1993). The SF-
36 was chosen as it is a valid and reliable measure of poststroke fatigue (Mead et al, 2007) 
and consists of only 4 questions: 
 How much of the time during the past 4 weeks did you:  
…have a lot of energy?  
…have you felt full of life?  
…did you feel worn out? and  
…did you feel tired?  
Participants choose from a five-point scale ranging from ‘none of the time’ to ‘all of the time’ 
for each of the questions. The latter two items are reverse coded prior to scoring. Scores 
range from 0-20, with higher scores indicating higher levels of fatigue.  The SF-36 has well 
established internal consistency, reliability, content validity, construct validity, and 






National Institutes of Stroke Scale 
In order to gain an indication of neurological outcome in all participants, I used the National 
Institutes of Health Stroke Scale. It only takes 10 minutes to administer and assesses severity 
of impairment in level of consciousness, ability to respond to questions and obey simple 
commands, papillary response, deviation of gaze, extent of hemianopia, facial palsy, 
resistance to gravity in limbs, plantar reflexes, limb ataxia, sensory loss, visual neglect, 
dysarthria and aphasia (Lyden et al, 1999). Items are graded on a 3- or 4-point ordinal scale 
where 0 means no impairment. Scores range from 0-42; where higher scores indicate greater 
severity. Stroke severity may be stratified based on NIHSS scores as follows: very severe >25; 
severe 15-24; mild to moderately severe 5-14; and mild 1-5 (Brott et al, 1989).  
 
 Patient Demographics and Medical History 
Data were collected using a standardised proforma for all patients. Information recorded 
from the patient, their hospital records and primary care records included details of the 
clinical event, medications, basic demographics, significant co-morbidities occurring before 
the index ICH (specifically TIA and ischemic stroke) and pre-existing level of dependency (as 
rated by the modified Rankin scale). Participants were asked to fill out a brief questionnaire 
at 6 and 12-24 months post-ICH to determine whether there have been any changes to the 
above information.  
 
 Radiological Assessment 
Brain CT scans were available for all patients on admission. At least one neuroradiologist 
evaluated CT images with a standardised pro forma derived from previous largescale stroke 
studies (Rodrigues et al, 2018). Using the CT scans, the following data were recorded:  
• location of haemorrhage (lobar or non-lobar) 
• haemorrhage volume 
• presence or absence of old vascular lesions (lacunes) 
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• severity of anterior and posterior white matter lucencies (3-point rating scale with a 
higher score denoting more severe white matter lucencies (van Swieten et al, 1990)) 
• severity of central (deep) or cortical cerebral atrophy (3-point rating scale where a 
higher score denotes a more severe atrophy (Sato et al, 2016) 
• composite SVD score (one point for each of the following: >1 lacune, severe white 
matter lucencies and severe atrophy) 
 
 Definition of lobar and non-lobar ICH 
ICH location was defined as either ‘lobar’ or ‘non-lobar’. At least one experienced consultant 
neuroradiologist reviewed diagnostic brain imaging and classified ICH location as ‘non-lobar’ 
if an adult had a single infratentorial ICH (located in the brainstem or cerebellum), a single 
supratentorial deep ICH (located in the basal ganglia, internal or external capsule or thalamus 
without extension to a lobar area), or multiple ICHs in solely non-lobar locations (either 
supratentorial deep or infratentorial). All other ICHs were ‘lobar’. 
 
 Hematoma volume 
Hematoma volume was calculated using the first CT brain scan after the adult’s presentation 
with ICH using the ABC/2 method where: A is the largest diameter of ICH on in the axial plane 
(cm), B is the largest diameter at 90o to A on the same slice (cm), and C is the maximal cranio-
caudal diameter (cm) (Newman 2007). 
 
 Composite CT SVD score 
A team of researchers from the Third International Stroke Trial created an aggregate SVD 
score by summing white matter changes, lacunes, and brain atrophy scores. White 
matter changes were rated with the Van Swieten Scale, where the posterior (range 0-2) and 
anterior (range 0-2) scores were combined into a 5-point ordinal scale (0-4) (van Swieten et 
al, 1990). The presence and number of lacunes was recorded, and brain atrophy was defined 
as central (deep) or cortical and rated with a 3-point ordinal scale as none, moderate, or 
severe (Sato et al, 2016). One point was assigned for each of the following if present: severe 
lucencies (Van Swieten Scale = 2) in anterior or posterior white matter, lacunes >1, and 
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severe (=2) central or cortical atrophy. The combined 4-point ordinal score therefore 
assessed the global burden of SVD from 0 (no imaging features of severe SVD) to 3 (imaging 
features of SVD scored as severe for each imaging variable) (Arba et al, 2017). 
 
 Composite MRI SVD score 
Participants recruited into the LINCHPIN study underwent a brain MRI at 3-6 months after 
their ICH. Participants were excluded if they had a contraindication to MRI (for example, a 
permanent pacemaker or metal implants) or were unable to tolerate MRI because they were 
too unwell, claustrophobic or unable to lie flat for the scan duration. MRI was done using a 
1.5T MRI scanner. The scan protocol consisted of T1 sagittal sequences and the following 
axial sequences: T2-weighted, FLAIR and gradient echo. All brain scans were rated by at least 
one neuroradiologist with an interest in stroke. The neuroradiologist rated all scans for 
presence and number of lacunes, presence and number of cerebral microbleeds, white 
matter hyperintensities (deep and periventricular white matter hyperintensities were both 
coded according to the Fazekas scale from 0 to 3, with a higher score denoting more severe 
white matter lesions (Fazekas et al, 1987)), enlarged perivascular spaces in the basal ganglia 
(rated on a validated semiquantitative scale from 0 to 4, where 0= no enlarged perivascular 
spaces and 4= >40 enlarged perivascular spaces (Doubal et al, 2010)).   
The total MRI burden of SVD was rated on an ordinal scale from 0 to 4, by counting the 
presence of each of the 4 MRI features of SVD (Staals et al, 2014). A point was awarded for 
each of the following: presence of lacunes and cerebral microbleeds were defined as the 
presence of one or more lacunes (1 point if present) or any cerebral microbleed (1 point if 
present). Presence of perivascular spaces was counted if there were moderate to severe 
(grade 2–4) perivascular spaces in the basal ganglia (1 point if present). Presence of white 
matter hyperintensities was defined as either deep white matter hyperintensities (Fazekas 
score 2 or 3) or periventricular white matter hyperintensities extending into the deep white 
matter (Fazekas score 3) (1 point if present). 
 
 Premorbid verbal IQ 
The National Adult Reading Test (NART) was devised to predict premorbid intellectual 
functioning in people suspected of having dementia so that the extent of cognitive decline 
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could be assessed by comparing these results with current performances (Nelson 1982). The 
NART is one of the most widely used objective measures to estimate premorbid IQ and 
consists of a list of 50 words, each of which the participant must try and pronounce correctly. 
The NART was initially developed to assist in the estimation of premorbid IQ in dementia, as 
reading is considered to be an over-learned skill that can be maintained, despite 
deterioration in other areas of cognitive functioning. Essentially, this test enables clinicians 
to estimate an individual’s level of intellectual functioning prior to the onset of injury.   While 
other measures have become available, such as the Wechsler test of Adult Reading and the 
Test of Premorbid Functioning, the NART has maintained its relevance and clinical utility. 
Although the NART has not been assessed for use in a stroke cohort, studies have established 
its validity and reliability as a method of estimating premorbid IQ in clinical populations 
(Nelson and O’Connell 1978; O’Carrol and Gilleard 1986; Crawford, Parker and Besson 1988).  
 
 Feedback 
After meeting with the RUSH patient reference group, it was decided that the option should 
be available for participants to receive written feedback with the results of their assessment 
(Appendix 10). Such feedback gave an indication of the cognitive areas that were impaired, 
as well as those that remained intact (Bisikier and Bickerton 2013). Participants were given 
my contact details and asked to contact myself or their GP if they had any queries or concerns 
regarding this feedback. 
 
 Reporting Results to GP 
Consent was sought from all participants to contact their GP with a summary of the cognitive 
and functional outcome assessment results. Having a record of the test results in all 
participants’ medical files could allow for a comparison to be made if they needed to be re-






 Statistical Analysis 
SPSS statistical software was used to conduct statistical analyses. The analysis of data were 
carried out separately for each of the research questions as outlined below.  
1. What is the prevalence of pre-existing cognitive impairment and dementia in patients 
who have had their first-ever ICH?  
Using descriptive statistics, the prevalence of cognitive impairment with no dementia and 
pre-existing dementia was described with 95% confidence intervals (CI).  
IQCODE scores between 53 and 63 were indicative of cognitive impairment with no 
dementia, and pre-existing dementia was recorded as an IQCODE score of 64 and above 
(Jorm 1994).   
2. What factors are associated with pre-existing cognitive impairment and dementia in 
patients who have had an ICH? 
To determine whether there were any differences between patients with and without pre-
existing cognitive decline (cognitive impairment or dementia), baseline characteristics and 6 
month cognitive and functional outcome assessment scores were compared using the chi-
square test for categorical variables and the Mann-Whitney U-test for continuous variables. 
Continuous data are reported as medians and inter-quartile range (IQR). Categorical data are 
presented as frequencies and percentages.  
2. What is the incidence of new-onset cognitive impairment in patients who have had their 
first-ever ICH at 6 months after their stroke? Is there a difference in cognitive assessment 
scores between 6 and 12-24 months? 
Using descriptive statistics, the incidence of new-onset cognitive decline was described with 
95% confidence intervals (CI). Following the recommendations of Pendlebury et al (2012), 
sensitivity and specificity for cognitive impairment are optimal with MoCA <26 (sensitivity 
87% and specificity 63%).  
To assess whether there was a mean difference in cognitive assessment scores between 6 
and 12-34 months, the Wilcoxin matched pairs test (the assumptions of normality were not 
met) was used.  
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3. How do the scores on MMSE, MoCA and ACE-III compare when assessing cognition in 
patients who have had an ICH? 
Spearman’s rank correlation was chosen to measure the strength of the association between 
the three cognitive assessments.  
4. What factors (demographic, clinical and radiographic) are associated with new-onset 
cognitive impairment at 6 months in patients who have had an ICH?  
To determine whether demographic, clinical or radiographic variables were associated with 
the occurrence of new-onset cognitive impairment (MoCA <26), univariate analysis was 
performed: chi-square test for categorical variables and the Mann-Whitney U-test for 
continuous variables (data were not normally distributed, as assessed by Shapiro-Wilk’s test). 
Continuous data are reported as medians and IQR and categorical data presented as 
frequencies and percentages. Missing data has been made explicit when presenting results 
and has only occurred for those participants who were not able to undergo an MRI scan.   
The following variables include known predictors of cognitive decline for stroke patients and 
the elderly population in general and were used for univariate analysis (Baumgart et al, 2015; 
Zulkifly et al, 2016): 
Clinical/demographic variables: age, sex, pre-ICH hypertension, pre-ICH diabetes, atrial 
fibrillation, previous ischaemic stroke or TIA, dependent before ICH (modified Rankin ≥2)  
Radiographic variables: ICH location (lobar or non-lobar), haematoma volume, presence of 
old vascular lesions, white matter lucencies score, cortical atrophy score, central atrophy 
score, composite SVD score (CT) and composite SVD score (MRI) 
5. Is cognitive decline at 6-months correlated with assessments of functional outcome? 
Analysis was conducted to determine whether new-onset cognitive impairment was 
associated with measures of functional outcome 6 months post-ICH. The variables selected 
for this part of the analysis were as follows: SF-36 vitality scale, PHQ-9, EQ-5D utility score, 
EQ-5D VAS, EQ-5D mobility sub-score ≥1, EQ-5D usual activities sub-score ≥1, EQ-5D self-help 
sub-score ≥1, EQ-5D pain/discomfort sub-score ≥1 and EQ-5D anxiety/depression sub-score 
≥1 (for EQ-5D sub-scores: No problems = 0; Problems ≥1).  
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Mann-Whitney U-Tests were run to determine whether there was difference in scores on the 
SF-36 vitality scale, PHQ-9, EQ-5D utility and EQ-5D VAS between those with and without 
new-onset cognitive impairment. To determine whether there was a difference in 
distributions between the categorical variables (EQ-5D sub-scores) and the two cognitive 
status groups (those with or without new-onset cognitive impairment), a Chi-squared test 
was conducted. 
 
 Strengths and limitations 
Strengths of the study include its prospective, population-based design with multiple 
overlapping sources of case ascertainment and comprehensive data collection. I examined 
exclusively a cohort of ICH patients and used detailed and standardised data collection, 
including the use of an established tool for evaluation of pre-existing and new-onset 
cognitive decline. A major strength is the detailed neuroimaging description of markers of 
SVD in the context of pre and post-ICH cognitive decline, including MRI investigations, with 
few missing data.  
 In this study, I chose to focus on cognitive decline instead of dementia as cognitive decline 
includes all cognitive consequences of stroke, even if criteria for dementia are not met. I 
chose an interval of 6 months after stroke for neuropsychological testing to avoid 
interference with unstable neurological conditions that are extremely frequent in severe 
strokes such as ICH. This design also increased the number of participants able to attend the 
follow-up clinic and undergo testing. One of the limitations is the use of the MoCA as an 
outcome measure. The MoCA is a rather crude measure of cognition and may lack sensitivity 
to vascular cognitive impairment. Nevertheless, the MoCA is a widely accepted test for the 
evaluation of cognition in elderly patients and is easily obtainable, thus maximising the 
number of patients with available data.   
A limitation is that recruitment of patients was not fully consecutive because participation 
was dependent on informed consent, therefore involving a selection bias. In addition, 
patients with severe aphasia or those who were severely disabled/bedbound were not 
included in the analysis as they were unable to complete the neuropsychological tests. As a 
result, I might have slightly underestimated the number of patients who developed new-
onset cognitive impairment. However, I did try to be as inclusive as possible to avoid the 
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effect of baseline selection criteria on the post-ICH cognitive impairment rates; only 
excluding 3 participants without any cognitive assessment (Pendlebury et al, 2015).  
I acknowledge that the study size is small, therefore the results should be interpreted 
cautiously.  I used a generic measure of HRQOL, designed to measure health-related quality 
of life outcomes for any disease, as opposed to stroke specific dimensions. Although the EQ-
5D has been shown to be a valid measure of HRQOL after stroke, the instrument may 
nevertheless not reveal the full spectrum of symptoms and impairments associated with 



















8. Results: LINCHPIN COG 
 Study population 
Of the 48 participants with spontaneous intracerebral haemorrhage who were recruited to 
LINCHPIN COG between March 2015 and February 2018 I excluded 3 participants without 
any cognitive assessment (two were confined to bed and severely cognitively impaired with 
a severe Clinical Dementia Rating (CDR) score, and the other had severe aphasia with a 
questionable CDR score). The study population at 6 months therefore consisted of 45 
participants (19 females; 42%; 95% CI 28-58%) with a median age of 72 years (interquartile 
range 54-79), all of which had available CT data from the time of their index ICH. Twenty-one 
participants had a lobar haemorrhage (47%; 95% CI 32-62%) and 24 participants had a non-
lobar haemorrhage (53%; 95% CI 38-68%). 
 Prevalence of pre-existing cognitive impairment and dementia  
To assess the prevalence of pre-existing cognitive decline, the IQCODE was used. IQCODE 
scores between 53 and 63 were indicative of cognitive impairment with no dementia, and 
pre-existing dementia was recorded as a score of 64 and above. Ten participants (22%, 95% 
CI 11 to 37) met the criteria for pre-existing cognitive decline (cognitive impairment or 
dementia). Of those ten, 8 participants (18%; 95% CI 8-32%) had cognitive impairment with 
no dementia and 2 met the criteria for pre-existing dementia (4%; 95% CI 1-15%). The 
prevalence of pre-existing cognitive decline was 24% among participants with a lobar 
haemorrhage (5 participants; 95% CI 8-47%) and 21% among participants with a non-lobar 
haemorrhage (5 participants; 95% CI 7-42%).  
A comparison of characteristics between participants with and without pre-existing cognitive 
decline can be found in Table 25. According to the scale of variances, differences in clinical 
as well as functional outcome and imaging features between the two groups were compared 
using bivariate analyses: Pearson Chi-square test or Mann-Whitney U-test where appropriate 
(data were not normally distributed, as assessed by Shapiro-Wilk’s test). Before comparing 
differences in medians with the Mann-Whitney U-Test, a visual inspection of distributions 
was made to ensure that the dependent variable had similarly shaped distributions across 
both groups of the independent variable. When running the chi-square test, if any cells had 
an expected count of less than 5, a Fisher’s exact test was applied. Continuous data are 
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reported as medians and IQR. Categorical data are presented as frequencies and 
percentages.  
Table 25: Characteristics of participants with and without pre-existing cognitive decline  
 Pre-existing cognitive 
decline (n= 10) (%) 
No pre-existing cognitive 
decline (n= 35) (%) 
p 
Demographics and medical history    
Agea 79 (68-83) 68 (52-77) .061 
Female sex 5 (50%) 14 (40%) .720 
Hypertension 6 (60%) 24 (69%) .710 
Diabetes 0 (0%) 6 (17%) .312 
Atrial Fibrillation 2 (20%) 1 (3%) .119 
Previous ischaemic stroke or TIAb 4 (40%) 3 (9%) .034 
Functional outcome    
Prestroke modified Rankin ≥2b 2 (20%) 1 (3%) .119 
PHQ-9a 3.5 (1-15) 0 (0-1) .008 
SF-36 vitality scalea 14 (9-15) 11 (9-13) .050 
EQ-5D utility scorea .55 (.42-.75) .74 (.55-.84) .171 
EQ-5D VASa 70 (67-80) 80 (70-90) .099 
IQCODEa 59 (55-63) 48 (48-48) <.001 
MoCAa 22 (18-27) 27 (21-28) .065 
NART errorsa 14 (6-21) 14 (9-21) .550 
Radiological data    
ICH Locationb   1.00 
    Lobar 5 (50%) 16 (46%)  
    Non-lobar 5 (50%) 19 (54%)  
Haematoma volume (ml)a 9 (1-17) 18 (2-28) .118 
Old vascular lesionsb 5 (50%) 9 (26%) .244 
White matter lucencies scorea 4 (1-4) 1 (0-3) .041 
Cortical atrophy scorea 1 (0-1) 1 (0-1) .619 
Central atrophy scorea 1 (1-2) 0 (0-1) .004 
CT composite SVD scorea 1 (1-2) 0 (0-1) .035 
MRI composite SVD scoreac 2 (1-4) 2 (1-3) .186 
aMedian (interquartile range); bFisher’s Exact test applied; c Missing data for 5 participants   
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Statistically significant differences were found between the following continuous variables 
and the two ICH groups: PHQ-9 (U = 270.5, z = 2.798, p = .008, r = .42), SF-36 vitality scale (U 
= 247.0, z = 1.977, p = .050, r = .29), IQCODE (U = 350.0, z = 5.319, p = <.000, r = .80), white 
matter lucencies score (U = 250.0, z = 2.123, p = .041, r = .32), central atrophy score (U = 
278.0, z = 3.121, p = .004, r = .47) and CT composite SVD score (U = 252.o, z = 2.294, p = .035, 
r = .34), using an exact sampling distribution for U (Dineen and Blakesley 1973; Figures 14-
18).   
Figure 14: Boxplot of PHQ-9 scores split by prestroke cognitive status 
 
 









Figure 17: Boxplot of central atrophy scores split by prestroke cognitive status 
 
 




Among the categorical variables, the only statistically significant result was found in 
participants who had had a previous ischaemic stroke or TIA (χ2(1) = 5.849; p= .034) (Figure 
19). There was a moderate effect size, where Cramer’s V = .36.  
Figure 19: Bar chart of the number of previous strokes or TIAs in participants with prestroke 
cognitive decline versus those without 
 
When conducting multiple analyses on the same dependent variable, the chance of 
committing a Type I error (rejecting the null hypothesis when you should not) increases, thus 
increasing the likelihood of observing a significant result by pure chance. To correct for this, 
or protect from Type I error, a Bonferroni correction was applied. The new p-value was the 
alpha-value (αoriginal = .05) divided by the number of comparisons (22): (αaltered = .05/22) 
= .002. To determine if any of the 22 comparisons was statistically significant, the p-value 
must have been p ≤ .002. Therefore, in bivariate analysis (with a Bonferroni corrected 
significance level of p ≤.002), pre-existing cognitive decline at 6 months was the only variable 
associated with IQCODE (p <.000)   
 
 Incidence of new-onset cognitive impairment  
New-onset cognitive impairment is defined as cognitive impairment that was present after 
the ICH but was not present beforehand (as assessed by IQCODE). Of the 45 participants, 10 
were therefore excluded from this part of the analysis due to pre-existing cognitive 
impairment or dementia. The study population for this part of the analysis is therefore 35 
participants (14 [40%] are female), with a median age of 68 years (IQR 52-77). Sixteen 
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participants had a lobar haemorrhage (46%; 95% CI 29-63%) and 19 participants had a non-
lobar haemorrhage (54%; 95% CI 37-71%).   
The MoCA has been chosen as the screening tool of choice following the recommendations 
of Pendlebury et al (2012). Although the MoCA and ACE-III both had good sensitivity and 
specificity for detecting mild cognitive impairment in the stroke population, the MoCA takes 
less time to administer and was completed in full by more participants in the study. For 
screening purposes, sensitivity and specificity for cognitive impairment are optimal with 
MoCA <26 (sensitivity 87% and specificity 63%) (Pendlebury et al 2012).  
Of the 35 participants without pre-existing cognitive decline, fifteen developed new-onset 
cognitive impairment, for an incidence of 43% (95% CI 26 to 61) at 6 months after ICH. The 
incidence of new-onset cognitive impairment was 6/16 (38%, 95% CI 15 to 64) after lobar ICH 
and 9/19 (47%, 95% CI 24 to 71) after non-lobar ICH (Figure 20).  
Figure 20: New-onset cognitive impairment 
 
 Difference in cognitive assessment scores between 6 and 12-24 months 
To assess whether there was a median difference in cognitive assessment scores between 6 
and 12-24 months, the Wilcoxin matched pairs test was chosen. Although the difference in 
MoCA scores between the two periods of time was normally distributed (as assessed by 
Shapiro-Wilk’s test, p = .525), an outlier was detected that was more than 1.5 box-lengths 
from the edge of the box in the boxplot, which meant that the assumptions of the paired-
samples t-test were not met.  
Of the 35 participants without pre-existing cognitive decline, 28 had two sets of cognitive 




New-onset cognitive impairment in participants with lobar ICH
New-onset cognitive impairment in particpants with deep ICH
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the 28 participants, 10 showed an improvement in their MoCA score, 11 participants showed 
a decline in their cognitive score and 7 experienced no change (Figure 21).  
A Wilcoxin matched pairs test determined that there was no statistically significant difference 
in median MoCA scores between 6 (score 26) and 12-24 (score 27) months (z = -.561, p = 
.575).   
Figure 21: Difference in MoCA scores between 6 and 12-24 months 
 
 Comparing scores on MMSE, MoCA and ACE-III  
Spearman’s rank correlation was run to measure the strength of the association between the 
three cognitive assessments. Preliminary analysis showed the relationships to be monotonic, 
as assessed by visual inspection of scatterplots. There were positive correlations between all 
three assessments however, the strongest relationship was between the MoCA and ACE-III, 
which is in agreement with the findings of Pendlebury et al (2012) (Table 26).  
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 Factors associated with new-onset cognitive impairment  
To determine whether demographic, clinical or radiographic variables were associated with 
the occurrence of new-onset cognitive impairment, univariate analysis was performed: 
Pearson Chi-square test or Mann-Whitney U-test where appropriate (data were not normally 
distributed, as assessed by Shapiro-Wilk’s test). 
Before comparing differences in medians with the Mann-Whitney U-Test, a visual inspection 
of distributions was made to ensure that the dependent variable had similarly shaped 
distributions across both groups of the independent variable. When running the chi-square 
test, if any cells had an expected count of less than 5, a Fisher’s exact test was applied. For 
those variables where a statistically significant difference was shown, the effect size was 
calculated. Continuous data are reported as medians and IQR. Categorical data are presented 
as frequencies and percentages.  
In univariate analysis (with a Bonferroni corrected significance level of p ≤.003), new-onset 
cognitive impairment at 6 months was associated with pre-ICH history of hypertension (p 
<.001) (Figure 22 and Table 27).   
 








No history of hypertension
History of hypertension in patients with new-onset cognitive
impairment
History of hypertension in patients without cognitive impairment
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Table 27: Factors associated with new-onset cognitive impairment  
 Participants with 
new-onset cognitive 
impairment (n= 15) 
Participants 
without cognitive 
impairment (n= 20)  
p  
Demographics    
   Agea 72 (58-80) 68 (48-76) .27 
   Female sex 5 (33%) 9 (45%) .49 
Vascular risk factors    
   Hypertensionb 15 (100%) 9 (45%) <.001 
   Diabetesb 4 (27%) 2 (10%) .37 
Medical history    
   Atrial fibrillationb 1 (7%) 0 (0%) .43 
   Previous ischaemic stroke or TIAb 3 (20%) 0 (0%) .07 
Functional status    
  Dependent before ICH (modified 
Rankin≥2)b 
1 (7%) 0 (0%) .43 
Radiological data    
   ICH location   .56 
      Lobar ICH 6 (40%) 10 (50%)  
      Non-lobar ICH 9 (60%) 10 (50%)  
   Haematoma volume (ml) a 19 (5-39) 10 (2-26) .31 
   Presence of old vascular lesionsb 7 (47%) 2 (10%) .02 
   White matter lucencies scorea 3 (1-4) 0 (0-2) .01 
   Cortical atrophy scorea 1 (0-1) 1 (0-1) .73 
   Central atrophy scorea 0 (0-1) 0 (0-1) .31 
   CT composite SVD scorea 1 (0-2) 0 (0-0) .01 
   MRI composite SVD scoreac 2 (2-3) 1 (0-2) .04 





 Correlation of cognitive impairment with assessments of functional 
outcome 
Analysis was also conducted to determine whether cognitive impairment after ICH was 
associated with measures of functional outcome. The variables selected for this part of the 
analysis were as follows: SF-36 vitality scale, PHQ-9, EQ-5D utility score, EQ-5D VAS, EQ-5D 
mobility sub-score, EQ-5D usual activities sub-score, EQ-5D self-help sub-score, EQ-5D 
pain/discomfort sub-score and EQ-5D anxiety/depression sub-score (for EQ-5D sub-scores: 
No problems = 0; Problems ≥1).  
Mann-Whitney U-Tests were run to determine whether there was a difference in scores on 
the SF-36 vitality scale, PHQ-9, EQ-5D utility and EQ-5D VAS between those with and without 
new-onset cognitive impairment. Distribution of all scores were similar across both groups, 
as assessed by visual inspection. An exact sampling distribution has been used for U (Dineen 
and Blakesley 1973). 
Median SF-36 vitality scale scores for those with (12) and without (11) cognitive impairment 
were not significantly different, U = 157, z = .235, p = .831.  
Median PHQ-9 scores for those with (0) and without (0) cognitive impairment were not 
significantly different, U = 147.5, z = -0.95, p = .934. 
Median utility scores for those with (.74) and without (.75) cognitive impairment were not 
significantly different, U = 150.5, z = 0.17, p = 1.00.  
Median VAS scores for those with (85) and without (80) cognitive impairment were not 
significantly different, U = 165.5, z = .521, p = 1.610. 
To determine whether there was a difference in distributions between the categorical 
variables (EQ-5D sub-scores) and the two cognitive status groups (those with or without new-
onset cognitive impairment), a Chi-squared test was conducted. If any cells had an expected 
count of less than 5, a Fisher’s exact test was applied. I could not detect statistically significant 
associations between new-onset cognitive impairment and any of the EQ-5D sub-scores at 6 




Table 28: Associations between new-onset cognitive impairment and functional outcome at 
6 months after ICH 









EQ-5D usual activity score ≥1 10 (67%) 8 (40%) .12 
EQ-5D self-help score ≥1 8 (53%) 7 (35%) .28 
EQ-5D mobility score ≥1b 12 (80%) 12 (60%) .28 
EQ-5D anxiety/depression score ≥1 7 (47%) 10 (50%) .85 
EQ-5D pain/discomfort score ≥1 6 (40%) 14 (70%) .08 
EQ-5D visual analogue scalea 85 (73-90) 80 (63-89) 1.61 
EQ-5D utility scorea .74 (.57-.82) .75 (.49-.84) 1.00 
Depression (Patient Health 
Questionnaire-9)a 
0 (0-1) 0 (0-1) .93 
Fatigue (Short Form-36 vitality scale)a 12 (9-14) 11 (9-13) .83 
aMedian (interquartile range); bFisher’s Exact test applied 
 
 Summary of results 
Pre-existing cognitive decline affects one-fifth (22%) of patients with ICH (18% cognitive 
impairment and 4% dementia). For survivors of ICH without pre-existing cognitive decline, 
new-onset cognitive impairment is frequent with 43% of participants scoring <26 on the 
MOCA (indicating mild cognitive impairment) at 6 months.  
Although not statistically significant after the application of the Bonferroni correction, those 
with pre-existing cognitive decline had lower mood (PHQ-9 score 3.5 v 0), lower EQ-5D utility 
scores (.55 v.74), lower scores on the EQ-5D VAS (70 v 80) and were more likely to be fatigued 
(SF-36 score 14 v 11) than those without pre-existing cognitive decline. Those with pre-
existing cognitive decline also had higher white matter lucencies scores (4 v 1), higher central 
atrophy scores (1 v 0), were more likely to have had a previous ischaemic stroke or TIA (40% 
v 9%) and had a higher composite CT SVD score (1 v 0) than those without pre-existing 
cognitive decline.  
166 
 
43% of patients without pre-existing cognitive decline scored <26 on the MoCA at 6 months. 
Surprisingly, the incidence of new-onset cognitive impairment was higher among participants 
with non-lobar ICH. Between 6 and 12-24 months, 10 participants showed an improvement 
in MoCA score, 11 showed a decline and 7 experienced no change.  
In univariate analysis of LINCHPIN COG, new-onset cognitive impairment at 6 months was 
associated with pre-ICH history of hypertension. This implies an important role of vascular 
processes. Cerebral blood vessels are the main target of the effects of hypertension on the 
brain. The resulting structural and functional cerebrovascular alterations underlie many of 
the neuropathological abnormalities responsible for the cognitive deficits, including white 
matter damage and brain atrophy.  
Although not statistically significant, participants with new-onset cognitive impairment were 
more likely to have a previous ischaemic stroke or TIA (20% v 0%), presence of old vascular 
lesions (47% v 10%), a higher white matter lucencies score (3 v 0), a higher CT composite SVD 
score (1 v 0) and a higher MRI composite SVD score (2 v 1).  
I could not detect statistically significant associations between new-onset cognitive 
impairment and functional outcomes at 6 months. The small sample size may have been a 
significant contributory factor, making it difficult to identify any statistically significant 
differences between those with and without cognitive impairment.  Despite this, participants 
with new-onset cognitive impairment were more likely to have problems with usual activities 
(67% v 40%), require more self-help (53% v 35%) and have more problems with mobility (80% 
v 60%). %). These last three points in particular will now be explored in-depth in the 
qualitative interviews, where participants spoke about their inability to take part in activities 
that were integral to the pre-stroke lives, in addition to not being able to perform simple, 






9. Methodology: Qualitative interviews  
To evaluate the experience of life after ICH with cognitive impairment, a simple qualitative 
study was embedded into LINCHPIN COG. Interviews were conducted with six LINCHPIN COG 
participants and four family members. It was hoped that by giving participant’s and their 
family members the chance to tell their story, the impact that the ICH had on their lives could 
be explored to a level and depth that could not be easily or feasibly captured through 
quantitative means alone. This chapter includes a detailed description of the method used 
to collect and analyse data, and the measures taken to ensure quality. Strengths and 
limitations are included at the end of this chapter to aid the reader in interpreting the 
generalisability of findings.   
Although the use of reporting checklists within qualitative research is debated, to help 
increase the reporting transparency, details about the researcher, study design, analysis and 
findings are summarised according to the consolidated criteria for reporting qualitative 
research (Tong, Sainsbury and Craig 2007; Appendix 11).  
 
 Research aim 
The overall aim of the qualitative interview was to:  
• Evaluate the experience of life after ICH with cognitive impairment.   




 Selection and recruitment of participants 
Participants were selected from survivors of ICH who had previously consented to take part 
in LINCHPIN COG. A purposive sampling technique was employed to identify participants with 
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a range of residual cognitive impairments who could provide depth and diversity of responses 
relevant to the study (Patton 2002).  
Participants were approached in the clinic or home setting by the researcher. They were 
informed about the study orally and asked for consent to have interviews audio recorded. 
Participants were initially recruited if they had their stroke 6-12 months prior to the 
interview. A design amendment later enabled inclusion of three participants who had their 
strokes 12-24 months prior to interview, to allow for the views of participants who were 
further along in their stroke journey.  
Survivors were eligible if they suffered from communication problems (i.e. aphasia) if it did 
not limit their ability to reveal their subjective experiences. In four cases, a family member 
was present during the interview for which additional consent was sought. Family members 
added another perspective on the stroke experience.  
Qualitative approaches usually aim to understand a relatively small number of participant’s 
views. Due to the constraints of time inherent in a doctoral thesis, this study aimed to recruit 
five to eight participants who collectively represented a range of views. A total of six stroke 
survivors and four family members participated in the imbedded qualitative study and 
offered a range of characteristics. It was felt by myself and my supervisors that this was 
enough participants to address the research aim and offer an insight into the impact of living 
with cognitive impairment after stroke due to haemorrhage.   
 
 Methods 
 Data collection  
Data were collected through individual face-to-face semi-structured interviews and took 
place between May 2016 and March 2018. Semi-structured interviews were the most 
appropriate method of collecting data as they allow a degree of consistency, whilst also 
allowing for exploration of particular issues of importance to respondents. 
Qualitative interviewing encourages participants to tell their story of a particular experience, 
providing time and opportunity to share experiences. In this study, this meant interviewing 
around the specific episode of the participant’s ICH and the time following it until the present 
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day. The interview schedule (Appendix 12) was developed with the assistance of colleagues 
and supervisors prior to the interviews. The first interview was a pilot for the interview 
schedule, where it was felt that the questions adequately covered the research areas of 
interest.  Agreement of the core topics to be covered increased consistency; however, the 
relevance and clarity of the questions were constantly considered during the conduct of the 
interviews. In addition, the semi-structured nature of the interviews gave me scope to ask 
some spontaneous questions, where I could address participants’ concerns and personal 
circumstances.  
When I initially met with the participants, I stressed that they were under no obligation to 
participate and if they did agree to take part, they could withdraw at any time without 
providing an explanation. Once participants gave their informed consent, a convenient time 
and place for the interview was selected. Participants were given a choice of settings for the 
interview- in their own home or in a clinic setting- to make them most comfortable. All 
participants opted to have the interviews in their own home. The interviews themselves 
lasted between 45-90 minutes. 
All interviews started with me asking the participants to describe what happened on the day 
of the stroke. This provided me with relevant background and allowed participants to 
describe their perception of events. Information was then sought on their experiences of life 
after stroke, services and support received and the impact of any residual cognitive 
impairments. 
 
 Transcription and analysis  
All interviews except one were digitally recorded using encrypted software. Personal 
identifiers were removed through the use of a bleep censor, and each interview was given a 
number. Each interview was then transcribed verbatim in full, either by myself or a reputable 
third party that had been recommended by my supervisor. If the interview was transcribed 
by a third party, I read the transcripts for the interviews and listened to the digital recording 
in full to confirm reliability and accuracy. In the interview that was not digitally recorded (the 
participant did not wish to be recorded), field notes were taken. Transcribed interviews were 
not returned to the participants.   
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As this was the first study to explore life after stroke in a cohort solely comprised of patients 
with cognitive impairment following an ICH, it was decided that this research should focus 
on identifying themes within the participant’s experiences.  The most appropriate method of 
analysis was therefore a thematic analysis. Although this has been criticised for its lack of 
transparency, the analysis of the data followed the six phases of thematic analysis (Figure 23) 
as described by Braun and Clarke (2006). Although I lacked experience of qualitative analysis, 
I sought appropriate academic supervision and consulted worked examples of thematic 
analysis within other healthcare research (e.g. Cassol et al, 2018 and Frith and Gleeson 2004). 
Where possible, I followed the 15-point checklist of criteria for good thematic analysis 
including transcription, coding, analysis, and fulfilling the report (Braun and Clarke 2006) 
(Appendix 13). 
Figure 23: Braun and Clarke’s (2006) six phases of thematic analysis 
Six phases of thematic analysis: 
1. Familiarising yourself with your data 
2. Generating initial codes 
3. Searching for themes 
4. Reviewing themes 
5. Defining and naming themes 
6. Producing the report 
The qualitative research software programme NVivo (Version 11) was used to support 
coding, management, and analysis of data.  It helped simplify the process of data sorting and 
led to a more exhaustive analysis. An inductive step-by-step thematic analysis was carried 
out on all anonymised interview transcripts. This form of thematic analysis is data-driven, 
where the themes are strongly linked to the data themselves (rather than being driven by a 
theoretical interest). It is also important to note that themes were identified within the 
explicit meanings of the data (semantic). With this approach, although the researcher is not 
looking for anything beyond what a participant has said, the analytic process involves a 
process of interpretation, where there is an attempt to theorise the significance of themes 
and their broader meanings (Braun and Clarke 2006). In the presentation of findings, 
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verbatim quotations from interviews have been used. All quotations are from stroke 
participants unless labelled otherwise.   
The first phase of thematic analysis is familiarisation with the data. I first became familiarised 
with the whole data set through repeatedly reading and reflecting on the transcripts and 
audio recordings. Writing was recognised as an integral part of the analysis and began in this 
first phase through the jotting down of ideas, initial concepts and recurring patterns or 
themes. 
The second phase involved the production of initial codes from the data in a systematic 
fashion. Codes identify a feature of the data that appears interesting to the researcher. 
Although initial codes were manually written on the texts that were being analysed in phase 
one as part of the familiarisation process, coding was later performed using NVIVO 11. See 
Figure 24 for an example of codes applied to a short segment of data.  
Figure 24: Data extract, with codes applied 
Data extract Code 
Everything’s more of an effort [1]…. So you 
kind of step back from what you were or 
what you done before [2]… ‘Cause you 
don’t want to be a burden on anybody [3].  
I mean, we went away on holiday… and it 
was so hard ‘cause I couldn’t walk properly 
[4]. So I felt embarrassed [5]… Like even 
going down to the beach or going down to 
the pool… I was walking like Quasimodo, 
this limp, dragging my leg [4]… Ken, I just 
didn’t feel right [6] and I felt insecure [7]… 
(Dawn) 
1. Everything is harder  
2. Taking a step back 
3. Feeling like a burden 
4. Physical impairment  
5. Feeling embarrassed 
6. Not feeling like the person they 
were before 
7. Feelings of insecurity 
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Once the entire data set had been coded and collated, phase three involved the combining 
of codes into overarching themes that accurately depicted the data. According to Braun and 
Clarke (2006 p.82): 
“a theme captures something important about the data in relation to the 
research question and represents some level of patterned response or 
meaning within the data set.”  
This phase led to an initial list of themes and sub-themes. 
In the fourth phase, I extracted and classified all quotations (i.e., phrases or paragraphs) that 
corresponded to one (or more) of the themes. During this phase, it became evident that some 
of the themes did not have enough data to support them, while other themes needed to be 
broken down into separate themes or sub-themes (for example, it was decided at this stage 
that ‘impact on family members’ had enough data supporting it to be a major theme, rather 
than being a sub-theme of ‘life after stroke’). This phase ended once all the themes had been 
reviewed and refined (see Box 18 for the final themes and sub-themes).   
Box 18: Final themes and sub-themes 
Themes Sub-themes 
The effects of stroke on 
sense of self and identity 
• No longer felt like the person they used to be 
• Changes in ability to perform simple, everyday tasks 
• Not being able to engage in usual activities 
• Impact to working life 
• Impact of cognitive impairments 
Adaptions and 
adjustment  
• Ways of adapting to disability 
• Benefits of health services and resources 
• Help of social supports 
Uncertainty  • Uncertainty during stroke onset 
• Uncertainty over course of stroke 
• Uncertainty about long-term recovery 
Impact on family 
members 
• Hospital admission: uncertainty about prognosis  
• After discharge: adjusting to life at home 
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The fifth phase included a comprehensive analysis to examine the extent to which the 
themes and sub-themes contributed to an understanding of the data. For each theme, all the 
included quotations were synthesised to bring out the main ideas. A summary was then 
produced for each theme using the content provided by the participants. In relation to each 
theme, I asked the question: ‘So what?’ in order to identify the key issues (Braun and Clarke 
2006). All summaries were compared to eliminate duplication and to ensure that all the 
relevant data from each theme was being grouped together in a logical and meaningful way.  
The sixth (and final) phase involved writing the findings and led to a detailed description of 
the results. To ensure validity, descriptive results were accompanied by rich and thick 
verbatim quotations to support the findings (Noble and Smith 2015).  
 
 Ensuring quality in qualitative research 
It is important to consider the quality of qualitative research. As stated by Morse et al (2002, 
p.1): 
 “Without rigor, research is worthless, becomes fiction, and loses its utility.”   
Although the tests and measures used to establish the validity and reliability of quantitative 
research cannot be applied to qualitative studies, in the broadest context, these terms 
remain applicable. While validity refers to the appropriateness and application of the 
methods undertaken and the precision with which the findings accurately represent the data, 
reliability describes consistency within the chosen analytical procedures.  
For the novice researcher, demonstrating rigour can be challenging as there is no accepted 
consensus about the standards by which qualitative research should be judged. Various 
authors have developed guidelines to facilitate researchers’ when thinking about quality. 
Noble and Smith (2015) outline several strategies that qualitative researchers can adopt to 
ensure the credibility of their study findings, some of which are discussed below.  
The first strategy suggested by Noble and Smith (2015), is accounting for biases (both 
personal and theoretical) which may have influenced the findings. The way to do this is by 
being reflexive:  
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“Reflexivity is an essential requirement for good qualitative research… [and] 
refers to the process of critically reflecting on the knowledge we produce, and 
our role in producing that knowledge” (Braun and Clarke 2014, p. 37).  
Although I had taken an inductive approach to thematic analysis: a process of coding the data 
without trying to fit it into the researcher’s analytic preconceptions; researchers cannot free 
themselves of the theoretical context of their research.  
Before interviewing participants, two pilot interviews were conducted, one with a lecturer of 
Nursing Studies from the University of Edinburgh and the other with a member of the RUSH 
patient representative group. Although I had prior experience of focus group interviewing, 
this was the first time that I would be carrying out in-depth semi-structured  interview 
discussions. The pilot interviews were therefore a great opportunity to practice this style of 
interviewing. These sessions were particularly useful for teaching me to tolerate silence and 
to be careful not to use leading questions.  
All the interviews were conducted by myself, a nurse who has previous knowledge and 
experience of working with older people who have cognitive impairments and dementia 
(Russell 1999). All potential participants were primed to the intended area of study (i.e. 
experiences of life after stroke) via the participant information sheets and through brief 
discussion. Prior to the qualitative interviews, I had met with participants on at least two 
previous occasions (e.g. during recruitment, clinic or MRI visits). I was careful not to use this 
pre-existing relationship to pressure people into participating in the qualitative study. It also 
meant having to be careful not to gloss over any relevant information during the interviews 
that was already known (Braun and Clarke 2014). I am also aware that analytic 
preconceptions may have been developed based on having worked with stroke patients as a 
student nurse and having developed a rapport with participants prior to the qualitative 
interviews. However, Lincoln and Guba (1985) describe building rapport and trust with 
participants prior to interview as a way of improving credibility. They suggest that by building 
a rapport with participants, the context of interviews will be appreciated, thus facilitating 
better understanding.    
The second strategy outlined by Noble and Smith (2015) is to acknowledge any biases in 
sampling and ongoing critical reflection of methods to ensure enough depth and relevance 
of data collection and analysis. To enhance validity, detailed description is offered of the 
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sample, findings, data collection and analysis. Purposeful sampling involves the intentional 
selection of participants who can provide a richness or depth of information pertaining to 
the research question. Although there was potential for bias in selection, the aim was not to 
acquire a sample that was statistically representative of the population or to achieve 
generalisation (Palinkas et al, 2015). Instead, purposive sampling was employed for the 
identification and selection of information-rich cases for the most effective use of limited 
resources (Patton 2002). Initial analysis was conducted concurrently with data collection and 
informed the point at which data were deemed sufficient. Recruitment was therefore 
stopped when data sufficiency (rather than saturation) was achieved.  
Noble and Smith (2005) also suggest including rich and thick verbatim descriptions of 
participant’s accounts to support findings and engaging with other researchers to reduce 
research bias. Selected quotations from participants are included in the findings chapter to 
allow the reader to judge interpretations and credibility of the analysis. Although I carried 
out all of the analysis, themes were discussed with supervisors who had stroke and 
qualitative research expertise. Often referred to as ‘peer debriefing’, exploring the analysis 
and conclusions with a supervisor allowed for the development of additional perspectives 
and explanations at various stages of the process of data collection and analysis (Lincoln and 
Guba 1985). 
 
 Strengths and limitations 
A strength of the present study was the use of a qualitative design with an inductive driven 
analysis. Thematic analysis made it possible to discover the most important themes from the 
material, and a semi-structured guide was used to ensure that I concentrated on specific 
topics related to the purpose of the study.  
Participants talked at length in interview and rich data were collected. A strength of this 
study, particularly in relation to many other studies on stroke, is my inclusion of participants 
with expressive language problems. Although this created challenges as at times, particularly 
when participants struggled to explain what happened, with the help of family members, 
participants attempted to make sense of their stories.  
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Participants were selected purposively, and findings need to be interpreted in this context. 
This study is confined to patients who were resident in the Lothian region of Scotland, and 
this needs to be considered when the knowledge is transferred to other cultural contexts. 
Future studies should include patients and carers in other settings to compare experiences. 
The six stroke survivors and four family members recruited to this part of the study are 
unlikely to fully represent the diversity of people living or caring for those who have had a 
stroke due to haemorrhage.  
A number of potential criticisms of this study surround the sample. The number of 
participants in this study was small: an increased number of interviews may have 
strengthened the study. However, because the aim of the interviews was not to reach data 
saturation, it was decided after six interviews that I had sufficient data to analyse in order to 
address the research aim.  
There was an age and gender imbalance within the study. Only two out of the six stroke 
survivors were female, and none of the family members were male. In addition, the research 
specifically involved younger, higher functioning survivors of stroke. All participants in the 
qualitative interviews were below the average retirement age. As such, they may have 
experienced different types of losses than those who were older. To explore the impact of 
gender and age upon the experience of life after ICH, a larger and more diverse sample of 
stroke survivors and family members is required. However, to the researcher’s knowledge, 
this is the first study to explore this phenomenon, it is therefore hoped that the findings will 
be of interest to those from similar populations.  
A further potential criticism of the study relates to the lack of triangulation through member-
checking, as there was no opportunity for participants to check their understanding or clarify 
meaning (Lincoln and Guba 1985). However, rather than representing a fixed truth, the 
interviews provide the reader with a snapshot of the participant’s experiences of having had 
a stroke at one point in time. It is possible that events or reflections that occurred after the 
interviews could alter their story.  
Although some findings have been reported on the impact of stroke on the lives of family 
members, that this was never the focus of the interviews. When planning the study, it had 
not been intended that interviews would be conducted in the presence of family members. 
The extent to which this altered the content and management of the interviews cannot be 
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known. However, all interviews were conducted by the same researcher, giving a level of 
internal consistency.    
 
 Introducing the participants 
Of the six stroke survivors who were interviewed, two were female and four were male. 
Respondents were all in their 40s to 60s. Five of the survivors were married and one was 
recently widowed and lived with their sister. All respondents were experiencing some 
residual impairments from their stroke including weakness or paralysis on one side of the 
body, slurred speech, spatial and perceptual deficits, vision loss, aphasia, memory 
impairments, word finding difficulties, reduced speed of information processing and fatigue.  
A brief introduction to each of the stroke survivors has been provided for the reader below. 
To preserve anonymity, some of the details have been changed. Each interview participant 
has been allocated a pseudonym. The severity of stroke is indicated by the National Institutes 
of Health Stroke Scale (NIHSS). Scores range from 0 to 42, with higher scores indicating more 
severe neurological deficits. Scores on the EQ-5D visual analogue scale have also been 
provided to give the reader a sense of how the stroke survivor perceived their own health. 
 
 Participant 1: Adam 
Adam was a male in his 40s who lived with his wife and young children. He was a self-
employed Software Developer who was studying for his MBA when he had the ICH.  He had 
a left-sided lobar ICH. MRI did not reveal any underlying cause.  
The participant was participating in a marathon on the day of the stroke. He had been feeling 
well on the day, but half-way through became dizzy and developed a right-sided weakness, 
hemianopia and aphasia. He spent 10 weeks recovering in hospital; the first 2 weeks was 
spent in an acute ward before he was moved to a rehabilitation facility.  
Once home, the participant was very motivated about recovery and was participating in 
physiotherapy once every fortnight, exercised regularly at home and had recently started 
running again. At the time of interview, he was very keen to return to work. However, he still 
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had some slurred speech, difficulties with producing spoken language (comprehension 
remained intact) with a mild right-sided weakness. NIHSS score was 3 and EQ-5D VAS was 80. 
 
 Participant 2: Jim 
Jim was a supermarket worker in his 50s who lived with his wife. The participant was working 
as a DJ at a local club when he developed a right-sided weakness and mixed receptive and 
expressive aphasia (difficulty with both comprehension and putting words together). He was 
very hypertensive at the time of the stroke and was admitted to hospital where a CT revealed 
a left-sided mixed lobar and non-lobar ICH.  
Since this time, the participant had made a gradual recovery but was unable to return to 
work. He walked with one stick and was able to walk around the shops with occasional stops. 
He had noticed less of an improvement in his speech than his mobility and still clearly had 
problems with expressive and receptive functioning. His mood was fine on Fluoxtine and he 
slept well. He continued to be affected by central poststroke pain affecting the right-hand 
side of his body and was on regular pain relief. NIHSS score was 5 and EQ-5D VAS was 80. 
 
  Participant 3: Colin 
Colin was a retired Enforcement Officer in his 60s who lived with his wife at the time of the 
stroke but who had subsequently died. His wife had found the participant collapsed on the 
toilet and CT revealed a left-sided non-lobar ICH with early hydrocephalus due to extension 
of the haemorrhage into the ventricles. The participant suffered from Type 2 diabetes and 
hypertension and scans showed he had a previous ischaemic stroke a few years earlier. The 
underlying cause for ICH was likely to be small vessel disease as the MRI revealed some non-
lobar microhaemorrhages and signs of white matter disease. 
After the stroke onset, the participant was transferred urgently to ITU for external ventricular 
drain and he gradually recovered on the stroke unit. Although he was a little fatigued after 
discharge, he had got back to his normal self and spent most days walking his dogs and 
watching television.  
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The participant’s biggest concern was undergoing a driving assessment so he could regain his 
licence. Although he felt as if he had not been affected by the stroke, at the driving 
assessment he was found to have residual cognitive impairments, and it was decided that his 
medical condition was having an adverse impact on his ability to drive safely.  NIHSS score 
was 0 and EQ-5D VAS was 90. 
 
  Participant 4: Helen 
Helen was a business manager in her 50s who lived with her husband. She developed a 
sudden right homonymous hemianopia following two days of migrainous headache. She was 
admitted to hospital and CT revealed a left-sided lobar ICH. Shortly after admission, the 
participant’s symptoms progressed, and her conscious level dropped. The participant needed 
ITU admission for intubation and ventilation after which she was noted to be dysphasic 
(impairment of speech and verbal comprehension) with a right-sided weakness. No 
underlying cause was revealed.   
The participant made gradual progress with her rehabilitation, thanks in part to her inpatient 
stay at a local rehabilitation facility. Her problems at the time of interview included fatigue, 
slow mental processing and right hemianopia. Despite this, she had started to read again, 
was participating in yoga with her husband and was using strategies to compensate for the 
right-sided inattention.  
Helen had occasional headaches and some left-sided limb symptoms, although these were 
thought to be attributable to anxiety. The participants was still receiving support from a 
psychologist at the time of the interview. NIHSS score was 2 and EQ-5D VAS was 60. 
 
 Participant 5: Paul 
Paul was a butcher in his 50s who lived with his wife. On the day of the stroke, the participant 
had finished his night shift and dropped his wife off at work. When the wife came home after 
her work, she found the participant collapsed of the floor and was unsure of how long he had 
been there. CT revealed a right-sided non-lobar ICH. The participant suffered from a dense 
left hemiparesis (including face) and dysphasia.  
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The participant had been married for nearly 30 years and had sons and a daughter. The 
participant admitted to drinking about 2 bottles of vodka per week but claimed he did not 
get drunk, did not experience withdrawal symptoms and did not need alcohol first thing in 
the morning.  
The participant had a mismatch of expectation vs reality. He had expected to recover to his 
pre-ICH level of functioning and was frustrated with not being there yet. He was also deeply 
dissatisfied with the healthcare he had been provided as he had expected more rehabilitation 
and physiotherapy. The participant had recently started to be able to walk some distance 
independently with a quad stick. NIHSS score was 11 and EQ-5D VAS was 50. 
 
 Participant 6: Dawn 
Dawn was a baker in her 40s who lived with her husband and son.  She had a primary non-
lobar ICH in the left side. MRI revealed multiple non-lobar microbleeds, white matter changes 
consistent with small vessel disease and a possible left sided lacunar ischaemic stroke. The 
participant also suffered from hypertension that had been difficult to control.  
ICH caused weakness in the right arm and leg as well as sensory loss down the right-hand 
side. These deficits had been gradually improving. Weakness in the right arm had meant that 
it was not possible for her to return to work. Central post stroke pain had been a problem for 
which she was taking Gabapentin. She also described frequent headaches which were quite 
severe, generalised and were sometimes accompanied by nausea with occasional flashes in 
her vision, as well as the need to sit down and rest. She experienced these headaches at least 
three times per month. 
On the week of the interview, the participant had suffered a right-sided bell’s palsy with no 
obvious explanation.  Although she has regained a considerable degree of mobility, she was 
unable to put fully dress herself, button her clothes or write. NIHSS score was 2 and EQ-5D 





10. Results: Qualitative interviews 
It would be difficult to overstate the impact that the intracerebral haemorrhage had on the 
lives of those affected. Participants experienced major changes due to loss of work, financial 
difficulties, inability to drive, and the loss of friends, leisure activities and social activities. 
Most interviewees (participants and family members alike) readily identified profound ways 
in which their lives had been affected since the ICH. In the quotations below, some of these 
issues have been illustrated.  
Analysis revealed four main themes relating to how survivor’s and their family members 
experienced life after stroke. In the presentation of findings, the overall effects of the stroke 
on survivor’s sense of self and identity will be described. Examples will then be given of the 
processes of adaption and adjustment that participants go through to minimise the effects 
of their functional limitations, including the use of health services and social networks to 
support this. Next, the findings move on to discuss the effects of uncertainty on participants 
quality of life, before finishing with some of the ways in which the stroke has impacted on 
family members. Each of the participants has been given a pseudonym that appears in 
brackets after the quote. 
 
 The effects of stroke on sense of self and identity 
This theme illustrates the tremendous impact that a chronic disabling condition like 
intracerebral haemorrhage can have on a person’s sense of self and identity. This theme has 
been explored through five sub-themes: ‘no longer the person I used to be’, ‘changes in 
ability to perform simple everyday tasks’, ‘not being able to engage in usual activities’, 
‘impact to working life’ and ‘impact of cognitive impairment’, each of which will be discussed 
in detail below.    
 No longer the person I used to be 
All respondents discussed how their lives had changed, often indicating how they could no 
longer be the person that they used to be before the stroke. This change was particularly 
devastating for some: 
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I’ve always been an independent person. I'll not ask anybody for anything. I’ve 
done it all myself… and to have to ask for help has been devastating.  That’s 
been the hardest bit of the stroke… having to adjust to getting help and not 
having the life that I had before. I worked my full-time job. I had a wee job at 
the weekend I used to do…  I’ve had the three kids. I was always on the go, 
always doing stuff, and having that taken away from me has been really… 
sorry… has been really, hard to adjust to, because that’s what I know.  That’s 
my life… I'm not the person that I was before.  I was outgoing.  I used to… go 
to the bingo or I used to do ballroom dancing, and things like that.  That’s been 
taken away from me because I can’t do that now. (Dawn) 
 
I keep saying it, but it’s frustrating because you feel like you’re a failure… that’s 
how I feel because everything that I could do before I can’t do as good or as 
well.  And it’s…it’s a struggle… to come to terms with that. (Dawn) 
 
In this first account, the respondent emphasises how the effects of the stroke were far 
reaching and affected all aspects of her life. Almost everything that the participant valued 
had been taken away: her independence, her capacity to work, her social activities, as well 
as her ability to look after her children. This last point had been particularly difficult for the 
participant to adjust to.  Identification of roles was associated with a sense of self-identity; 
feelings of helplessness and frustration were frequently expressed in relation to forced 
changes in role. Having a stroke can have a profound impact on participant’s ability to help 
others, and this change of status from giver to receiver was very deeply felt by some of the 
respondents. This was particularly stressful for Dawn, who was finding it hard to accept that 
she was no longer able to fulfil her role as wife and mother, particularly as an independent 
person in the past who had never relied on anybody to do anything: 
 My kids and my husband have always been there, but at the same time 
it’s like… they’ve been there but they didn’t understand fully what I was 
going through. They’re trying to help, ‘Mum, it’s alright, we’ll do it’, but 
they didn’t realise that was making me worse. That’s what I should be 
doing and they’re…taking it away from me. And it maybe sounds selfish 
but it’s just…that’s how it was, that…what they thought they were doing 
to help me was taking away even more of my independence… And wee 
things that I could scrape at doing: ‘Just leave it, we’ll do it’.  And I 
thought…no I want to do it.  I want to feel normal. I want to feel like I 
should. Like I'm your mum, ken. I'm your wife, ken. I don’t want to seem 




For one of the participants with young children, not being able to read to them or pick them 
up from school became a difficult reality. Although the participant recognised that they 
should be focussed on getting better, not being the person that they were before brought on 
intense feelings of guilt:  
    
Guilty for my wife, thinking I could never be the husband she married ever 
again. Guilty for my kids thinking I could never be the parent I thought I could. 
Guilty as a friend thinking I could never be a friend the way I have been. Guilty 
in general. (Adam) 
While physical impairments reduced opportunities for getting out, perceived personality 
changes were deeply felt by many of the participants. Some were uncomfortable with their 
current disabled state and were either ashamed or did not wish to burden their friends or 
relatives with their poststroke selves:  
 Everything’s more of an effort…. so you kind of step back from what you 
were or what you done before… ‘Cause you don’t want to be a burden on 
anybody.  I mean, we went away on holiday… and [it] was so hard ‘cause 
I couldn’t walk properly. So I felt embarrassed… like even going down to 
the beach or going down to the pool… I was walking like Quasimodo, this 
limp, dragging my leg… ken, I just didn’t feel right and I felt insecure… 
(Dawn) 
 
 You go out for something to eat and people… if you’re dropping your food 
or getting your cutlery the wrong way around… they automatically turn 
and look.  And it’s… to me it’s embarrassing.  And they’re probably not 
giving it another thought, but some people you can see them whispering… 
it’s hard. (Helen)   
Some stroke survivors felt frustrated, especially in circumstances where they lacked control. 
Some of the participants described feeling as if everything, including their choices, had been 
taken away from them. For example, one of the participants struggled with having to ask 
others for help:  
 Your dignity, you’ve none!  And as much as other people are trying to 
respect your wishes and that, it’s hard saying, ‘Right, can you take me to 
the toilet and clean me?’  ‘Can you dress me?’  ‘Can you help me out of my 
bed?’  ‘Can you help me down the stairs?’ Ken, no being able to cook for 
your family. No being able to do anything for your family!  The physical 
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side was hard but I’ve always said the mental side’s been even harder. 
(Dawn) 
Some stroke survivors were able to cope with this change, while others experienced degrees 
of depression. Paul initially felt like “life was not worth living” as he thought he could “never 
walk again”. His attitude has now changed, and he remains hopeful that he will be “able to 
stand and use my hand again”. For one participant however, these feelings of depression 
were brought on from lack of understanding of others. Dawn struggled to convince others 
that she could no longer do things like she used to: 
 I was getting really depressed about it because outside, people think, ‘Oh 
she looks fine’.  But they didn’t know the struggles I was going through… 
having to get people to cut up my food for me… no being able to hold a 
fork properly and having to use my other hand, and then sitting with a lap 
tray and a bib and things like that, ken. It was like… I felt like a kid.  (Dawn) 
 
 Changes in ability to perform simple, everyday tasks 
Almost every participant reported how having a stroke had radically changed their lives. 
Survivors noted changes in their ability to perform simple, everyday tasks such as getting 
washed and dressed, making a cup of tea, filling in letters etc:   
 I mean, it was so hard. Not being able to do anything. Couldn’t dress 
myself.  Couldn’t put my bra on.  Going to the toilet, I couldn’t clean myself. 
I’ve had to teach myself to write with my other hand ‘cause I couldn’t hold 
a pen.  I couldn’t cook.  I couldn’t hold a knife, ‘cause I’ve no feeling in two 
of my fingers.  Cutting food is still a nightmare.  I still struggle with things 
like that.  Couldn’t lift a cup out the cupboard or cutlery out the drawer. I 
just didn’t have the grip. (Dawn) 
Some reported how much more effort was required to do things which had seemed simple 
before:  
 Everything takes longer to do now. Ken, it’s no just a case, ‘oh give me that 
and I'll do it’, ken.  It’s, ‘right, oh here we go’. Kind of, got to psyche 
yourself up to do it… I used to have a couple of hours sleep and I'd be up 
and that’d be me all day and night.  And now it’s…everything: hoovering, 
dressing myself, making a bed. Everything is such an effort! Things like 
that can get you angry and frustrated, ‘cause you feel stupid.  You’re no, 




The thing with Stroke as bad as mine is, you cannot do it yourself. That’s 
what left me helpless. But after a few weeks, I felt that I could do the things 
that people were doing, even if I needed to struggle with it. (Adam) 
 I'm just a bit slow at doing things now, ‘cause my hand’s slower. (Jim) 
 
These residual impairments and disabilities were a great source of distress, with one of the 
participants feeling like a failure because of them: 
I keep saying it, but it’s frustrating because you feel like you’re a failure… that’s 
how I feel because everything that I could do before I can’t do as good or as 
well.  And it’s…it’s a struggle… to come to terms with that. (Dawn) 
 
 Not being able to engage in usual activities 
Loss of valued activities for participants included disruption to their employment, ability to 
drive, recreational activities and ability to socialise with friends. Many of the interviewees 
had rich and varied social lives before their strokes. Having the stroke often left them unable 
to engage in those activities that had been regular aspects of their lives previously. For 
example, physical impairments made previous recreational activities impossible for Dawn:   
 I’d maybe go to the bingo or I used to do ballroom dancing, and things like 
that.  That’s been taken away from me because I can’t do that now.  It’s 
harder to do. ‘Cause I’ve still not got the full power in my arm. Trying to 
hold a frame as they call it in the dancing, or carrying out the moves… it’s 
tricky when you’ve no got full power in your leg and got a bit of a limp and 
your arm’s no the same… (Dawn) 
Two of the respondents used to be very physically active before their stroke, engaging in 
sports such as running, cycling and swimming, which they could no longer do. Even less 
physically vigorous pursuits were restricted after stroke, as most respondents reported that 
they could no longer engage in activities such as cooking, gardening or reading:   
I can’t read anymore. I used to be one of these people who always had a book 
under my arm. Instead I listen to the audiobooks, but it’s not the same. (Helen) 
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When the residual disabilities following the stroke prevented the participant from engaging 
in activities that had previously been an important component of their identity, then their 
well-being tended to be considerably reduced:   
The hardest thing is not being the person that I used to be. I used to be really 
active. I loved my job. Now I can’t do any of that. (Helen). 
 Interviewer: How have things been since you’ve been back home? 
Participant: It’s been a struggle, and frustrating, to be honest… I like to be a 
hands-on person. I’ve always been somebody on the move. All the time. 
Somebody that would be up there, or be out there in the car… So, I think I’ve 
had to learn a lot of like, well… this is going to be sore for you, you’re going to 
have to give into this, and so… well that’s what I’ve done. Or else I wouldn’t get 
on.  And, it just annoys me. At times.  
Participant’s Wife: And it would get him down if he seen me out there in the 
garden, he would get all upset. He wanted to be outside doing it… what I was 
doing. And then he’d sit and apologise to me because he wasn’t able to help 
me: ‘I’m sorry hen, I’m sorry, I want to be doing that with you’... You know? 
(Paul) 
None of the stroke survivors were able to drive at the time of interview. Participants who 
experienced a disability that prevented them from driving found it to be a significant 
handicap and an erosion of their independence: 
Interviewer: So what’s the biggest thing that you can no longer do that you 
could before? 
Participant: Driving is one of them. Because I like going everywhere. I had two 
cars. Ehm… I just like driving. And I like going to places. Like I was saying to my 
wife the other day, I’m not the type of guy that come the weekend I’d go I’m 
away to the football with the guys. I was more like, ‘come on, we’ll go away 
down to Berwick’. That’s how we led our lives at that time. And I miss that, you 
know. (Paul) 
That’s my main bugbear as a result of it is that I’ve not been able to drive… 
Until you can’t drive, or told you can’t drive, you have no idea how much you 





 Impact to working life 
Respondents expressed frustration at not being able to engage in their intellectual pursuits 
that had been an integral part of their prestroke identity. Five of the survivors could no longer 
engage in their work-related activities (the other was already retired prior to the stroke). 
Their residual impairments and disabilities were therefore a great source of distress, often 
leading to a reduced quality of life: 
They’ve said that I'll never be how I was… before I had the stroke.  I have to 
come to terms with that.  That life… I'll never ever go back to work.  I'll never 
be able to stand and do the job that I was doing… I'll never be like that again.  
I’ve got to let my body know that I'll not… I'll no be able to do things that I could 
do before. (Paul) 
One of the participant’s wives found it particularly distressing having to come to terms with 
their husband not being able to work. They had accepted that the participant would not be 
able to go back to his previous customer service role because of his aphasia:  
He couldn’t do it because he can’t get his words… he gets frustrated.  And 
sometimes we don’t know what word’s going to come out! (Jim’s Wife)  
However, his wife felt that despite what the occupational therapist had told them, there must 
be an environment that would be suitable:  
Participant’s wife: When I phoned [the occupational therapist] up, she says she 
didn’t think it was worth her while… [because] in her opinion, he was never 
going to work again. Which, kind of upset me… To have somebody say that 
they never think your husband’s going to work again…it’s hard. And I couldn’t 
understand that, because I thought, well we know his speech is not very 
good…but he can function.  He can walk. Can lift things.  So there must be a 
role somewhere. You can’t just turn round and say, ‘you’ll never…’ you know, 
he’s only in his fifties! (Jim)  
As many of the effects of stroke are invisible, some of the participants found that other 
people quickly forgot that they had a stroke and expected too much of them. Although one 
of the participants had accepted that she would no longer be able to work as a result of her 
residual impairments, because she ‘looked fine’, she felt pressure from those around her to 
return to work: 
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I was getting a bit of problem from my work.  They were contacting me like, 
‘when are you coming back?’ ’Cause obviously it’s a wee village and people 
were like, ‘oh we’ve seen her walk to the corner, so she must be fine’ and er, 
because my face and that wasn’t affected, people maybe just thought I had a 
sore leg or that.  People didn’t know… They just assumed that I was fine. So my 
work were giving me a lot of hassle… Wanting to know when I was going back…  
They didn’t realise I couldn’t hold cutlery. I couldn’t go back and prepare food.  
I didn’t have the power. Didn’t have the means… It was getting quite 
frustrating. I was getting really depressed about it… (Dawn) 
 
 Impact of cognitive impairments  
Many of the participants alluded to long-term cognitive impairments. While some 
participants described losing concentration whilst reading a book or forgetting to take 
medication as changes form pre to post illness, for others, the change was much more 
marked. One participant described how she used to have a ‘really, really sharp memory’, and 
that it had been a running joke among the family that she would ‘forget nothing’ and ‘ken 
everything’. Since the stroke, the participant has struggled with her short-term memory and 
feels as if it’s continually getting worse:  
 Over the last few months, I’ve noticed my memory’s a bit… less than what 
it was. Like, forgetting dates… appointments… things that I had on.  
Whereas before I was like: ‘I'm doing this’,  ‘I’m going here’,  ‘The weans 
have got this’, ‘They’re doing that’, and I could rhyme them off, ken…it’s 
frustrating now, ‘cause the wee boy’s transitioning up to the high school, 
so they’ve got a lot of dates coming up of what they’re doing and where 
they’re going and things like that. And it’s a nightmare, cause he’ll say, 
‘Mum, where’s that letter that I had to…’?  And I'm like, [sharp intake of 
breath] what one was that?...  Whereas before I'd say, ‘oh right, that’s 
filled out and it’s sitting there’…  And I just, kind of, feel useless… I just 
want to be normal. (Dawn) 
 
The participant then goes on to describe several instances of doing things that were out of 
character from how she had been before the stroke:  
 
I mean, the other day there my husband went in to the fridge and there was 
the iron lying in the fridge.  I'd done ironing… And then when it was cool, I went 
to put it away and I put it in the fridge…and I knew it had to go in the cupboard 
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but I put it in the fridge… And all that… That’s nothing.  It’s nothing.  But it’s 
like… the other morning, the wee boy had a letter and he showed me it and I 
filled it out and he never took it to school.  I lost it.  In the space of five minutes, 
I lost it.  And it was in the oven.  I put it in the oven! Why I put it in the oven, I 
don’t know.  And I tore my cupboard… my wee drawer apart that I keep all the 
letters and things.  It wasn’t in there.  I checked his school bag.  I checked his 
packed lunch bag.  I checked the… I even checked the fridge.  Checked 
everywhere.  And then it was that night, we had to put the oven on, and there 
it was.  It was in the oven. So, I mean, things like that… ken, it’s out of character.  
And it’s… the other day there I run my kid’s bath.  And I said, ‘mind and check 
it before you step in to it’.  And he’s screaming… It was freezing cold water.  I'd 
run the bath with cold water. I always put the hot in and then top it up with 
the cold. I'd done it the other way round and it’s like… things like that that are 
more frequent… (Dawn) 
 
For one of the participants, problems with speech was the biggest thing to happen to them. 
Adam ‘couldn’t face not being able speak properly ever again’. Speech was everything to this 
participant. It was the difference between being able to communicate with his wife, kids, and 
friends. In addition, because of the nature of Adam’s job, he faced significant difficulties 
when trying to get back into work:   
I have only been looking for one month and had four interviews, so things are 
progressing well. It’s just different and, somewhat, surreal. I used to be okay 
at interviews, never been out of work since I turned 17 but things have 
changed. Now I cannot explain things, like ‘tell me about the time that you 
turned things round from a customer experience perspective’.  I could if it was 
writing the answer, but speaking is a different beast. (Adam) 
Other participants described difficulties they faced when trying to remember people’s names 
or describing things:  
It’s funny.  Sometimes you just can’t… you can’t talk. I really don’t know what 
it is… you’d like to talk to people… but you can’t because you forget who they 
are… And it’s awful saying, ‘I don’t know who you are’.  And then other times I 
can… ken, I don’t know, it’s…it’s strange… Sometimes it works and sometimes 
it doesn’t.  I don’t…I really don’t know.  I mean, compared to what I used to be, 
it’s bad.  You know, before I had this stroke. It’s really quite…I could do things 
no problem... Now, I don’t know who they are. But I know who they are. It’s 
really stupid. But what can you do?  Somebody talks to you, you try to talk to 
them but…It’s just one of these things.  I…I don’t know. The people that know 
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you are okay, but the people who don’t know… people are a bit strange. It’s 
just the way it is. (Jim) 
Trying to describe stuff was a nightmare!  I could see what I was talking about, 
but I couldn’t get out the words of what I was trying to describe and...um, well 
I would get frustrated, ‘cause I could see it and I'm trying to describe…and I'm 
going round this big circle trying to describe one simple wee word…so that 
was…it was really frustrating. (Dawn)   
As mentioned previously, Colin’s biggest concern was undergoing a driving assessment so he 
could regain his licence. Although he felt as if he had not been affected by the stroke, at the 
driving assessment, he was found to have a cognitive assessment score indicative of cognitive 
impairment. According to the notes from his driving assessment, Colin had difficulties in 
maintaining a safe road position and would adopt quite a wide position to the right without 
being aware of this. He also had difficulties anticipating the road traffic environment he was 
approaching, which led to several errors in judgement and decision making. His reactions and 
decision making were quite slow at times, as was his speed of travel, particularly when he 
was distracted by navigating more complex road traffic situations. There was also one 
significant lapse in concentration at a pedestrian crossing. On approach to the crossing he 
had failed to notice that the traffic light had changed to red and failed to slow down as a 
result. It was therefore decided that his medical condition was having an adverse impact on 
his ability to drive safely. Despite this, the participant seemed unaware (and unaccepting) of 
the impact that the stroke was having on his judgement and speed of information processing: 
Interviewer- Do you know why they failed you? 
Participant- Yeah, they came up with some stupid things about my driving… 
like, when I got back to the hospital… this is a daft one this…. Ehm, I can’t 
remember now exactly what happened but they marked me down because I 
moved out and there was a van coming. And eh, they said that, you know, it 
was dangerous. But, again, I keep on saying to them that it could of happened 
to anybody... It’s nothing to do with the stroke… I didn’t move in front of that 
car because of the stroke. It was just bad driving on my part… And nothing to 






 Summary  
Following the stroke, all individuals felt that some aspect of their self had been disrupted. 
Common challenges included a compromised ability to perform activities of daily living, in 
addition to problems with speaking and remembering. These challenges often improved over 
time however, the lasting impact tended to manifest as a feeling that they were no longer 
the person that they used to be. Individuals perceived themselves differently due to changes 
in their ability to fulfil certain roles (e.g. in the family or workplace), and their ability to engage 
in activities that were important to them, including driving and having active social lives.  
 
 Adaptions and adjustment  
The theme ‘adaptions and adjustments’ illustrates the different strategies that participants 
used to minimise the effects of their functional limitations. This theme will be explored 
through three sub-themes: ‘ways of adapting to disability’, ‘benefits of health services’ and 
‘help of social supports’.  
 Ways of adapting to disability 
Although participants were willing to accept that their capabilities had changed, they were 
determined to reclaim activities that were important to their sense of identities. For one of 
the participants, being a DJ was an important part of his social life. After the stroke, he had 
worried that he would never be able to DJ again due to his right-sided weakness. Determined 
to get this activity back, and with the encouragement of his wife, the participant started to 
practice with his left hand at home. Although a bit slower, the participant was pleased to 
inform me during the interview that he was now able to fully engage in this activity and had 
played a slot at a local soul festival the month prior. According to his wife ‘he got a good 
reception’.    
Helen, who had been physically active prior to her stroke, spoke about her difficulties when 
being in crowded places. Her right hemianopia meant that people often seemed to appear 
out of nowhere, sending her off balance. She had recently started going for walks by the 




The paths are really wide which makes it easier. You’re not getting in people’s 
way, or going to bang into something. Whenever I walk there I feel normal. 
Like how it was before the stroke. (Helen)  
Engaging in adaption to disability was important for survivor’s quality of life, even for more 
simple day-to-day activities. From using an app that would read recipes aloud, to re-arranging 
clothes in drawers to make everything easier to find, participants gave several examples of 
ways in which they had adapted their homes to make life easier: 
Everything in my kitchen used to be black, which made it difficult to see. So we 
decided to buy everything in red. The kettle, toaster…. It makes them easier to 
find. We also re-arranged the jars so that they’re always in alphabetical order- 
coffee, sugar, tea. (Helen) 
Individuals who had started to adapt to their disabilities often made optimistic statements 
about their situation and made more positive social comparisons to indicate how fortunate 
they felt they were. For example, even though Paul was still not able to walk without an aid, 
he felt grateful that his speech hadn’t been affected and that he could think for himself.  
Likewise, although Colin couldn’t drive as a result of the stroke, he felt grateful that the stroke 
was not worse than it had been and felt lucky in comparison to others: 
I’ve been very, very lucky with my stroke, because a lot of people with strokes 
find that their arms are like that… or they can’t walk... Or they can’t talk 
properly or whatever… So I’ve found that I’ve been very very lucky. Very lucky 
indeed. (Colin) 
 
 Benefits of health services and resources 
It was evident that various resources were important for participant’s ability to successfully 
engage in adaption and report a positive sense of well-being. All survivors identified the help 
they received from rehabilitation programmes as extremely important for enabling them to 
overcome their disabilities and to learn new skills: 
Participant’s wife: Well he does… you do woodwork there [speaking about the 
local stroke club]… They’ve made quite a few things with his hands…um, a lot 
of things for the garden…The twirly thing…and the plant…there’s two planters 
now.  Er, and he’s done one each for his daughters… the girls, and he’s doing 
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one for his mum… So that’s something that he’s never done before.  So that 
was really…we think that’s really good that he’s done that. (Jim’s Wife) 
Rehabilitation goals were initially centred around the ability to perform simple, everyday 
tasks, for example, to be able to ‘tie shoelaces on trainers’, ‘make a cup of tea’ and ‘string 
more words together’. However, participant’s also set goals that would allow them to re-
engage with those activities that had been an integral part of their poststroke lives. For 
instance, the occupational therapist set goals with Adam that revolved around his children, 
for example, being able to take them to bed and bathe them. Similarly, Helen specifically 
identified the help she received from the psychologist, where a home visit every couple of 
weeks helped her to come up with strategies to use the bus by herself and attend family 
events without feeling like a burden:  
I’ve only just finished seeing the psychologist. She would work with me and I 
could tell her things that I was finding difficult. Like my niece’s wedding. I didn’t 
want to go. I get really tired and I was worried that I would use my cutlery the 
wrong way or drop my food. But we talked about it and she came up with 
suggestions, like booking a room at the hotel so that I could go for a nap. And 
having my family… like my husband beside me, in case I got the knife the wrong 
way round… I ended up going, and it was great! (Helen) 
 
In addition to helping with rehabilitation goals, many of the participants spoke about the 
emotional support that they received from healthcare practitioners in the community:  
  
Participant’s wife: Your speech therapist was superb and they very quickly built 
up quite a good bond and she was really good, a very good emotional support 
to [participant]. And to me… she was really, really good and a very good…I felt 
it was more than just speech therapy she offered. In the sense that she’d built 
up a really good rapport with [participant] and she sensed if he wasn’t doing 
so well that day in terms of confidence… And she would spend time talking with 
him about it… 
 
Participant: But, er, also… my physio, I mean, she was brilliant mentally as 
well…as physically.  She was amazing. Wasn’t just the physio side she was there 
for.  I mean, she was there for the mental side, for the days that I was having 
my breakdowns [laugh] and things like that… just feeling sorry for myself 
and…and she…she was really good for that. (Adam) 
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Stroke survivors who were discharged into the care of rehabilitation services in the 
community often spoke positively about their experiences and commended staff involved in 
their on-going care. However, they also spoke about the inconsistency in follow-up and the 
rehabilitation process post-discharge from hospital. For example, it took several weeks 
before services were put in place for Paul. He stated feeling like he could have been ‘doing a 
lot more’ and should have been ‘wasting less time lying around’. Similarly, Jim never received 
physiotherapy in the community, causing a great deal of distress for him and his wife as they 
believed that the lack of adequate access to therapy hampered his recovery.  
This lack of structured rehabilitation for stroke survivors led to some feeling isolated in the 
community and being unaware of support services:  
The downside about being back home… It’s like the hospital just forget you… 
and once you are discharged you are on your own. (Adam)  
Wheelchair transportation and other mobility aids were named as an important resource, 
helping survivors with mobility disabilities to get around and return to valued activities. Paul 
was initially reluctant to get a scooter, as he wanted to be able to walk again.  However, his 
wife eventually convinced him, stating that it was just a temporary measure until he got 
better and that it would help him to do the things that he wanted to: 
So when I sat and thought about it, I thought, wait a minute, I could go walk 
with my wife, and I could go down to the shop with her at the same time... And 
went, aye that’s what I’ll do! So I’ve got the scooter. If the weather wasn’t like 
this I’d be out in it today... I’ve been on a wee trip with the wife up North. I can 
get on a bus with steps. Get in the chair thing. So… the last few months I’ve 
been really good, because of that… Things are getting better... The quality of 
how I can get about, is totally changed from when I first came home. (Paul) 
 
 Help of social supports 
Despite the changes in social relationships and family roles as noted in the sections above, 
survivors indicted that they benefited from the help of various social supports- spouses, 
family members, friends- as providing emotional and instrumental supports that were 
important in their poststroke lives. Helen identified her husband as a key source of support 
and gave examples of the ways in which he was helping her adapt and adjust to life after the 
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ICH. In addition to joining yoga together to help improve the participant’s balance and raising 
the beds in their allotment so she could start gardening again, Helen’s husband was also 
helping her to read to her grandchildren:  
My husband will read the book with me first and then I memorise it so I can 
read it to my granddaughter. I don’t want her to think her grandma can’t read. 
(Helen) 
Similarly, Adam’s wife, who used to be a primary school teacher, would download resources 
and do extra speech and language therapy with the participant. Without a spouse, one of the 
stroke survivors relied on other family members for social support. The participant had 
recently been widowed and identified his sister as the one providing support with activities 
such as driving and shopping: 
Anywhere I want to go, my sister has to take me. Luckily she only works in the 
evenings so therefore if I ever want to go somewhere in the day, like to the 
shops, she can take me… (Colin) 
Stroke survivors also benefited from the support of peers. These supports were not only 
important for the provision of emotional support, but also for well-being, as they helped the 
survivors to maintain important aspects of their prestroke identity: 
Participant’s wife: And he’s got…I mean, he’s got good mates, and, umm… 
Interviewer: Did you find that your relationship with friends changed at all? 
Participant: No, I…I thought that, err, they generally got, err, closer as well. 
You know? Because, err, I…I saw some of them once a week in the hospital. 
Err, and I’d never seen them that much before [laughs]…You know what I 
mean?   
Participant’s wife: I…I think, yeah, I think it…it hit a chord with a lot of his 
pals…And it made them realise, you know, how, like, quickly life can change… 
(Jim) 
Attempts at adaption can fail if social support is negative. Absence or withdrawal of support 
can have an ill-effect on survivor’s well-being:  




Participant: [Sigh]. My friends, aye because [sigh] I feel they look at me 
different.  Like…to me, I feel an embarrassment to them...  And I know I'm no, 
and they tell me I'm no, but that’s how I perceive it.  I perceive that I'm alone 
in this…and you, kind of, single yourself out and, kind of, shy away from 
everything.  Ken, so it has changed…ken, I was quite bubbly, outgoing, ken, ta-
da, I'm here so to speak, ken.  Life and soul and…and now I feel very self-
conscious and I…I mean, I never cared what anybody said.  I…I just…so what, 
ken.  That…I am what I am and that’s me.  But it’s made me more withdrawn… 
(Dawn) 
Because I’m speaking to you like I am, as if there’s nothing wrong with me, they 
don’t realise how hard it is for me… That’s the side they don’t see. And I never 
show… I never show being upset or angry or anything. I just stay the same. But 
for me, there’s times when some of them could say, ‘awk well, I’m going up to 
the centre, do you want me to get you something, or take you?’ They just 
assume that I’m not wanting to do anything like that. (Paul) 
Similarly, not all spousal support is positive in the lives of stroke survivors. Dawn reported 
that she felt dissatisfied with the emotional support she received from family members. She 
admits to feeling lonely and wishes there was group for stroke survivors that she could go to 
for emotional support: 
 There was nothing here for me like that when I had the stroke.  Like, other 
people so you don’t feel that you’re alone.  Just to have somebody else say 
to me, ‘oh I felt like that today’ or ‘I picked up my toothbrush and put my 
toothpaste on myself today’… I ken it feels good, but to other people, 
they’ll just look at you and think, aye, alright, ken… But it’s…to have they 
kind of things taken away from you and not have anybody to talk to about 
it… So for that side, it would be better if there was something in place… 
like even a support group. So you…don’t feel like you’re alone. ‘Cause you 
do, you feel like… you’re going through it and nobody else has. And 
that’s…that’s hard (Dawn). 
 
 Summary 
Several respondents engaged in processes of adaption and adjustment following their stroke 
to minimise the effects of their functional limitations. All participants wanted to re-engage 
with familiar routines and activities, and to reclaim previously valued identities. For many, 
processes of adaption and adjustment required the use and support of health services and 
social networks.  
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 Uncertainty  
All respondents reported feelings of uncertainty throughout the course of their stroke. These 
feelings occurred at all stages of the stroke journey and were felt by stroke survivors and 
family members alike. This theme will be explored through the following sub-themes: 
‘uncertainty during stroke onset’, ‘uncertainty over course of stroke’ and ‘uncertainty about 
long-term recovery’.      
 Uncertainty during stroke onset  
Stroke is a traumatic event. For many it is unexpected, and hits without warning; for others, 
the onset of stroke is gradual, with vague symptoms being experienced over the course of 
several days. No matter how the stroke started, while recounting the events leading up to 
hospital admission all respondents expressed uncertainty as they tried to understand exactly 
what happened. For many, the first signs of stroke was often a realisation that something 
was not quite right:  
Participant: I came in from my work…  I'd had a pounding sore head for about 
three weeks before it.  And I felt like something was going to pop.  It felt funny 
this time.  Just felt like something was going to pop.  That was the only way I 
could describe, like, when you see a balloon going to go and it’s like…that this 
feeling I had…and I came in from my work and I just…I just felt funny. I went to 
sit down and I fell on the floor.  And I went to get up and my arm was dead… 
and I had this metallic taste in my mouth… And then the…it started…my arm 
started tingling and it started…and I'm saying… it’s no a stroke…but at the back 
of my mind somewhere I knew it… was some…something wasn’t right.  Er, so I 
sat on the couch and I must have sat for about ten minutes and I just had this 
horrible, horrible taste, a metallic taste in my mouth.  And I went to move my 
arm and it was a dead weight. Couldn’t move.  And I went to stand up and my 
leg was heavy. And I'm trying to walk and I was dragging it.  Every time I tried 
to move my arm, I just couldn’t.  Couldn’t move anything at all down my right 
side. (Dawn) 
For others, there had been no warning signs. This was particularly the case for Adam, who 
was at his peak fitness, and was competing in a marathon at the time of the stroke: 
Participant: Err, about ten kilometres in, I took a…a sore head, and I…my 
balance really went off. Umm, and… I collapsed. My right side, err, collapsed, 
and I…I…I was speaking to the steward, err, and it was gobbledegook…that 
was coming out. Umm, so he said that he would phone an…an ambulance. Err, 
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so the ambulance came about five minutes, err, and then, err, I was bundled in 
the back, err, and then, err, err, I was taken to the hospital, err, where I was, 
umm, I was, umm, was…what was I? Err… 
Interviewer: Assessed? 
Participant: Yeah, and… Umm, then it was really blank because, err, I was 
obviously on morphine or something. Err, and then I was really away with it for 
three days… (Adam).  
The onset of the stroke was vividly imprinted in the memory of stroke survivors as a sudden 
incident for which they were not prepared, and which changed their lives irrevocably. The 
sudden and unscheduled event seemed less problematic for some, while for others, it was 
particularly devastating. One participant described this experience: 
But that day in particular, ehm…. I was exhausted the whole week. I hadn’t 
been sleeping, at all! I felt totally exhausted. At work, just, that last shift I felt 
drained. Totally. So I was sitting here, watching the tele, and…. I felt… that 
something was wrong. But I couldn’t… no sore or anything like that. No pain, 
nothing. I just put it down to tiredness. And…. Stuff like that. So, I don’t know, 
maybe another hour had passed… so I remember, I got up, went to the kitchen, 
and I came back, and I sat down, and I went, I said no, something is wrong. and 
I couldn’t put my finger on it. The next minute I remember, I turned round, and 
I watched my arm fall down. My left arm fall down. I watched it! So I went like 
that, aw nah…. Something’s happening. So, I was trying to think, what am I 
going to do, I was starting to panic. So, I tried to stand up, and eh, get to the 
table there. Then my leg went as well. Then I fell. Then I remember, I was 
holding on. I was underneath the table. And I was holding myself up. And, ehm, 
I just kept on talking. And then I must have passed out. (Paul) 
Across interviews, most participants could remember the onset of the stroke, however 
few could recall the first few days in hospital: 
That was it.  So…so that was the last time…um, and I don’t remember anything, 
being in hospital or anything…Little bits and pieces, nothing for me, I don’t 
know. (Jim) 
 Interviewer: When did your memories start kicking back in? 
 Participant: Uh… probably the day after. Over two days after… 
 Participant’s sister: No, you were out for it for a week 
 Participant: Was I? 
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Participant’s sister: You were in intensive care for a week. So it was about a 
week… I would say, It was about 7 days later… (Colin) 
Many of the individuals were shocked that they had a stroke at such a young age, particularly 
if they perceived themselves to be in relatively good health beforehand. One of the 
participants struggled to accept that they had a stroke, believing that it is a disorder that only 
effects the elderly: 
Participant: The thing is I didn’t see it as…as a stroke. Err, I saw it as a brain 
haemorrhage, which…which is different from a stroke, you know? 
Participant’s wife: You…your perception…you still…you kind of have… 
Participant: I…I still, aye… 
Participant’s wife: …a stigma about a stroke… 
Participant: Yeah.  
Participant’s wife: …where you think it’s an old man’s thing. (Adam) 
 
 Uncertainty over course of stroke 
Uncertainty was also difficult for survivors throughout the course of their stroke as they 
anticipated the likely degree of disability. For some, this uncertainty began in the first few 
days of being in hospital:  
It felt as if you were a patient rather than somebody… who can get better. I 
was put in a ward… beside 3 other patients, who em… didn’t even have similar 
conditions to me. I felt all alone… To top it off this was the time realised what 
position I was in… From, em, needing a hoist to get out bed… to needing a 
wheelchair to go to the toilet… (Adam) 
Participant: I couldn’t understand why they were keeping me here when I can 
talk alright and stuff like that. And then getting the physio, I was just getting 
upset all the time, crying all the time.  
Interviewer: What was making you upset?  
Participant: Em, you know… I could walk before, why can’t I do it now? I 
couldn’t realise the… I couldn’t believe that…. How can I not… drive my car, or 
walk away or, stuff like that. And I’d be sitting on the chair in the hospital, 
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ehm… next to my bed… and I was just like, why is this getting done to me? 
(Paul) 
Many of the participants also felt a sense of uncertainty and unpredictability around stroke 
outcomes. Adam had a conversation with one of the healthcare professionals whilst in 
hospital that highlighted the unpredictability of recovery. Although the healthcare 
professional was simply highlighting the worse-case scenario, and reassured the participant 
that they would do everything to make sure this didn’t happen, he found it hard to accept: 
I didn’t know what to expect but was unprepared for her chat… She basically 
said em, I might never walk again… might never speak again… the right side 
might always be disabled... I was taken aback! How can a fit and healthy guy 
go to this in a few weeks? (Adam).  
Some survivor’s behaviour poststroke was very changeable, making daily life uncertain. Jim 
expressed frustration with the uncertainty of his ability to speak on a day-to-day basis. He 
experiences receptive and expressive aphasia that can some days be more severe than 
others. He is never sure when his speech will give him trouble or when it will be more fluent:  
Interviewer: And have noticed change in your speech? 
Participant: Yes. 
Participant’s wife: Um…not since he woke up from his sleep.  I mean, his speech 
was bad… 
Interviewer: Right. 
Participant’s wife: I think it’s got a bit better…some days… some days it can be 
absolutely…and other days, it’s just…like, you know, being back at the 
beginning… 
Participant: I'm no sure…  Sometimes it works and sometimes it doesn’t.  I 
don’t…I really don’t know. I'm…I mean, compared to what I used to be, it’s bad.  
You know, before I had this stroke. (Jim) 
There was also a degree of uncertainty over whether participants would ever be able to do 
certain activities again:  
And then, up at the hospital as well… I’d been up there maybe, two and a half, 
three months… And my wife kept on saying to me, what if I bring your laptop 
up. And I was like naw!  I was frightened, I would open it and it meant mothing 
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to me or I couldn’t do anything… I think a lot of it was just shock. And 
frightened. That’s the two things I think… I was very frightened I wouldn’t get 
any better. (Paul) 
Once home, there was often uncertainty about survivor’s long-term disability and the 
unreliability of formal support. Uncertainty about when therapies would start and how 
arrangements were made left some individuals and family members feeling abandoned:  
 Participant’s wife: And there wasn’t…we didn’t know when she [speech 
therapist] was coming back, and it was no fault of her and she again…she 
ended up coming back and apologising saying you should have been 
passed onto somebody, because you were then just left and it was a real 
crucial time where you were starting to get really anxious… thinking I’m 
not gonna make progress, that’s not…my speech is terrible. (Adam’s Wife) 
Survivors were also afraid of having another stroke. The uncertainty about whether a stroke 
would happen again persists over time and is coupled with the fear that the next stroke might 
be worse. For one participant, the fear of having another stroke, or of symptoms worsening, 
was still present two years after onset: 
Participant: I kept on expecting some kind of physical manifestation of my arm 
not being right or my leg, not being able to walk on it. But it never materialised. 
And I kept on thinking about things like, I thought, surely my brains going to go 
shortly. And you know, I won’t be able to reply to this letter or go on the 
computer. But things were fine. Surprisingly. I kept on waiting for something 
to happen.  
 
Interviewer: Has that fear gone away now? 
 
Participant: No, I still let her [sister] know that I’m going for a walk and ehm… 
if I’m not back within the hour or so she’ll know that something has happened. 
 Participant’s sister: He’s still got that fear of having that…. 








 Uncertainty about long-term recovery 
The standard often used by patients to measure recovery was their prestroke lives. Some of 
the participants admitted to having dissatisfaction with the progress of their recovery and 
where they wished to be: 
Interviewer: How long did it take you get the movement back in your arm and 
leg? 
Participant: My leg was a lot quicker.  My leg was only about maybe three 
months. My arm, it wasn’t…about six/seven months…and even now it’s still 
no… 
Interviewer: Not back to where it was?  
Participant: No.  No.  Nowhere near…in fact I'd…I’ve been getting physio at the 
house and then they started me on a programme at the local sports centre… 
kind of, building up my…my muscle again…in my arm and just…and that 
stopped in September.  And it was…it was okay.  It wasn’t a hundred per cent, 
but it was a lot better…and then it started…the weakness started coming back 
again (Dawn) 
Their expectations often did not match up to the reality of their condition. This gap 
highlights one of the major difficulties of adjustment, the acceptance of continuing and 
relatively permanent disability. At the onset of stroke, patients may still be hoping for 
a complete recovery. After a year, the realisation that this might not occur was usually 
difficult to accept:  
People say to me, ‘it’s only been a year’.  But I feel like…it has only been a year, 
but at the same time, I should be better than what I am.  And then other times 
I think, ken, I am alright for it just being a year, ken…so it just depends, I think, 
what you’re doing and how…how you feel… (Dawn) 
Many participants had unrealistic expectations of how fast they would recover. It was only 
over time that some participants realised the long-term nature of recovery: 
One thing that struck me… where your brain is concerned… things take a lot 
longer to heal. I have had knee injuries… back injuries, but you do physio and 
in few weeks you are back to normal. With brain injury… things take so much 
longer. Even when things have improved… it takes one bad day to put it back… 




Although expressions of uncertainty varied over time, it remained a central reoccurring 
theme and related to both short- and long-term issues. Initially it centred on prognosis, likely 
degree of disability and difficulty in imagining what it would be like away from hospital. Once 
home, continued uncertainty about survivor’s longer-term disability and the unreliability of 
formal support was evident.  
 
 Impact on family members 
The theme ‘impact on family members’ revealed the ways in which the stroke affected the 
lives of three of the participant’s spouses. Findings for this theme start at onset and continue 
through to one to two years after the stroke.  
 Hospital admission: uncertainty about prognosis  
The few days and weeks after a stroke were often quite stressful for families as they had to 
deal with the shock of the event. Due to the sudden nature of the stroke, family members 
experienced anxiety about the prognosis and uncertainty about what the future would hold. 
Family members described themselves as agitated and stressed by A&E, particularly 
regarding lack of information. As one family member said: 
Participant’s Wife: As soon as we got to the hospital, I was taken away to the 
family room. But nobody gave me any information.  I sat in the family room 
with [laugh] my daughter for about…nearly forty-five minutes… 
I: Okay…  And nobody told you what was going on?  
Participant’s Wife: No.  They just said sit there…er, they…says, you know, they 
were taking him for a scan… But they didn’t actually explain what was 
happening… (Jim’s Wife) 
IF the stroke survivor was found to have aphasia, this was particularly distressing for the 
family members. In addition to the inherent communication difficulties, aphasia was a new 
and scary experience for some of the survivors. As a result of these communication 
difficulties, it is important that any relevant information regarding the care of the patient is 
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passed on to family members. However, medical and nursing staff weren’t always as forth-
coming with information-giving as hoped:     
Participant’s Wife: You know, there’s a time…time that he was really quite bad 
in there [referring to the hospital].  Um, on the night that I didn’t… ’cause I had 
a special doo that night, um… it was the only night I was never at the hospital.  
And they moved him from a side ward in to a mainstream ward.  He didn’t 
know what was happening… and although he was still sleeping, he was still, 
sort of… He knew something was different…and, er, you know, strange sort of 
people round about him… Going in to a ward with five other people from being 
in a single room… you know… there was a lot of different activities going on… 
and his mood went down a bit and I had says [to the doctor], ‘his mood’s 
dropped a bit’… I'm, kind of, worried about it.  ‘Oh that’s fine, so we’ll put him 
on mood tablets’… ‘because we expect this to happen’.  But nobody explained 
that’s what they expected to happen.  Was his mood down because he went in 
to a different environment?  I wasn’t there!  (Jim’s Wife) 
One of the aphasic stroke survivor’s wives also vividly remembered worrying that the 
connection between her and her husband had been lost:  
Participant’s Wife: …and although he knew who I was, there was still a…it was 
a very strange thing, like he…he knew that I was his wife, but it was almost like 
that connection between us had gone from his perspective, so the…like I knew 
that if he was really aware of everything, he would have been worried about 
me… and he would have been trying to go, it’s okay, everything’s fine… kind of 
thing, I’ll be okay. But there was none of that and it was almost this slight kind 
of detachedness… It’s really hard to explain and that’s what I’ve… I was most 
worried about was what if he doesn’t remember the connection that we have. 
He knows I’m his wife, but somehow in this…through this, you know? So that’s 
what kind of upset me the most. (Adam’s Wife) 
Once patients had been admitted, family members had to cope with their symptoms, 
including physical limitations, cognitive impairments and the possibility of a second stroke.  
Expectation of recovery varied, with some of the family members fearing the worst: 
Participant’s Wife: I got a call to say, err, we’ve done the scan and it looks like 
he’s got a massive abscess in his brain that’s gonna need to be, err, drained 
and surgery, but he’s not gonna be stable enough for that to happen just now. 
So it just felt like my world…that was the worst day for me… 
Participant: That was two weeks after the stroke?  
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Participant’s Wife: This was two weeks after… So that was the day I thought 
he was going to die because… they basically…, err, said that within a month, 
you can die or you can be, err… And I thought this is it, he’s not gonna make it, 
it was, umm, horrendous! (Adam’s Wife) 
 
 After discharge: adjusting to life at home 
For many, returning home is a transition that is eagerly anticipated and one that signals a 
return to ‘normal’. Often however, the reality is very different. One of the couples reported 
worrying about the practical implications and their ability to cope. With this couple, 
circumstances were also a bit different because they had a very young family, so they had to 
be sure that the wife was ready for him to come home:   
Participant’s Wife: We had one episode where staff were starting to tell Adam  
about him getting home and it was quite early, and he was getting all excited 
and I’m thinking, oh my god, you can’t go home just now…because I can’t cope 
with you at home, and the house isn’t equipped for you being home just now… 
’cause you were still heavily using your wheelchair and everything then and our 
bedroom’s upstairs, and I’m starting to panic… and that’s when it’s really hard 
because you’re like… I don’t want to appear to you that I don’t want you 
home… But at the same time, I’ve got, I mean, my youngest is only a year and 
a half! (Adam’s Wife).  
The transition from hospital to home was often an anxious time for families. A few of the 
participants spoke about the ‘bubble’ of being in hospital where your food, personal care and 
rehabilitation is all taken care of for you. Once home, a lot of this responsibility is taken on 
by the family member. There was also a sense of uncertainty and unpredictability over stroke 
outcomes. In the presence of consistent cognitive impairment, a few of the family members 
had to assume responsibility for every aspect of their mutual lives. For some, constant 
physical attention was also required for toileting or eating, particularly if the person had poor 
awareness of his or her limitations. Family members were therefore often unwilling to leave 
survivors alone in the house. One of the family members found the stroke survivor very 
dependent on them for all activities, something for which they had not been prepared: 
Participant’s Wife: I don’t think there’s enough information given…for me.  You 
know, in hospital you’re in this bubble…Because the staff are doing everything. 
And you know… if you ask a question, they will answer it, but there was 
never…you know, not a lot of information’s given to you. But you see, you, kind 
206 
 
of, just go with the flow…and then you come to this point where they suddenly 
say, by the way he’s going home on Tuesday. And you’re thinking…panic sets 
in…you know.  And then, you know, he came home and it was strange ‘cause, 
I mean, nearly three months he was in hospital…and I thought, you know, I'm 
left to, sort of, cope with this and I don’t know if I'm doing it right, am I doing 
it wrong, are we doing too much… doing too little?   
Interviewer: And was there never anybody that you felt you could talk about 
that with?   
Participant’s Wife: No. Nobody at all. And you’re suddenly left…you know, at 
night time.  And you just don’t sleep because you’re thinking, if he gets up 
through the night, am I going to hear him? Is he going to fall?  Is he going to 
manage, you know?  So panic set in for me.  A lot of nights lying crying, 
thinking, am I doing it right?  (Jim’s Wife) 
Family members of stroke survivors required support in their roles yet this was not always 
available. Primary care could play an important role in the care of stroke survivors and their 
caregivers however, the feeling of abandonment that people with stroke seemed to 
experience following hospital discharge suggests this role is not being completely fulfilled. 
Lack of proactive follow-up from the hospital or primary care services left patients and family 
members feeling dissatisfied and unsupported. One of the family members felt that their 
husband had been forgotten and written-off: 
Participant’s Wife: We were told that he was coming out the hospital, um…and 
I…I did express to the hospital I was anxious about it.  Um, and they’re, ‘oh no, 
we’ll put this care plan…’ and all the rest of it and I got the assurance and just 
before he came out of hospital, well there’s been a delay because, you 
know…but community rehabilitation will be put in place.  And don’t forget 
you’ll see your consultant six to eight weeks after you come out of hospital…   
Interviewer: So what happened? 
Participant’s Wife: Well after a while we thought, we haven’t had anything 
from the hospital.  So we asked his GP to get in touch to find out.  And I wasn’t 
happy with the answer that we got back… ‘well there’s not a lot we can do for 
his stroke.  So really we had better not put him through the trauma to come 
down and see a specialist, ‘cause… we can’t do anything for him’ And that’s it.  
So we’ve not had any contact since… (Jim’s Wife) 
Health professionals assumed that family members would provide most of the care needed, 
with little or no support. Preparation for caregiving seemed to be a neglected dimension 
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where spouses felt they could have benefited greatly from advice before their family member 
returned home. Information provided by professionals was often considered inadequate and 
was an unmet need. Information about stroke-related impairments, how to prevent future 
strokes, access to community services and benefits to which they might be entitled seemed 
to be particularly lacking. For some, a lack of information was an unnecessary source of 
anxiety:   
Participant’s Wife: What I would say was lacking for me from support was… 
that kind of support for families when something like this happens. In terms of 
just to get your head around, like, what to expect, what not to expect…and the 
kind of, umm, you know I was really worried in the early days when he got 
home of leaving him. I didn’t want to leave him in the house by himself, I 
just…kept…I had this picture in my head of coming back and finding him lying 
on the floor somewhere… Then I became unwell, but it was all anxiety, really, 
but I think that’s the thing I would say…that needs to be improved…is that kind 
of support. And I think because you hear about it with people who’ve got 
cancer, whose recovery can be just as long and just as hard, and there’s great 
teams like the Macmillan nurses and stuff who give a lot of emotional support, 
financial support, you know, financial advice, etc…There’s a whole package…. 
But there doesn’t seem to be that in this case. (Adam’s Wife) 
Initially uncertainty at home was centred around the possibility of survivor’s having another 
stroke or falling and was often given as a reason for not leaving survivor’s alone. One of the 
participant’s wives vividly recounts the worry they felt with regards to leaving their husband 
alone in the house and the difficulties this caused: 
Participant’s Wife: Um, when he was in hospital…you’re in that bubble because 
somebody’s looking after your husband and you can see the progress that he’s 
making.  But when you come home, you just realise… how hard it is…that 
you’ve got to be there constantly so you know… um, making sure he’s safe, the 
environment is safe, having to think things through you know.  Before when 
you used to say, ‘oh I'm just going out to the shops’, put your coat on and just 
go to the shops.  Now I’ve got to think, can he come with me?  If he can’t come 
with me… is there somebody here safe with him?  Or if I leave him, how long 
can I leave him for before I get back because he can’t do a lot of things for 
himself. Uhm… He can make… a cup of tea…and he’s now learned to make a 
sandwich, but that’s…taken up to now……to do that.  So to be out the house 
for any length of time, he could be sitting without a drink or anything to eat 
and that’s something you’ve got to think about… (Jim’s Wife) 
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Even though some of the family members knew they could go out without the survivor, they 
felt it was unfair to go out and enjoy themselves. For example, a wife of one of the survivors 
talked about the dilemma that she faced during the summer holidays when taking the kids 
for a day out at the beach: 
Participant’s Wife: I was basically saying to the kids this is not gonna stop us 
being a family and doing family things, so that they don’t see everything as a 
negative. And…or saying, well, we can’t go there, ‘cause Dad can’t do that and 
I didn’t want to make him feel that everything’s having to change… But that 
was challenging as well ‘cause the youngest one was in a buggy, and I had my 
husband in the wheelchair… but we had, I think, one family day out… down to 
the beach. We had a nice day and the kids wanted to go on the beach, but we 
couldn’t take the wheelchair onto the sand, so he said, yeah, I’ll just stay up 
here, and he found that really hard, because…he sat and…and that’s where I 
felt completely torn because I thought, I don’t want this, I don’t want you 
sitting up there watching them like some old man. But at the same time the 
kids want to play on the beach, and I don’t want to say, no, you can’t go to the 
beach, it’s a lovely hot day, so that was really, really hard… (Adam’s Wife) 
 
 Summary 
The three spouses of stroke survivors who participated in the interviews all spoke about the 
impact that the stroke had on both their lives. The sudden and unexpected nature of a stroke 
means that there is very little time for family members to prepare for a caring role, with 
family members often feeling like they had no support.  
 
 Chapter summary 
Thematic analysis of the qualitative interviews identified four overarching themes relating to 
how survivor’s and their family members experienced life after stroke: ‘the effect of stroke 
on sense of self and identity’, ‘adaptions and adjustment’, ‘uncertainty’, and ‘impact on 
family members’. These findings indicate the profound impact that stroke due to 
haemorrhage can have on the lives of survivors and their family. Their lives of survivors are 
abruptly altered, with participants often indicating that they could no longer be the person 
that they used to be. In addition to finding themselves unable to perform simple, everyday 
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tasks, physical and cognitive impairments often prevented the participants from engaging in 
those activities that had played integral parts in their prestroke lives. Overall, the qualitative 
accounts suggest the necessity for individualised assessment of needs and a person-centred 
approach to the planning and delivery of services to best assist stroke survivors in coming to 





















This chapter will go through each of the principal findings of the study individually, relating 
them to existing literature, and discussing any differences. Next, the chapter will move 
towards a discussion of any clinical implications of the research, what questions remain 
unanswered and what further research is required. The chapter will then end by bringing the 
main findings together, into a succinct conclusion.  
 
 Summary of principal findings 
 Prevalence of pre-existing cognitive impairment and dementia 
Using data from LATCH COG, I found that approximately 1 in 4 patients (23%) had cognitive 
decline prior to their ICH. Forty-one patients (10%) had cognitive impairment with no 
dementia and fifty-two patients met the criteria for pre-existing dementia (13%). The 
prevalence of pre-existing dementia was 19% in the lobar group and 7% in the non-lobar ICH 
group.  
The prevalence of pre-existing cognitive impairment and dementia is similar to the findings 
of Cordonnier et al (2010) who recruited 417 consecutive patients with ICH. The prevalence 
of pre-existing cognitive impairment and dementia was 14% and 16% respectively. Although 
the proportion of patients with pre-existing cognitive decline in LATCH COG was slightly lower 
than that reported by Cordonnier et al (2010) (23% vs 29.5%; with this difference being 
present both with regards to pre-existing cognitive impairment and pre-existing dementia), 
this may be explained by the design of my study. Pre-existing cognitive decline was based on 
review of the patient’s medical records, where diagnosis would have been made by a variety 
of physicians and methods (e.g. geriatrician, neurologist, psychiatrist, primary care physician 
etc). Given evidence of under-recording of dementia in primary care in the United Kingdom, 
it is therefore likely that I underestimated the prevalence of pre-existing cognitive decline 
(Iliffe et al, 2009). Despite this, other studies have demonstrated a similar prevalence of pre-
existing cognitive decline to that of LATCH COG. For example, in a study of 166 patients with 
neuroimaging confirmed CAA, Banjeree et al (2018) found the prevalence of cognitive 
impairment before ICH (as determined using the IQCODE) to be 24.7%. However, the authors 
acknowledged that those included in the study were younger and had a lower IQCODE than 
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those who did not have an MRI and were therefore not included in the study. Collectively 
however, these data suggest that pre-existing cognitive decline is common in patients with 
ICH.  
 
 Factors associated with pre-existing cognitive impairment and dementia 
One of the most interesting findings in univariate analysis was the association of CT 
neuroimaging markers of CAA (Edinburgh CAA criteria (CT only)) and SVD (composite SVD 
score) with pre-existing cognitive decline. The damage caused by the haematoma is clearly 
not the only mechanism contributing to cognitive decline and supports the hypothesis that 
cognitive impairment in ICH is also related to the underlying small vessel disruption. My 
findings add to the growing evidence that CAA and its resultant small vessel disease play an 
important role in the development of cognitive decline in patients with ICH (Banjeree et al, 
2018).     
While participants without pre-existing cognitive decline had a median modified Rankin score 
of 1, those with pre-existing cognitive impairment and pre-existing dementia had median 
modified Rankin scores of 2 and 3 respectively. The finding that pre-existing cognitive decline 
is associated with higher levels of disability is echoed in a study by Yim et al (2018) who 
recruited 3537 participants with ICH. Like LATCH COG, dementia prior to stroke was defined 
as a positive history in medical records or treatment with cognition enhancing medication.  
In addition to the finding that dementia was associated with greater levels of disability and 
less independence at 3 months poststroke, the authors also found that pre-existing dementia 
was more common in lobar ICH than non-lobar ICH.  
In my study, logistic regression analysis showed that patients who had a lobar ICH were twice 
as likely to exhibit pre-existing cognitive decline and 3 times more likely to exhibit pre-existing 
dementia than those who had a non-lobar ICH. In the study by Cordonnier et al (2010), the 
prevalence of pre-existing dementia was 23% in patients with a lobar ICH, compared to 12% 
in patients with deep haemorrhages. Lobar haemorrhages are associated with cerebral 
amyloid angiopathy, which often occurs alongside an Alzheimer’s disease pathology 
(Arvanitakis et al 2011). Available postmortem data from 5 patients with lobar haemorrhages 
in the study by Cordonier et al (2010) confirmed both Alzheimer’s disease and CAA pathology. 
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In line with these results, pathological results from another study demonstrated that in 109 
ICH patients, Alzheimer’s disease pathology was found in 68% of CAA-related ICH patients 
versus 9% of non-CAA-related ICH patients (Attems, Lauda and Jellinger 2008). It is therefore 
possible that the higher rates of pre-existing cognitive decline in lobar ICH patients could 
result from the underlying amyloid-based pathologies, including Alzheimer’s disease and 
CAA, and the interplay between the two (Ghiso et al 2011). 
Patients with central (deep) atrophy were over 4 times more likely to exhibit cognitive decline 
and 8 times more likely to exhibit dementia before their stroke than those without, 
suggesting a neurodegenerative process. Severity of white matter changes (SVD score) was 
also associated with pre-existing dementia. The finding that white matter damage is 
associated with pre-ICH cognitive decline was previously shown in the study by Viswanathan 
et al (2008), who found that MRI markers of chronic tissue disruption (as measured by the 
global mean apparent diffusion coefficient) was associated with pre-ICH cognitive 
impairment. Cordonner et al (2010) also found increasing severity of leukoariosis (white 
matter hyperintensities on MRI) to be associated with pre-existing dementia, but only in 
patients with deep ICH.  
In line with previous findings, increasing age (Cordonnier et al 2010) and haemorrhage 
volume (Liable 2017) were also associated with an increased likelihood of patients having 
cognitive decline prior to their ICH. 
 
 Incidence of new-onset cognitive decline at 6 months 
Cognitive impairment is frequent after ICH with 43% of LINCHPIN COG participants scoring 
<26 on the MOCA at 6 months. This is significantly higher than the general population. Recent 
clinical and population-based samples suggest a mild cognitive impairment prevalence of 10-
20% for adults aged 65 years and over (median age of LINCHPIN COG was 72 years), although 
lack of standardised diagnostic criteria and differences in sample characteristics across 
studies have led to significant uncertainty around these estimates (Petersen 2011; Langa and 
Levine 2015).  
In a study of 44 survivors of ICH, Tvieten et al (2014) found cognitive impairment to be a 
frequent finding after ICH, with 61% of patients scoring <24 on the MoCA and as much as 
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71% of patients scoring <26. Another study including 78 survivors of ICH reported cognitive 
impairment without dementia in 77% of patients (Garcia et al, 2013). In this study, cognitive 
impairment without dementia was diagnosed when participants showed a significant 
impairment in one cognitive domain (according to a comprehensive clinical and 
neuropsychological assessment) without significant impairment in activities of daily living.  
Although these studies found a higher frequency of cognitive impairment during follow-up 
than in LINCHPIN COG, data on pre-ICH cognition was not available, potentially leading to 
bias in the reported incidence.  
More recently, a prospective study was conducted to determine the prognostic factors for 
cognitive decline in ICH patients (Benedictus et al, 2015). In this study, of the 167 consecutive 
ICH survivors without pre-existing dementia, 62 patients (37%) showed cognitive decline 
during follow-up. The slightly lower incidence of new-onset cognitive decline compared to 
LINCHPIN COG may be explained by the use of the MMSE. The MMSE is a rather crude 
measure of cognition and may lack sensitivity to vascular cognitive impairment, potentially 
leading to an underestimation of cognitive decline.  
 
 Incidence of new-onset cognitive impairment and dementia within 1-5 years 
During the first 5 years of follow-up of LATCH COG, of the 168 patients who survived longer 
than 30-days after their ICH, 47 patients developed new-onset cognitive decline (cognitive 
impairment and dementia). Cumulative survival rates for patients remaining free of cognitive 
decline were 82% in the first year and reached 65% at 5 years. During the first 5 years of 
follow-up, 22 patients developed new-onset dementia. Cumulative survival rates for patients 
remaining free of dementia were 95% in the first year and reached 84% at 5 years. Dementia 
diagnosis were about two-fold compared with the general population where current 
estimates in the UK suggest that the total age-standardised prevalence of dementia for those 
over 65 years is 7.1% (Prince et al, 2014). 
My findings extend those of a recent nationwide population-based cohort of stroke survivors 
where 10-year absolute risk of dementia (based on data collected in medical databases) after 
ICH was 8.89% and 30-year risk was 13.3% (Corraini et al 2017). Compared with the general 
population in Denmark (comparison cohort matched to stroke patients by age and sex), the 
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hazard ratio for dementia among ICH survivors was 2.70 (Corraini et al 2017). Haemorrhagic 
stroke survivors were found to have higher relative risks of dementia than ischaemic stroke 
survivors- unadjusted hazard ratios were 1.72 after ischaemic stroke and 2.70 after ICH. In 
this study, ICH survivors were younger than ischaemic stroke survivors, with younger patients 
also facing higher risks of poststroke dementia than older patients.  Given the higher societal 
burden of early-onset dementia, younger survivors of ICH therefore represent an important 
target for planning dementia prevention strategies in the future. 
In the LATCH COG cohort, it is important to note that cognitive impairment and dementia 
were classified based on medical records alone. In a recent study of 738 patients who had 
experienced ICH, the modified Telephone Interview for Cognitive Status test determined that 
19% of patients developed dementia within 6 months (Biffi et al, 2016). A total of 435 
patients without dementia at 6 months were then followed up longitudinally (median follow-
up 4 years), with an estimated yearly incidence of dementia of 5.8%, corresponding to 32% 
of patients being diagnosed during follow-up. This number is significantly higher than the 
incidence seen in LATCH COG, suggesting that the prevalence of cognitive impairment and 
dementia after ICH may be higher than that demonstrated for my cohort (see further 
discussion of accuracy of GP records in section 12.1.6). Despite this, adequate 
communication of the risk of cognitive decline, especially beyond the immediate period after 
ICH, is essential if we are to prepare patients, their family members and caregivers for the 
potential long-term effects of ICH.      
 
 Factors associated with new-onset cognitive impairment and dementia 
In univariate analysis of LATCH COG, modified Rankin score >2 was associated with new-
onset dementia 1-5 years after ICH. This first finding adds to those of Garcia et al (2013) who 
determined that Rankin score >1 at discharge, haemorrhage volume and discharge to a 
nursing home were all associated with long-term dementia (median time since ICH 40 
months), suggesting that the severity of the acute ICH predicts future cognitive outcome. 
However, presence of posterior white matter lucencies (hypodensities on CT) was also 
associated with new-onset dementia in univariate analysis of LATCH COG, indicating an 
association between markers of small vessel disease and risk of developing new-onset 
dementia. In a study of 50 ICH survivors (median time since ICH 3.8 years), cognitive 
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impairment- as defined by a MoCA score of <24- was associated with leukoariosis score 
(presence of posterior and anterior white matter lucencies) in univariate analysis (Tveiten et 
al, 2014). In a more recent study of the risk factors associated with early vs delayed dementia 
after intracerebral haemorrhage, CT-defined white matter hypodensity was associated with 
delayed (onset after 6 months) post-ICH dementia (Biffi et al 2016). The authors could not 
exclude the possibility that pathological processes of Alzheimer’s disease had played a role 
in the observed findings. Certainly, SVD related markers- such as white matter abnormalities- 
have been previously observed in patients with Alzheimer’s disease (Brickman 2013).   
In line with my findings for pre-existing cognitive decline, in Cox regression analysis of LATCH 
COG, patients who had a lobar ICH were twice as likely to exhibit new-onset cognitive decline 
than those who had a non-lobar ICH.  In those who survived past 30 days, the incidence of 
new-onset cognitive decline was 37% in patients with lobar ICH and 20% in patients with non-
lobar ICH. The most immediate assumption is that an underlying cerebral amyloid angiopathy 
is contributing to the risk of cognitive decline after ICH (Tvieten et al 2014; Moulin et al 2016). 
CAA has been shown to be associated with both cognitive impairment and lobar ICH 
(Banjeree et al, 2018). CAA is a common small vessel disease of the brain, characterised by 
the deposition of amyloid b protein in the walls of small to medium sized arteries. Population-
based autopsy studies have indicated CAA in 20-40% of non-demented patients, 50-60% of 
demented elderly patients, and more than 90% of patients with Alzheimer’s disease 
(Charidimou, Gang and Werring 2012). Moreover, cerebral amyloid angiopathy is not 
thought to extensively contribute to vascular dementia, suggesting that an Alzheimer’s 
disease degenerative process could be associated with lobar ICH (Thal, Grinberg and Attems 
2012; Moulin et al, 2016). However, it is also worth noting that lobar ICH is more likely to 
affect cortical functions than non-lobar ICH, which might consequently affect cognition. The 
only factor associated with new-onset dementia in Cox regression analysis of LATCH COG was 
increasing age (Tvieten et al 2014; Moulin et al 2016).  
In the LINCHPIN COG cohort, new-onset cognitive impairment at 6 months was associated 
with pre-ICH history of hypertension (p .001). Although hypertension is common in both 
patients with and without poststroke cognitive decline, all participants with new-onset 
cognitive impairment in my study suffered from pre-ICH hypertension. This implies an 
important role of vascular processes on the pathophysiology of post-ICH cognitive decline. 
This would coincide with the findings of numerous studies that have demonstrated that 
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hypertension increases the risk for cognitive impairment, vascular dementia and Alzheimer’s 
disease (Aronow 2017). Cerebral blood vessels are the main target of the effects of 
hypertension on the brain. The resulting structural and functional cerebrovascular 
alterations underlie many of the neuropathological abnormalities responsible for the 
cognitive deficits, including white matter damage and brain atrophy (Pantoni 2010). Although 
my findings would support the reduction of cognitive impairment by antihypertensive drug 
therapy, the link between hypertension, its treatment and cognition remain poorly 
understood (Iadecola at el, 2016).   
 
 Accuracy of GP medical records for identifying cognitive impairment and 
dementia 
In the LATCH cohort, pre-existing and new-onset cognitive impairment and dementia were 
classified based on medical records alone however, an IQCODE was available for 132 of these 
patients. The IQCODE formed part of the clinical assessment in LINCHPIN, and therefore its 
use is limited to those who gave written informed consent. This number is further limited by 
the substantial number of participants who either died soon after admission, when it was not 
appropriate to approach a close relative for completion of a questionnaire.  When the 
IQCODE was compared to medical records for the detection of pre-existing cognitive 
impairment or dementia, screening of medical records alone did not detect 10 cases of 
dementia (although 6 were recorded as having cognitive impairment) and 27 cases of 
cognitive impairment, which is in keeping with reported under-recording of dementia 
diagnosis in primary care (Iliffe et al, 2009). Although I tried to correct for this by hand 
searching of the entire GP consultation record including individual consultation records and 
all hospital clinic and discharge letters to look for evidence of cognitive impairment satisfying 
the DSM-IV criteria for dementia, the prevalence of cognitive impairment and dementia may 
still be higher than that demonstrated for this cohort.   
Half of the patients with pre-existing dementia had been previously diagnosed by their GP, 
which is in line with findings from Iliffe et al (2009) and Connolly et al (2011). In their narrative 
review, Iliffe et al (2009) state that dementia is probably underdiagnosed and under treated 
with an estimated 50% of primary care patients over the age of 65 not diagnosed by their GP. 
Similarly, Connolly et al (2011) found that the prevalence of dementia amongst patients 65 
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years and over identified using GP dementia registers was less than half that expected based 
on epidemiological data. Underdiagnosis of dementia occurred across all regions involved in 
the study (six Primary Care Trusts across Greater Manchester; 351 GPs; 1.8 million patients), 
suggesting that it is probably happening elsewhere in the UK.   
Previous research has shown that dementia diagnosis may be missed by carers, patients and 
professionals because symptoms and loss of daily living skills are often misconstrued as part 
of the normal aging process (Iliffe 1997). It might also be the case that new-onset dementia 
in my study population was misconstrued as a normal consequence of the stroke. This study 
adds to existing evidence of the current and ongoing underdiagnosis of dementia in primary 
care. Given that almost two-thirds of adults with ICH are aged 75 years or older, its incidence 
is likely to become more prevalent in our aging population. Further research should therefore 
focus on understanding the factors that lead to underdiagnosis to ensure that the gap 
between those who are diagnosed and those who are missed does not get wider. Otherwise, 
with the growing elderly population, increasing numbers of patients will be denied access to 
potentially beneficial treatment and support.  
Regarding pre-existing cognitive impairment with no dementia, the results are also 
worrisome. Although frequent (one ICH patient out of three with an available IQCODE had 
cognitive impairment with no dementia), only a few patients could be identified with having 
cognitive impairment in their medical records. Of those patients with an IQCODE score 
indicative of cognitive decline (37 patients), 27 were recorded as having no history of 
cognitive decline in baseline characteristics, 6 as having cognitive impairment (no dementia) 
and 4 as having dementia. These patients are at high risk of developing poststroke dementia 
therefore clinicians might need to pay close attention to cognitive status in patients with 
intracerebral haemorrhage (Henon et al 2001).   
 
 Correlation of cognitive impairment with assessments of functional outcomes 
I could not detect statistically significant associations between new-onset cognitive 
impairment and any of the measures of functional outcome at 6 months. The small sample 
size may have been a significant contributory factor, making it difficult to identify any 
statistically significant differences between those with and without cognitive impairment.  
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EQ-5D is an instrument for measuring HRQOL across five different domains: Mobilty; Self-
care; usual activities; Pain/discomfort; Anxiety/depression. From the results in the five 
dimensions, an index value was derived. At 6 months after the ICH (in those without pre-
existing cognitive decline), mean VAS was 77 and the mean utility score was 0.68. No 
participants had a utility score <0 (HRQOL worse than death); 3% a utility score <0.2; 20% a 
utility score <0.5; and 60% a utility score <0.8 (average score in general population of UK). 
On the other end of the scale, 9% had a utility score of 1 (perfect HRQOL).  
Although ICH patients were more likely to report problems in each of the five domains on the 
EQ-5D than the general population, the EQ-5D utility score was only slightly lower than 
population norms for the UK (for ages 75 and above). It is also worth noting that while 49% 
of ICH patients reported having problems with anxiety/depression in the EQ-5D, PHQ-9 
scores were below the cut-off for depression, with only 17% of participants reporting 
problems with mood and going beyond the initial screening questions. These findings suggest 
that problems with health-related quality of life and functional outcome questionnaires go 
beyond that of not being able to obtain statistical significance and may also have something 
to do with the inadequacy of the tools that were selected for the assessment of these 
outcomes (further discussion provided in section 11.1.8).  
To date, only two studies have assessed HRQOL after ICH and its clinical predictors 
(Chrsitensen, Mayar and Ferran 2009; Delcourt et al, 2017).  Analysis from the Factor Seven 
for Acute Haemorrhagic Stroke Treatment (FAST) trial showed that low overall HRQOL- as 
measured by the EQ-5D utility score in 621 patients at 90 days after their ICH- was associated 
with age, clinical factors (stroke severity, systolic blood pressure (BP) and neurological 
deterioration) and imaging features (larger and deep ICH). However, individual HRQOL 
dimensions within the EQ-5D were not reported. At 3 months after the ICH, mean VAS score 
was 62.2 and the mean utility score was 0.62. Although the EQ-5D scores are lower than that 
reported in LINCHPIN COG, participants were significantly younger (mean age 64 years). 
The INTERACT study aimed to determine baseline factors associated with HRQOL in 2756 
patients using the EQ-5D at 90 days, completed by patients or proxy responders. Like the 
findings of LINCHPIN COG, median utility score was 0.7. The distribution of EQ-5D utility 
scores was left skewed, with 1251 patients having a utility score equal or lower than the 
median (≤0.7), and 1505 patients with a utility score higher than the median (>0.7). Higher 
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NIHSS score (≥14), larger ICH and use of proxy responders were associated with problems in 
all five dimensions of the EQ-5D. Neither of the studies recorded participant’s cognitive 
status, therefore no previous data exists on the associations between cognitive impairment 
and HRQOL after ICH.     
 
 Measuring HRQOL 
As discussed in Chapter 1, there is no universally accepted definition for the term HRQOL. 
However, there is a substantial body of literature devoted to discussing and identifying 
important domains to be included. The theoretical framework of HRQOL was essentially 
developed to give a multidimensional perspective of health as a combination of physical, 
psychological and social functioning. These domains have since formed the basis for the 
development of psychometric tools to measure health-related aspects of an individual’s 
quality of life. Tools are generally developed to be either disease specific or generic measures 
of HRQOL, where data are typically collected using checklists or scaling devices.  Although 
the use of such questionnaires has potential benefits- including richer information about 
patients and an improved awareness of the personal and social consequences of illness- they 
may not produce results that are meaningful (for example, what does a utility score of 0.6 
really mean?) (Fitzpatrick 1999). Carr and Higginson (2001) point out that simply listing 
quality of life domains is not a satisfactory way of measuring quality of life as it is not known 
whether all the important domains have been covered. The challenge of measuring quality 
of life lies in its uniqueness to individuals. They suggest that many of the existing measure of 
health-related quality of life fail to take this into account, imposing standardised models of 
quality of life and pre-selected domains, thus measuring general health status rather than 
health-related quality of life.  
Although an impressive body of work has been developed around HRQOL and recovery 
following stroke using (almost exclusively) standardised HRQOL questionnaires, serious 
concerns have been raised about the extent to which these measures reflect the experiences 
and perspectives of patients. As stated by Dowswell et al (2000): 
 “Lives encompass more than physical function; they are a complicated 
mesh of roles, relationships, activities and perceptions.” (p. 514).  
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Improvements that are measured through instruments such as the EQ-5D may therefore not 
be regarded as significant by the stroke patients themselves. The most frequent criticism of 
the EQ-5D is its lack of responsiveness to change (likely due to a ceiling effect), however this 
was addressed with the restructuring of the EQ-5D to include five levels of severity (prior to 
this there had only been three) (Wu et al, 2002). Although the EQ-5D would appear to provide 
rather crude insights into HRQOL and its recovery among survivors of critical illness, it 
remains one of the most widely used measures within health research and has been 
administered and validated for use among a diverse range of patient populations, including 
stroke (Golicki et al, 2015) and dementia (Hounsome, Orrell and Edwards 2011). 
Health-related quality of life data can provide important information concerning the impact 
of chronic illness on the lives of individuals. A great deal of research has been conducted 
using a qualitative approach to assess the quality of life of stroke survivors. Prevalent 
criticisms of a qualitative approach include its “impressionistic” and “unscientific” nature 
(Bryman 1984, p79) and the specificity of findings to the individuals or settings involved (i.e. 
limited generalisability). As such, researchers in the field of quality of life research are now 
suggesting that a combination of questionnaires and interviews may be a more appropriate 
way of exploring the health-related quality of life of patients (Clarke 2009). Although there is 
limited guidance available on the use of a mixed methods approach to HRQOL, a primary 
concern in this research is that of merging analyses of quantitative and qualitative data to 
provide an integrated analysis (Bryman 2007). Certainly, guidance on how to present mixed 
methods findings in such a way that the quantitative and qualitative findings are genuinely 
integrated is lacking among the literature in this field. This thesis therefore provides an 
opportunity for the researcher to contribute to the methodological debate on the usefulness 
of these measures (and their combination) in assessing the health-related quality of life of 
patients.  
When considered at group level, the numerical data produced by the functional outcome 
questionnaires could easily give the impression that cognitive impairment after ICH had a 
negligible impact on patients’ quality of life. The data also seems to suggest that cognition 
neither improved nor got worse over the stroke trajectory (6-24 months). Means such as 
these that stay the same can easily mask decreases at an individual level. Contrary to the 
quantitative data, interview data quite clearly demonstrated the devastating effects that 
stroke due to haemorrhage can have on the lives of survivors and their families. Although the 
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small sample size would have made it difficult to identify any statistically significant 
differences between those with and without cognitive impairment, it seems as if the problem 
with quality of life questionnaires goes beyond that of not being able to obtain statistical 
significance.  
While the scores on the functional outcome assessments indicated a particular trend, on 
their own they were relatively meaningless, requiring further descriptive information in order 
to interpret and explain them. Because of this problem, the tools alone appear to offer little 
understanding of the impact of stroke due to haemorrhage on the quality of patients’ lives 
in this study. One potential reason for the mismatch of scores against the interview data 
could be that the questionnaires asked participants to rate how they have been feeling over 
the last week/two weeks (dependent on scale), whereas the interviews allowed for a much 
broader coverage, going back to stroke onset. Another reason could be that the 
questionnaires were answered prior to the interviews; ratings may have been more accurate 
after an exploration of the issues. Interview material also indicated that for these 
participants, quality of life was a much broader concept than the criteria expressed in the 
generic functional outcome questionnaires. In effect, the use of the in-depth interviews 
allowed a greater exploration of experiences, in a more comprehensive way than would have 
been possible relying on HRQOL and functional outcome questionnaires alone.  
 
 Life after stroke- biographical disruption 
Some authors have suggested that the experience of stroke represents a continuity with 
patient’s previous lives, where individuals are resilient in finding ways to maintain valued life 
activities (Atchley 1989; Pound, Gompertz and Ebrahim 1998). However, for the sample in 
this study, experiences were predominantly negative, where the stroke represented a clear 
discontinuity with a previous way of life. In this way, the stroke can be seen to represent a 
major biographical disruption in the lives of patients and family members. The reporting of 
findings will therefore draw on biographically informed approaches to understanding chronic 
illness, particularly the work of Bury (1982) and Charmaz (1995), to explore the extent to 
which participants within the first two years following diagnosis experience stroke due to 




The notion of illness as biographical disruption is attributed to Michael Bury (1982) and 
represents a significant turning point in our understanding and conceptualisation of 
experiences of chronic illness. In his classic paper, Bury (1982) reported on his work with 
newly diagnosed rheumatoid arthritis sufferers. For this study, participants were selected to 
allow the impact of the emerging illness to be explored. Bury criticised the assumption 
underlying the Parsonian concept of the sick role which viewed illness/disablement as a 
relatively stable condition. Bury’s approach argued that a person with a chronic illness has a 
more fluid trajectory, which includes periods of adaptation and other periods where 
symptoms were more pervasive (for example, after a surgical episode or sudden 
exacerbation of symptoms). The concept of biographical disruption therefore acts as both a 
descriptor of people’s experiences as well as an explanatory device to comprehend how 
people respond and adapt to chronic illness. Although biographical disruption is a multi-
faceted process, Bury (1982) reveals three sequential aspects of disruption (see Figure 25; 
reproduced from Ramsay 2010): 
• The disruption of taken-for granted assumptions about our bodies, selves and the social 
world in which we live. 
• Profound disruptions in the explanatory systems normally used by people, such that a 
fundamental re-thinking of the person’s biography and concept of self is involved. 
• The response to disruption involving the mobilisation of resources. 





Disruption to ‘common sense boundaries’ refers to an event (such as chronic illness) that 
brings to the fore a: 
 “recognition of pain and suffering, possibly even death, which are 
normally only seen as distant possibilities or the plight of others” (Bury 
1982, p.169) 
The emergence of chronic illness elicits both a raised awareness of one’s previously ‘invisible’ 
and normally functioning body and disrupts the sense of unity between body, self and one’s 
identity (Charmaz 1995). Like Bury, Charmaz (1995) suggests that chronic illness compels 
people to have an awareness of death. She emphasises how this disrupts their identity, 
particularly if the individual defines themselves as healthy and had no previous experience 
of illness.  
The second disruption to pre-illness ‘explanatory systems’ relates to the ways in which 
individuals have to re-consider their own concept of self and identity. This stage tends to 
raise questions of a ‘why me, why now?’ nature in relation to causality. Importantly, Bury’s 
respondents were ultimately confronted by the limitations of a scientific explanation and 
medical intervention, most notably in terms of how to live with their debilitating illness. 
Among Bury’s younger respondents, uncertainty in relation to the aetiology and legitimacy 
of symptoms was often compounded by the common cultural paradigm of arthritis as a 
disease associated with the ageing process. On the other hand, those respondents who were 
invariably older attributed the disease process to ‘normal wear and tear’.  
The third stage- ‘mobilisation of resources’, relates to the adaptive response of the individual 
to the disruption, in light of their differing circumstances. The response to disruption 
comprises the mobilisation of resources- physical, social, financial, medical etc- available to 
the individuals and their family. Bury’s (1982) work is largely descriptive here and somewhat 





Biographical disruption, in summary, constitutes: 
“…a useful concept, shedding important sociological light on the nature of 
chronic disabling illness and the coping processes, practical strategies and 
symbolic styles of adjustment it calls forth.” (Williams 2000, p.49)  
Bury developed his theory further by identifying two distinct types of meaning; the practical 
consequences for the individuals (in terms of the impact and management of the symptoms 
on everyday life) and the symbolic significance (different conditions carry with them different 
connotations and imagery) attributed to the illness by the individual (Bury, 1991).  Bury also 
differentiated between three aspects of adaption that individuals can draw upon to manage 
their level of disruption. ‘‘Coping’ refers to the methods the ill person uses to manage his or 
her situation emotionally. ‘Strategy’ refers to the way in which the ill person tries, through 
his or her actions, to deal with illness. ‘Style’ reflects how different people have different 
attitudes towards illness’’ (Hubbard and Forbat, 2012, p2034).  
Importance of context: 
In recent years, other researchers have extended Bury’s analysis or critically developed work 
in a similar vein. In arguably the most authoritative critique of Bury’s construct, Williams 
(2000) argues that: 
“Biographical disruption cannot simply be assumed or “read off” as a 
standard response, with similar effects, to a similar event, illness-related or 
otherwise” (Williams; 2000: 54).  
Put simply, the experience of illness as biographically disruptive differs depending on the 
context; where the disruptive effects of illness may be mediated by the timing and normality 
of various illnesses (Williams, 2000).   
The importance of age and stage in the life-course at which a person becomes unwell has 
been a central theme within much of the work that sought to revisit Bury’s (1982) concept of 
biographical disruption. The participants in Bury’s original project were relatively young, 
recently diagnosed rheumatoid arthritis sufferers. Bury (1982) pointed to the age of his 
participants and the stereotype of rheumatoid arthritis as being a disease of the older 
generation in order to present one explanation for why they experienced the onset of the 
225 
 
disease as being so disruptive. In applying the concept to different populations of varying 
ages, research has demonstrated discrete differences to Bury’s original work (Pound, 
Gompertz and Ebrahim 1998; Sanders, Donovan and Dieppe 2002). In a sample of 
predominantly elderly stroke patients (from a predominantly lower socioeconomic 
background), all respondents described the considerable ways in which the stroke had 
impacted on their lives. However, the majority of those interviewed viewed the stroke as a 
normal part of their biographical trajectory- or a ‘normal crisis’ in their ‘hard-earned lives’- 
and played down its significance (Pound, Gompertz and Ebrahim 1998). A similar observation 
was made by Sanders, Donovan and Dieppe’s (2002) elderly respondents who perceived the 
highly disruptive effects of osteoarthritis on their daily lives as a ‘normal’, and a biographically 
anticipated aspect of the ageing process. In this study, the rate of disease deterioration was 
found to impact on the level of biographical disruption experienced (Sanders, Donovan and 
Dieppe 2002).  
Additionally, the presence of co-morbidities has been shown to reduce the amount of 
disruption experienced by individuals as they are likely to be accustomed to the illness role 
and thus already lead restricted lives (Pound, Gompertz and Ebrahim 1998). Carricaburu and 
Pierret (1995) make a similar observation in their exploration of the experience of illness of 
asymptomatic HIV positive men who were infected either through medical treatment for 
haemophilia or same sex relations. While those infected because of same sex relations 
tended to experience HIV as biographically disruptive, many of the haemophiliacs had 
already organised their lives and biographies around an illness trajectory and were used to 
living their lives in the face of uncertainty. As such, an HIV diagnosis served as what 
Carricaburu and Pierret (1995) coined ‘biographical reinforcement’. We cannot assume that 
all chronic illness is experienced as a ‘shattering’ of our taken-for-granted assumptions about 
our bodies and selves. In doing so: 
“we fail to account for a range of other possibilities in which illness may 
already be a central part of one’s biography” (Williams 2000, p. 60). 
It is clear from the literature that the type of illness can also affect the level of biographical 
disruption experienced by patients. For example, those diagnosed with conditions perceived 
to have elements of stigma attached to them (e.g. epilepsy) appear to experience greater 
biographical disruption (Scrambler 2009). Alternatively, conditions such as arthritis which are 
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perceived as a natural progression of ageing, are more likely to be attributed to a ‘normal’ 
biographical trajectory (Sanders, Donovan and Dieppe 2002). Whether a chronic illness is 
suffered as a biographical disruption therefore depends on multiple context-dependent 
contingencies. As stated by Pound, Gompertz and Ebrahim (1998), the key issue highlighted 
in these papers is:  
“the importance of contextualising illness, both within the life of the 
individual and the collective to which they belong” (p.491).  
 
 Effect of stroke on sense of self and identity 
Numerous sociological studies have illustrated the impact that chronic illness can have on 
someone’s sense of self and identity (Charmaz 1983). Self can be seen as the product of a 
person’s own attributes (goals, aspirations, experiences, interests, behaviours etc). It is 
separate from identity, which relates to how an individual defines, locates, and differentiates 
the self from others. Identity implicitly takes into account the ways people wish to define 
themselves (Charmaz 1995). According to Charmaz (1983), ‘loss of self’ is experienced by 
people with chronic illness because their former lives and selves are precluded by illness. 
Drawing upon her experience of working with people with a variety of chronic illnesses and 
who were severely disabled or housebound, Charmaz (1983) developed the concept of ‘loss 
of self’ to describe the participants experience of: 
 “former self-images crumbling away without a simultaneous 
development of equally valued new ones” (p168) 
In several of the interviews, participants perceived that they were no longer the person that 
they were before the stroke, suggesting that a disruption to their sense of self had occurred. 
This was often due to changes in their physical and cognitive dispositions. Physical and 
cognitive disability as a result of stroke can be problematic for an individual’s sense of self 
and identity if they limit the person’s ability to return to activities that were integral to their 
prestroke lives.   
Compared to older persons, young people (below retirement age) who have a stroke are 
more likely to survive their initial illness and live for many years with functional or cognitive 
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deficits that impact their daily living (Varona et al, 2004). Adults who are in the midst of 
working and raising children may experience a particularly profound diversion from their 
anticipated life trajectory. In a literature review of qualitative studies exploring the 
experience of stroke from the perspective of younger adults (18-65 years old), Lawrence 
(2010) unearthed three main themes: disorientation; a disrupted sense of self; and altered 
roles and responsibilities. Many of the effects of stroke (such as cognitive impairment) are 
‘invisible’ but have significant impacts on relationships and social participation, including the 
ability to return to work and to enjoy an active social life. Lawrence’s findings lend support 
to Bury’s (1982) work which found that diagnosis of a chronic illness at a young age left 
individuals feeling shocked and confused. Stroke at a young age marks a significant 
divergence from the life trajectory that individuals perceived themselves to be on prior to 
their diagnosis. Although the shock of diagnosis and symptoms can be hard at any age, 
research by Pound, Gompertz and Abrahim (1998) suggests that older age can sometimes 
serve as a buffer, as chronic illness may be expected as a normal part of the aging trajectory. 
Lawrence (2010) also found that altered roles and relationships emerged when individuals 
felt that they were a burden to others. Similarly, Charmaz (1983) found that following chronic 
illness, people tended to lead a more restricted life, became socially isolated and felt that 
they were a burden to others.     
The notion of ‘burden’ was commonly found within the transcripts analysed. As well as 
reporting the burden of illness upon themselves, participants often felt as if they were 
becoming a burden to friends and family as a result of their condition. Participants frequently 
reported not wanting to worry or concern family members about their health. In my study, 
burden was particularly marked within participants’ relationships with their family (spouse 
and children) and was most significant amongst women.  Burden is a theme commonly found 
within the literature on terminal and chronic illnesses (Cousineau et al, 2003; McPherson et 
al, 2007). Self-perceived burden in this way has been defined as: 
 “empathic concern engendered from the impact on others of one’s illness 
and care needs, resulting in guilt, distress, feelings of responsibility and 
diminished sense of self.” (McPherson et al, 2007 p. 425) 
 This definition has been chosen as it proposes a psychological construct not linked to 
dependence, as people could feel like they were a burden even when they were not 
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dependent on others. The feeling of being a burden had clear implications for participant’s 
social interactions, relationships, and mood.  
Several theoretical perspectives on stroke recovery have emerged over recent years. A key 
concept in much of this work has been centred around the idea of loss, whereby the lives of 
stroke patients and family members are turned upside down. Patients lose physical functions, 
social networks, activities, suffer cognitive decline and sometimes lose their sense of self and 
identity. Individuals can combat biographical disruption by either adapting to the disrupted 
identity or accepting it and establishing a new identity in the process (Locock et al, 2009). 
This echoes the work undertaken by Corbin and Strauss (1991) on the process of overcoming 
disability through comeback, which refers to returning to a satisfactory way of life, within the 
physical/mental limitations imposed by a disabling condition. 
 
 Adaption and adjustment 
Individual approaches to adaption and adjustment can minimise the effects of disability on 
the person’s sense of identity. Bury’s (1991) concept of coping is particularly relevant here 
as it refers to the ways in which individuals manage the level of disruption. It involves: 
 “maintaining a sense of value and meaning in life, in spite of symptoms and 
their effects” (Bury 1991 p. 461) 
Similarly, Williams (1984) uses the term ‘narrative reconstruction’ to describe how 
individuals with chronic illness establish a sense of order and meaning in their lives over time. 
Adapting implies that the individual acknowledges their impairments and alters their life and 
self in socially and personally acceptable ways (Charmaz 1995). While some survivors 
employed strategies to keep their pre-illness lifestyle intact by maintaining as many pre-
illness activities as possible (even in a modified way), others found ways to incorporate their 
illness into an altered lifestyle. Specific elements of adaption included other family members 
or friends taking on tasks for them, individuals learning to cope without being able to drive, 
or learning to do tasks and activities at a lower level or frequency. 
Both Bury (2001) and Charmaz (1995) describe some of the biographical work that individuals 
undertake to regain, restore and preserve a pre-illness sense of self. Bury (2001) emphasises 
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the importance of people trying to normalise their lives by keeping their pre-illness lifestyle 
and identity through the maintenance of pre-illness activities. However, the journey towards 
recovery often involved overcoming various perceived barriers. None of the participants in 
the study had been able to return to their paid employment following their stroke. For many, 
their job had given them a sense of value and meaning in life, both of which were now being 
threatened with the onset of chronic illness (Bury 1982). Although returning to work would 
have brought about a sense of normality, unfortunately for the participants in the study, 
there appeared to be a lack of genuine support and understanding in relation to employment. 
This reinforces Bury’s (1982) finding regarding the importance of ‘external resources’ to the 
ways in which illness and experience is lived out. This is also highlighted in Hart’s (2001) study 
of ‘system induced setbacks’ in stroke recovery. Hart (2001) emphasised the ways in which 
setbacks in stroke recovery can appear to be due to a problem with the patient (at least from 
a medical perspective), but in reality often result from a problem with the health and social 
care systems put in place in the aftermath of stroke.        
Access to supports and resources is essential for enabling stroke survivors to engage in 
adaptive strategies. As highlighted by Bury (1982), the onset of disease not only disrupts 
structures of meaning, but also relationships and practical affairs. Stroke can often lead to a 
growing dependency on the help of others, where the strength of the person’s social network 
(for example, how supportive family, friends and colleagues are willing to be) and their ability 
to mobilise physical resources become crucial to the ways in which the illness is subsequently 
experienced. In the interviews, participants spoke about the importance of health and social 
services, family members and peers for the provision of emotional and instrumental supports 
that assisted them in their everyday lives. Working-age stroke survivors suffered disruption 
to their identities and abilities in relation to age-appropriate roles, such as employment. For 
those younger survivors who were interviewed, recovery goals often related to raising 
children, re-arranging finances, employment and spousal relationships (Lawrence 2010; 
Morris 2011). From the interviews however, it became apparent that services in the 
community (including physical rehabilitation) were predominantly geared towards the older 
age group. Stroke survivors need to feel supported if they are to achieve their best possible, 




 Uncertainty  
The notion of uncertainty as a form of disruption is a common theme within research on the 
experience of chronic illness (Bury 1982). For many, uncertainty began at stroke onset. 
Within the interviews, the direct relationship between stroke, bodily sensation and 
communication is evident. As the individuals started to feel the effects of having a stroke, an 
internal dialogue often began between the body and self (Faircloth, Boylstein, Rittman and 
Gubrium 2005). For example, as symptoms started to appear (e.g. weak arm/leg, loss of 
speech) many of the participants knew in their mind that something wasn’t right but couldn’t 
quite figure out why their bodies were responding in such a way. The separation of mind and 
body that occurs during the stroke event is often continued into the stroke trajectory as 
participants start to question why their bodies can no longer function as they could before 
the stroke. There may be intrusive symptoms such as pain; there may be interruptions to 
usual physical and social routines; and there may be cognitive disorientation or confusion 
(Kelly and Field 1996). Having a serious chronic illness like stroke can therefore be seen to 
disrupt the taken-for-granted assumptions that individual’s make about possessing a 
smoothly functioning body. As pointed out by Charmaz (1995), this was particularly evident 
when individuals defined themselves as previously fit and healthy. 
A major issue which seems to have emerged from the study is the need to review the 
meaning and experience of the term ‘recovery’. The Oxford dictionary definition of the term 
‘recovery’ refers to ‘A return to a normal state of health, mind, or strength’. However, this is 
rarely possible when it comes to life after stroke. Patients and caregivers provided vivid 
descriptions of the recovery process. Recovery was often perceived in terms of personal 
factors and prestroke lives, with participants therefore having very individual and diverse 
measures of their recovery.  
Recovery across time following stroke involves transitions. Here, we define transition is a 
“passage from one life phase, condition or status to another” and is usually precipitated by a 
triggering event (Chick and Meleis 1986, p.239). Stroke is a triggering event with initial 
concerns centred around survival. Once the initial onset and impact of the stroke have 
occurred, individuals begin to face the longer-term implications of their altered 
circumstances (Bury 1991). As previously discussed, all participants experienced changes in 
their bodies, both soon before hospitalisation and after being diagnosed with the stroke. The 
changed body was directly related to many different aspects of the participant’s experience, 
231 
 
such as their relationships with others, their roles and identities, their jobs, their physical and 
functional limitations, and their ability to cope and manage with life after stroke. Thus, the 
experience of transition from hospital to home is greatly influenced by the bodily changes 
post stroke.  
The transition from hospital to home following a stroke is a critical period in the recovery 
trajectory. Survivors must learn how to manage their functional limitations within the context 
of their family and home (Rittman et al, 2004). Survivors often receive vague medical 
responses to concerns over the uncertainties of recovery. Uncertainty was therefore 
exacerbated by a perceived lack of information about prognosis and chronic illness 
management. While stroke survivors adapt to their illness over time, they continue to 
experience impairments and disruptions in their personal and work lives. To understand the 
meaning of recovery, the physician must understand what is important and valued by the 
person. Treatment strategies and poststroke education therefore need to address the 
concerns of the survivor within their social context. In addition, a holistic model of 
rehabilitation that helps individuals regain the capacity for everyday activities related to 
work, family life and leisure is needed if we are to help survivors restore wellness and work 
towards minimising the burden felt by family members.   
Bury (1991) argues that only the passage of time and trial and error provide the mechanism 
for re-establishing some form of certainty. Indeed, processes of adaption and adjustment are 
likely to become more successful over time. As such, examples of participants establishing 
some form of certainty and regaining control of their lives may be less visible in my study 
since the strokes had all occurred in the 2 years prior to interview. Frequent interviews 
collecting data from a larger sample of stroke survivors over repeated periods of time are 
therefore needed to explore the impact of time on uncertainty and notions of recovery.    
 Life after stroke for family members 
The sudden nature of stroke tends to place family members into the role of carer with little 
or no warning or preparation (Smith et al, 2003). Family members reported feeling 
abandoned by services but did not have the knowledge or skills to re-engage. A lack of 
continuity of care: including lack of active follow-up, limited and delayed access to 
community services, as well as inadequate information about stroke, recovery and 
healthcare services, left individuals and family members feeling frustrated and dissatisfied.  
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A need for information or skills training seemed to be a major issue for family members and 
has been consistently reported as an unmet need in previous studies (Brereton 2002; Cecil 
et al, 2010). There is a clear demand for the provision of timely and targeted information 
about stroke and available resources, as well as a need for regular follow-ups (either from 
primary care or hospital) from healthcare professionals.  
Caregivers and family members may benefit from understanding that as the stroke survivor 
manages the transition period from hospital to home, not only are the testing their functional 
capabilities, but their sense of self and identity is changing at the same time. Family members 
and caregivers need to support the stroke survivor as they attempt to regain participation in 
a meaningful role in the family (Rittman et al, 2004).  
 
 Clinical implications 
This study found a substantially higher rate of cognitive impairment in ICH patients than 
would be expected in an age‐matched general population. Cognitive impairment before ICH 
is common and is associated with imaging findings consistent with a contribution from 
cerebral amyloid angiopathy. For those without pre-existing dementia, more than 2 out of 
every 5 patients will exhibit new-onset cognitive decline at 6 months. My findings are of 
clinical relevance in the management of ICH survivors and will allow patients and family 
members to be adequately informed about the risk of cognitive decline.  
Stroke rehabilitation tends to be concentrated in the first 6 months following a stroke, but 
data from my research highlight that stroke recovery is a much longer process, characterised 
by periods of uncertainty. A survey conducted by the Stroke Association in the UK found that 
services are lacking after patients are discharged from hospital (Stroke Association 2012). 
Half of the individuals who were surveyed had only been assessed once after being 
discharged from hospital, with coordination of care falling to the family. There is a need to 
acknowledge that patients want and require a variety of services which must be finely 
tailored to meet their individual needs as they arise. Patients should be assessed 
systematically to determine their information deficits and agreed interventions should be put 
in place to meet these needs, at the appropriate time that it is required (Smith et al, 2003). 
Understanding the long-term impact of stroke and the strategies that individuals use to 
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restore their lives can help inform the design of person-centred approaches to care and 
rehabilitation, ultimately helping to restore a sense of wellness. 
This study also highlights the need for suitable interventions to support carers. Support for 
carers should focus on increasing understanding and management of the stroke. Nurses must 
address the needs of carers alongside the needs of stroke patients and provide appropriate 
support to family members involved in their care. The need for information on all aspects of 
stroke- diagnosis, prognosis, potential long-term outcomes and what to expect as a carer- 
stood out as a major concern, and one that clinicians and nurses must continue to address.  
To the researcher’s knowledge, this is the first study to explore patients’ and family members’ 
experiences of living with cognitive impairment following stroke due to haemorrhage. 
Experiencing a stroke and its aftermath can be devastating for patients and their families, 
and may be associated with severe physical, social and psychological consequences for 
patients. The emotional impact of stroke is unpredictable and requires ongoing attention 
throughout the years following the stroke. There is a need for ongoing psychosocial support 
for survivors and their families, including strategies to help individuals re-engage in their 
social networks. Greater efforts should be made to support people to return to paid 
employment, continue with daily household tasks and participate in social activities, if this is 
what they want to do. A holistic model of rehabilitation that helps individuals regain the 
capacity for everyday activities related to work, family life, and leisure, can begin to address 
the emotional ramifications of the stroke, restore quality of life and work towards minimising 
the burden felt by family members.  
It is also worth noting the age of interviewees. The qualitative interviews tended to explore 
the experiences of younger, higher functioning stroke survivors as they re-established their 
identity and attempted to return to their prestroke roles, responsibilities and activities. Many 
individuals identified themselves through their work and leisure activities and were at a loss 
when these activities were no longer possible. From the interviews, it was evident that the 
younger survivors of stroke valued age-appropriate, identity-affirming goals, such as 
resuming employment. Return-to-work rehabilitation pathways could play a much greater 
role in supporting survivors’ resumption of valued life roles (Wolfenden and Grace 2015). 
Some of the participants identified a need to belong among peers and individuals who 
understood the enormity and significance of their specific recovery challenges. Current 
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stroke support groups were not perceived as suitable for the needs of survivors in my sample. 
Stroke peer groups geared towards the specific needs of younger, higher functioning 
survivors on their recovery journey were identified as desirable, although not easily found.  
 
 Unanswered questions and directions for future research  
Cognitive impairment is common both before and after ICH and has serious implications for 
experiences of life after stroke. Further research should investigate the impact of cognitive 
rehabilitation strategies using a mixed-method design that could combine patient 
perspectives with quantitative data.  
There is a need for further mixed methods research into the experiences of younger, higher 
functioning stroke survivors. Interventions that assist people in navigating life changing 
circumstances and dealing with uncertainty might help maintain hope and should be tested 
with this population. Research is warranted on the impact of psychosocial interventions on 
recovery outcomes, unmet needs and experiences of anxiety and depression.  Complex 
interventions can be guided by the Medical Research Council Framework, which directs the 
development, implementation and assessment of health-improvement initiatives (MRC 
2000).  
Implicit to some of the findings of studies exploring biographical disruption as a concept is 
the notion that the impact of chronic conditions on sense of self and identity is not static. 
Sense of self and identity are expected to change over time as individuals grasp new 
understandings of their situations. These new understandings can occur as a result of 
reflection over time as well as changes in physical conditions, or domestic and social 
environments. Although these changes are implied in biographical disruption literature, they 
have not been explored using a longitudinal methodological approach. This apparent gap in 
the existing literature suggests the need to adopt an approach capable of exploring changes 
to people’s sense of self and identity over time, which may influence notions of recovery.  
Further research is also required into finding ways to best help stroke survivors and families 
come to terms with the long-term consequences of stroke (Pollock et al, 2012). There 
remains a lack of interventions that address psychosocial symptoms that may hinder social 
and workforce participation (Lyons, Rudd and Alvaro 2007). Those who experience stroke as 
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a threat to identity may particularly benefit from interventions that support them to do 
effective biographical work to support them to retain as much of their pre-illness identity 




This thesis has addressed explicit questions about the long-term effects of intracerebral 
haemorrhage from the points of view of patients and family members. While the cohort 
study used standard, quantitative measures to determine the incidence of cognitive decline, 
its risk factors and the associations of cognitive decline with functional outcomes after an 
intracerebral haemorrhage, the qualitative interviews uncovered the devastating affect that 
a stroke due to haemorrhage can have on the lives of survivors and their families. Risk of 
cognitive impairment with intracerebral haemorrhage is a major concern for patients and 
family members, with participants often indicating that they could no longer be the person 
that they were before the stroke. By using both quantitative and qualitative methods, this 
study sought to gain a more comprehensive understanding of the outcomes and experiences 
of people living with cognitive impairment and intracerebral haemorrhage. The results of this 
study show a complicated picture of the difficulties faced by patients and family members in 
the two years following a stroke due to haemorrhage. Accepted instruments for estimating 
recovery are not comprehensive enough. By combining methodologies, we can avoid a 
simplistic or over-generalised assessment of functional outcomes, allowing differing 
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Appendix 1: PRISMA checklist 




TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.   
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic review registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.   
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it 
could be repeated.  
 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 




Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether 
this was done at the study or outcome level), and how this information is to be used in any data 
synthesis.  
 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).   
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
 
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified.  
 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).   
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for 
each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.   
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).   
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see 




DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
 





Appendix 2:  STROBE checklist  
 




Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the 
abstract 
(b) Provide in the abstract an informative and balanced summary of what was 
done and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation being 
reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of 
recruitment, exposure, follow-up, and data collection 
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of 
selection of participants. Describe methods of follow-up 
Case-control study—Give the eligibility criteria, and the sources and methods of 
case ascertainment and control selection. Give the rationale for the choice of 
cases and controls 
Cross-sectional study—Give the eligibility criteria, and the sources and methods 
of selection of participants 
(b) Cohort study—For matched studies, give matching criteria and number of 
exposed and unexposed 
Case-control study—For matched studies, give matching criteria and the number 
of controls per case 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and 
effect modifiers. Give diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if 
there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, 
describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for 
confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 
(d) Cohort study—If applicable, explain how loss to follow-up was addressed 
Case-control study—If applicable, explain how matching of cases and controls 
was addressed 
Cross-sectional study—If applicable, describe analytical methods taking account 
of sampling strategy 
(e) Describe any sensitivity analyses 





Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, 
examined for eligibility, confirmed eligible, included in the study, completing follow-up, 
and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive 
data 
14* (a) Give characteristics of study participants (eg demographic, clinical, social) and 
information on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of interest 
(c) Cohort study—Summarise follow-up time (eg, average and total amount) 
Outcome data 15* Cohort study—Report numbers of outcome events or summary measures over time 
Case-control study—Report numbers in each exposure category, or summary measures of 
exposure 
Cross-sectional study—Report numbers of outcome events or summary measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their 
precision (eg, 95% confidence interval). Make clear which confounders were adjusted for 
and why they were included 
(b) Report category boundaries when continuous variables were categorized 
(c) If relevant, consider translating estimates of relative risk into absolute risk for a 
meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity 
analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or 
imprecision. Discuss both direction and magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, 
multiplicity of analyses, results from similar studies, and other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present study and, if 




Appendix 3: STROBE quality assessment scores for studies of intracerebral haemorrhage and cognitive decline 
Study 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Total 
Altieri et al, 2004 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 0 0 19 
Arauz et al, 2014 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 21 
Banjeree et al, 2018 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Barba et al, 2000 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 20 
Barba et al, 2001 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 20 
Bejot et al, 2011 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Benedictus et al, 2015 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Biffi et al, 2016 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Chaudhari et al, 2014 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 0 19 
Cordonnier et al, 2010 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
De Koning et al, 1998 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 21 
De Koning et al, 2005 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Douiri, Rudd and Wolfe, 2013 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 21 
Garcia et al, 2013 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 21 
Henon et al, 1997 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 21 
Henon et al, 2001 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Ihle-Hansen et al, 2011 1 1 1 1 1 1 1 1 0 1 0 0 1 1 1 1 1 1 1 1 0 1 18 
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Study 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Total 
Khedr et al, 2009  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 20 
Jacquin et al, 2014 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 20 
Klimkowitz et al, 2002 1 0 1 1 1 1 1 1 0 0 0 0 1 1 1 1 1 1 0 1 0 0 14 
Laible et al, 2017 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 21 
Lefebvre et al, 2005 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Madureira et al, 2001 1 1 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 1 1 1 1 1 20 
Moulin et al, 2016 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Nys et al, 2007 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Patel et al, 2002 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Planton et al, 2017b 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Qu et al, 2015 1 1 1 1 0 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 20 
Rost et al, 2008 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 21 
Smith et al, 2004 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 20 
Tang et al, 2004 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 
Tang et al, 2006 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 20 
Tveiten et al, 2014 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Viswanathan et al, 2008 1 1 1 1 1 1 1 1 0 0 1 1 0 1 1 1 1 1 1 1 0 1 18 
Zhang et al, 2012 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
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Appendix 4: STROBE quality assessment scores for studies of the influence of cognitive impairment on health-related 
quality of life after stroke 
Study 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Total 
Adamit et al, 2015  1 1 1 1 1 1 1 1 1 1 1 1 1` 1 1 1 1 1 1 1 1 1 22 
Alvarez-Sabin et al, 2016  1 1 1 0 1 1 1 0 1 0 1 1 0 1 1 1 1 1 1 1 0 0 16 
Ankolekar et al, 2014  1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 21 
Barker-Collo et al, 2010  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Boosman et al, 2017  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 21 
Bugge et al, 2001  0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 19 
Canuto et al, 2016  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 20 
Carod-Artal et al, 2009   0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 20 
Chahal et al, 2011  1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 21 
Chen-Min et al, 2015  0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 20 
Chou et al, 2015  0 1 1 1 1 0 1 1 1 0 1 1 0 1 1 1 1 1 0 1 0 0 15 
Clarke et al, 2002  0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 21 
Cumming et al, 2014  0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 21 
Dhamoon et al, 2010  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 20 
Dhamoon et al, 2014  1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 0 1 19 





1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Total 
Franceschini et al, 2010  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 20 
Gurcay et al, 2009  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 20 
Haacke et al, 2006  0 1 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 18 
Haug et al, 2010  0 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 0 17 
Hilari et al, 2010  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 21 
Hochstenbach et al, 2002   1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Howitt et al, 2011  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Huang et al, 2010  0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 
Huang et al, 2013  0 1 1 1 0 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 18 
Jeong et al, 2012  0 1 1 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 1 19 
Jonkman et al, 1998   0 1 0 1 0 0 1 1 1 0 1 0 0 0 1 1 1 1 1 1 0 1 13 
Jonsson et al, 2005  1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 20 
Karmel et al, 2010  1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 1 0 0 18 
Kauhanen et al, 2000  1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 20 
Kwa et al, 1996  0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 19 
Kwok et al, 2006  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Larson et al, 2003  0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 19 





1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Total 
Mayer et al, 2002  0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 21 
Meyer et al, 2010  0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 19 
Noble et al, 2008  1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 0 1 19 
Nys, G.M.S 2005  0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 20 
Park et al, 2013  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Passier et al, 2012  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 21 
Patel et al, 2007  1 1 1 1 1 1 0 0 1 1 0 1 1 1 1 1 1 1 1 1 0 0 17 
Peixoto et al, 2017  0 1 1 1 0 1 1 1 1 0 0 1 0 1 1 1 1 1 1 1 0 0 15 
Rachpukde et al, 2013  0 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 1 19 
Safaz et al, 2016  0 1 1 1 0 1 1 1 0 0 1 1 0 1 1 1 1 1 1 1 0 0 15 
Sarfo et al, 2017  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 21 
Scott et al, 2008  1 0 1 1 1 0 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 19 
Springer et al, 2009  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Takemasa et al, 2016  0 1 1 1 0 0 1 1 0 0 1 1 0 0 0 1 0 1 0 1 0 0 10 
Taufique et al, 2016  1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 20 
Van Wijk et al, 2007  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
Verhoeven et al, 2011a  1 1 1 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 1 1 1 0 19 





1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Total 
Vilkki et al, 2012  0 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 0 19 
Van Zandvoort et al, 2005  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 22 
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Appendix 6: Research & Development approval- LINCHPIN COG 
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Appendix 7: LINCHPIN COG consent form  
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Lothian study of INtraCerebral Haemorrhage 
Pathology, Imaging and Neurological 




Participant information sheet 
Thank you for taking part in the LINCHPIN study. We would now like to invite 
you to take part in an extension of LINCHPIN, called LINCHPIN COG. The aim 
of this sub-study is to look at how stroke due to bleeding into the brain 
(known as ‘brain haemorrhage’) affects mental abilities such as thinking, 
knowing and remembering.  
Joining LINCHPIN COG is entirely up to you. Before you decide we would 
like you to understand why this additional research is being done and 
what it would involve for you. Please feel free to talk to others about the 
sub-study study if you wish. 
Part 1 of the Participant Information Sheet tells you the purpose of the 
additional assessments and what will happen to you if you take part. 





What is the purpose of the sub-study? 
About 1 in every 5 strokes are caused by brain haemorrhage.  Around 
15,000 people in the UK will have a bleed like this every year and the 
effects can be very serious.  
LINCHPIN COG aims to assess what impact a brain haemorrhage has on 
your mental ability, health and daily life.  
Gaining a greater understanding of the impact of this type of stroke could 
help identify strategies to help with the long-term consequences of brain 
haemorrhage.   
 
Why have I been asked to take part? 
We are asking you to take part because you have had a brain haemorrhage 
and have already consented to all or part of LINCHPIN. We are giving you 
the opportunity to participate in this sub-study because it may help us to 
understand more about the impact that a brain haemorrhage can have on 
your health and life.  
 
 Do I have to take part? 
It is up to you. If you agree to take part, we will ask you to sign a consent 
form. You are free to withdraw at any time, without giving a reason. This 
will not affect the care you receive or your participation in LINCHPIN. 
 
What will happen to me if I take part? 
1. Clinical Assessment 
As part of this sub-study, we ask that you attend a 60 minute 
appointment with a member of our team. At the appointment, the 
researcher will work through a number of questionnaires. These 
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questionnaires will be used to assess your mental ability, physical 
function, mood and overall health and wellbeing.   
 
If you are attending the follow-up clinic at the Anne Rowling Centre as 
part of LINCHPIN, it may be possible to combine the two sessions in order 
to save you further trips. If it is more convenient, the researcher can 
come to your home at a time that is suitable for you. 
  
2. Checking how you get on in the future 
We would like to check how you are getting on at a follow-up 
appointment in six months. This can either be held at the Anne Rowling 
Clinic or the researcher can come to your home if this is more convenient.  
 
There may also be a further opportunity to speak with the researcher 
one-to-one about your experiences of having a stroke and how it has 
impacted upon your daily life.  
 
If the information in Part 1 has interested you and you are considering 
taking part, please read the additional information in Part 2 before 
making any decision. 
 
Part 2 
Will my taking part be kept confidential? 
Yes. Your identity is totally confidential and no identifying details will ever 





How will information about me be handled? 
LINCHPIN COG is run by a team from the Centre for Clinical Brain Sciences 
in Edinburgh.  The information is processed by this team, which includes 
medical, computing and administrative staff. All members have NHS 
contracts and a professional duty of confidentiality.  The information is 
held securely in a password protected database.  All identifying 
information is removed before the data are analysed.  We comply with 
the Data Protection Act, 1998. 
 
Will I get the results of the assessment? 
The researcher will be more than happy to give you feedback on the 
assessments that you complete.  
 
What are the potential disadvantages? 
Apart from the time taken in order to carry out the questionnaires, there 
are no disadvantages of this assessment.  
 
What happens when the research study stops? 
Information about you will be retained indefinitely.  
 
Will my GP be informed about my participation? 
Yes. Your GP will be informed of the results of the additional 
assessments.  
 
If I agree now, can I change my mind later? 
Yes. Do contact us if you need to discuss anything (see back page). 
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What if there is a problem? 
If you have a concern about any aspect of this study, you should speak to 
one of the research team who will do their best to answer your questions. 
If you remain unhappy and wish to complain formally, you can do this via 
the NHS Complaints Procedure, whose details can be obtained from the 
hospital. 
Can I find out the results of the research? 
We would be very happy to send you a yearly newsletter about the 
results of the research, if you wish.   The results of the sub-study will be 
submitted for publication in relevant professional journals and also made 
available in a format appropriate to the general public.  When the results 
are published, we will not include any individual information about you 
that would be identifiable.   
 
Who is funding this research? 
LINCHPIN COG is funded by The Stroke Association. 
 
Who has reviewed the study? 
The Scotland A Research Ethics Committee approved this study. 
 







Independent advice about this study is available from: 
Professor M Dennis, Chair of Stroke Medicine, Centre for Clinical Brain 
Sciences, The University of Edinburgh, The Chancellor’s Building, Little 
France, Edinburgh, EH16 4SB.  
Telephone: 0131 465 9602 Email: martin.dennis@ed.ac.uk 
 
If you would like further information please contact one of the research 
team: 
Katie McGoohan (LINCHPIN COG researcher) 
Prof. Rustam Al-Shahi Salman (chief investigator of LINCHPIN)  
















































































                





                      
 
 

























Appendix 11: Consolidated criteria for reporting qualitative studies 
(COREQ): 32-item checklist  
(Tong, Sainsbury and Craig 2007) 
No.  Item  
 
Guide questions/description Notes 
Domain 1: Research 
team and reflexivity  
  
Personal Characteristics    
1.Interviewer/facilitator Which author/s conducted the 
interview or focus group?  
KMcG 
 
2. Credentials What were the researcher’s 
credentials? E.g. PhD, MD  
Bachelor of Nursing (Hons) and 
Master of Nursing in Clinical 
Research 
3. Occupation What was their occupation at 
the time of the study?  
Postgraduate Nurse Researcher 




5. Experience and 
training 
What experience or training did 
the researcher have?  
Clinical and research experience 






Was a relationship established 
prior to study commencement?  
No relationship was established 
prior to commencement of 
LIICHPIN COG. However, prior to 
the qualitative interviews, 
participants would have met with 
the researcher on at least two 
previous occassions (clinic and MRI 
visits) 
7. Participant 
knowledge of the 
interviewer  
What did the participants know 
about the researcher? e.g. 
personal goals, reasons for 
doing the research  
Participants were informed that 
the research was to fulfill the 
requirements for a PhD in Nursing 
Studies and to further 
understanding of patient and 
family experiences of life after 
stroke due to haemorrhage. 
Participants were informed that 
their participation would not affect 





What characteristics were 
reported about the inter 
viewer/facilitator? e.g. Bias, 
assumptions, reasons and 
interests in the research topic  
The interviewer (KMcG) was a 
nurse and member of the 
LINCHPIN research team, but not a 
member of the participants’ direct 
clinical team. To reduce the risk of 
researcher bias, the interview 
schedule was created with the 
support of the researcher’s 
academic and clinical supervisors 
and the patient representative 
group. In addition, the researcher’s 
supervisor provided alternative 
viewpoints to the researchers 
throughout several phases of the 
thematic analysis 
Domain 2: Study 
design 
  
Theoretical framework    
9.Methodological 
orientation and Theory  
What methodological 
orientation was stated to 
underpin the study? e.g. 







Participant selection    
10. Sampling How were participants selected? 
e.g. purposive, convenience, 
consecutive, snowball 
Purposeful 
11. Method of 
approach 
How were participants 
approached? e.g. face-to-face, 
telephone, mail, email  
Face-to-face  
 
12. Sample size How many participants were in 
the study?  
6 patients and 4 family members 
13. Non-participation How many people refused to 




Setting   
14. Setting of data 
collection 
Where was the data collected? 
e.g. home, clinic, workplace  
Participants were given a choice 
between a clinic setting or their 
home for the interviews. All opted 
for their home 
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15. Presence of non-
participants 
Was anyone else present 
besides the participants and 
researchers?  
Four of the participants requested 
that their partners be present 
during the interview 
16. Description of 
sample 
What are the important 
characteristics of the sample? 
e.g. demographic data, date  
Participants are introduced in 
section 10.8 
Data collection    
17. Interview guide Were questions, prompts, 
guides provided by the authors? 
Was it pilot tested?  
Semi-structured interview schedule 
provided in Appendix 2, developed 
in collaboration with academic and 
clinical supervisors, as well as the 
patient representative group 
18. Repeat interviews Were repeat inter views carried 




Did the research use audio or 
visual recording to collect the 
data?  
Audio recorded using encrypted 
software 
20. Field notes Were field notes made during 
and/or after the inter view or 
focus group? 
Reflective notes made during and 
just after each interview 
21. Duration What was the duration of the 
inter views or focus group?  
Mean: 
Range: 
22. Data saturation Was data saturation discussed?  Recruitment was stopped when 
data sufficiency (rather than 
saturation) was achieved. 
23. Transcripts 
returned 
Were transcripts returned to 
participants for comment 
and/or correction?  
No 
 
Domain 3: analysis and 
findings  
  
Data analysis    
24. Number of data 
coders 
How many data coders coded 
the data?  
Only the main researcher coded 
the data (KMcG) 
25. Description of the 
coding tree 
Did authors provide a 
description of the coding tree?  
Not provided 
26. Derivation of 
themes 
Were themes identified in 
advance or derived from the 
data?  
 
Themes derived from data 
27. Software What software, if applicable, 




28. Participant checking Did participants provide 
feedback on the findings?  
Participants were not invited to 
provide feedback 
Reporting    
29. Quotations 
presented 
Were participant quotations 
presented to illustrate the 
themes/findings? Was each 
quotation identified? e.g. 
participant number  
Participant quotations presented 
to illustrate the findings and 
identified by participant 
pseudonym 
30. Data and findings 
consistent 
Was there consistency between 
the data presented and the 
findings?  
 Consultation with supervisor to 
help ensure consistency between 
the data presented and the 
findings 
31. Clarity of major 
themes 
Were major themes clearly 
presented in the findings?  
Major themes presented under 
four main headings 
32. Clarity of minor 
themes 
Is there a description of diverse 
cases or discussion of minor 
themes?       
Discussion of major and minor 















Appendix 12: Interview Schedule  
 
Why don’t you start by telling me about the day that you had the stroke? 
How did it feel to be told that you had had a stroke?  
What has life been like since your stroke? Has it changed in any way? 
Have you noticed any changes in your memory or thinking abilities? Has this changed over 
time? Better? Worse? 
Did you have trouble with memory or concentration before your stroke? If so, is this 
experience different than before the stroke? 
Have these problems affected your ability to work?  
Has it affected your relationship with your family and/or friends? 
What about your normal activities? Has this changed since the stroke? 
Have you had to change or adapt because of the memory problems? If so, how have you 
done that? How are you coping with the change? Are there specific things you do to help? 
How effective are they? 
Have you experienced any other symptoms from the stroke? Like fatigue, change in mood or 
personality, loss of functional ability etc? Are you still experiencing these symptoms? 
Have you had any access to services (i.e. physiotherapy, access to stroke clubs etc) since you 
got home? If so, what? 
Is there any support or services that you would have liked to have access to?  





Appendix 13: 15-Point Checklist of Criteria for Good Thematic Analysis 
Process  
(Braun and Clarke 2006) 
Transcription 1. The data have been transcribed to an appropriate level of 
detail, and the transcripts have been checked against the 
tapes for ‘accuracy’. 
Coding 2. Each data item has been given equal attention in the 
coding process. 
 3. Themes have not been generated from a few vivid 
examples (an anecdotal approach) but, instead, the coding 
process has been thorough, inclusive and comprehensive. 
 4. All relevant extracts for all each theme have been collated. 
 5. Themes have been checked against each other and back to 
the original data set. 
 6. Themes are internally coherent, consistent, and 
distinctive. 
Analysis 7. Data have been analysed rather than just paraphrased or 
described. 
 8. Analysis and data match each other – the extracts illustrate 
the analytic claims. 
 9. Analysis tells a convincing and well-organised story about 
the data and topic. 
 10. A good balance between analytic narrative and illustrative 
extracts is provided. 
Overall 11. Enough time has been allocated to complete all phases of 
the analysis adequately, without rushing a phase or giving 
it a once-over-lightly. 
Written report 12. The assumptions about thematic analysis are clearly 
explicated. 
 13. There is a good fit between what you claim you do, and 
what you show you have done – ie, described method and 
reported analysis are consistent. 
 14. The language and concepts used in the report are 
consistent with the epistemological position of the 
analysis. 
 15. The researcher is positioned as active in the research 
process; themes do not just ‘emerge’. 
 
